ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
ENSG00000198754	3-oxoacid CoA-transferase 2(OXCT2)	Homo sapiens			Lipid metabolism,	GO:0008152~metabolic process,GO:0046952~ketone body catabolic process,	GO:0005739~mitochondrion,GO:0031514~motile cilium,	GO:0008260~3-oxoacid CoA-transferase activity,GO:0008410~CoA-transferase activity,	IPR004163:Coenzyme A transferase binding site,IPR004164:Coenzyme A transferase active site,IPR004165:Coenzyme A transferase family I,IPR012791:3-oxoacid CoA-transferase, subunit B,IPR012792:3-oxoacid CoA-transferase, subunit A,IPR014388:3-oxoacid CoA-transferase,	hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,		PIRSF000858:3-oxoacid CoA-transferase,	SM00882:SM00882,	Complete proteome,Mitochondrion,Polymorphism,Reference proteome,Transferase,Transit peptide,	chain:Succinyl-CoA:3-ketoacid-coenzyme A transferase 2, mitochondrial,region of interest:CoA-binding,sequence conflict,sequence variant,transit peptide:Mitochondrion,
ENSG00000087116	ADAM metallopeptidase with thrombospondin type 1 motif 2(ADAMTS2)	Homo sapiens				GO:0007283~spermatogenesis,GO:0016485~protein processing,GO:0030199~collagen fibril organization,GO:0030324~lung development,GO:0030574~collagen catabolic process,GO:0043588~skin development,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR002870:Peptidase M12B, propeptide,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,IPR013273:Peptidase M12B, ADAM-TS,IPR013275:Peptidase M12B, ADAM-TS2,IPR024079:Metallopeptidase, catalytic domain,		225410~Ehlers-Danlos syndrome, type VIIC,		SM00209:TSP1,	Alternative splicing,Collagen degradation,Complete proteome,Disulfide bond,Ehlers-Danlos syndrome,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:A disintegrin and metalloproteinase with thrombospondin motifs 2,compositionally biased region:Cys-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
ENSG00000182196	ADP ribosylation factor like GTPase 6 interacting protein 4(ARL6IP4)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016607~nuclear speck,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR019532:Nuclear RNA-splicing-associated protein, SR-25,					Alternative splicing,Coiled coil,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA editing,	chain:ADP-ribosylation factor-like protein 6- interacting protein 4,compositionally biased region:Lys-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000251503	APITD1-CORT readthrough(APITD1-CORT)	Homo sapiens				GO:0000712~resolution of meiotic recombination intermediates,GO:0006281~DNA repair,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0031297~replication fork processing,GO:0031398~positive regulation of protein ubiquitination,GO:0034080~CENP-A containing nucleosome assembly,GO:0036297~interstrand cross-link repair,GO:0051301~cell division,GO:0051382~kinetochore assembly,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0043240~Fanconi anaemia nuclear complex,GO:0071821~FANCM-MHF complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR009072:Histone-fold,IPR018142:Somatostatin/Cortistatin, C-terminal,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA damage,DNA repair,DNA-binding,Fanconi anemia,Kinetochore,Mitosis,Nucleus,Proteomics identification,Reference proteome,
ENSG00000180389	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit pseudogene 2(ATP5EP2)	Homo sapiens				GO:0015986~ATP synthesis coupled proton transport,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0016887~ATPase activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR006721:ATPase, F1 complex, epsilon  subunit, mitochondrial,					Acetylation,ATP synthesis,CF(1),Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Transport,	chain:ATP synthase subunit epsilon, mitochondrial,chain:ATP synthase subunit epsilon-like protein, mitochondrial,modified residue,
ENSG00000105409	ATPase Na+/K+ transporting subunit alpha 3(ATP1A3)	Homo sapiens				GO:0006883~cellular sodium ion homeostasis,GO:0007613~memory,GO:0008344~adult locomotory behavior,GO:0008542~visual learning,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0030007~cellular potassium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0036376~sodium ion export from cell,GO:0042493~response to drug,GO:0060048~cardiac muscle contraction,GO:0071383~cellular response to steroid hormone stimulus,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1903416~response to glycoside,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0042383~sarcolemma,GO:0043209~myelin sheath,GO:0044326~dendritic spine neck,GO:0044327~dendritic spine head,GO:0045202~synapse,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0031748~D1 dopamine receptor binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0046872~metal ion binding,GO:0051087~chaperone binding,GO:0086037~sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,GO:1990239~steroid hormone binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	128235~Dystonia-12,601338~CAPOS syndrome,614820~Alternating hemiplegia of childhood 2,		SM00831:SM00831,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Deafness,Disease mutation,Dystonia,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Parkinsonism,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sodium/potassium-transporting ATPase subunit alpha-3,metal ion-binding site:Magnesium,modified residue,region of interest:Interaction with phosphoinositide-3 kinase,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000110987	BCL tumor suppressor 7A(BCL7A)	Homo sapiens				GO:0045892~negative regulation of transcription, DNA-templated,		GO:0005515~protein binding,	IPR006804:BCL7,		B-cell non-Hodgkin lymphoma, high-grade~B-cell non-Hodgkin lymphoma, high-grade,			Alternative splicing,Chromosomal rearrangement,Complete proteome,Isopeptide bond,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:B-cell CLL/lymphoma 7 protein family member A,modified residue,sequence variant,splice variant,
ENSG00000136573	BLK proto-oncogene, Src family tyrosine kinase(BLK)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0030154~cell differentiation,GO:0032024~positive regulation of insulin secretion,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045087~innate immune response,GO:0050764~regulation of phagocytosis,GO:0050853~B cell receptor signaling pathway,GO:0071801~regulation of podosome assembly,	GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,		613375~Maturity-onset diabetes of the young, type 11,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	ATP-binding,Cell membrane,Complete proteome,Diabetes mellitus,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase Blk,domain:Protein kinase,domain:SH2,domain:SH3,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
ENSG00000095739	BMP and activin membrane bound inhibitor(BAMBI)	Homo sapiens				GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0016477~cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0032092~positive regulation of protein binding,GO:0035413~positive regulation of catenin import into nucleus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005109~frizzled binding,GO:0005114~type II transforming growth factor beta receptor binding,	IPR009345:BMP/activin membrane-bound inhibitor,	hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,		PIRSF037456:BMP and activin membrane-bound inhibitor,		Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:BMP and activin membrane-bound inhibitor homolog,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000176720	BOK, BCL2 family apoptosis regulator(BOK)	Homo sapiens				GO:0001836~release of cytochrome c from mitochondria,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0010506~regulation of autophagy,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0048709~oligodendrocyte differentiation,GO:0051259~protein oligomerization,GO:0051402~neuron apoptotic process,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1900119~positive regulation of execution phase of apoptosis,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901382~regulation of chorionic trophoblast cell proliferation,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903899~positive regulation of PERK-mediated unfolded protein response,GO:1904708~regulation of granulosa cell apoptotic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005640~nuclear outer membrane,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0031966~mitochondrial membrane,GO:0032588~trans-Golgi network membrane,GO:0033106~cis-Golgi network membrane,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051400~BH domain binding,	IPR002475:Bcl2-like,IPR026298:Blc2 family,IPR026309:Bcl-2-related ovarian killer protein,					Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Endoplasmic reticulum,Endosome,Golgi apparatus,Isopeptide bond,Membrane,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Bcl-2-related ovarian killer protein,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,short sequence motif:BH4,
ENSG00000261740	BOLA2-SMG1P6 readthrough(BOLA2-SMG1P6)	Homo sapiens						GO:0016301~kinase activity,						Kinase,Transferase,
ENSG00000108691	C-C motif chemokine ligand 2(CCL2)	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,19.Cytokine_microglia,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,35.Chemokines_EAE_Autoreactive_T_Cells,	h_ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage,h_LDLpathway:Low-density lipoprotein (LDL) pathway during atherogenesis,h_mspPathway:Msp/Ron Receptor Signaling Pathway,		GO:0000165~MAPK cascade,GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002548~monocyte chemotaxis,GO:0002693~positive regulation of cellular extravasation,GO:0006468~protein phosphorylation,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007010~cytoskeleton organization,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007259~JAK-STAT cascade,GO:0007568~aging,GO:0008360~regulation of cell shape,GO:0009408~response to heat,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0009617~response to bacterium,GO:0009887~organ morphogenesis,GO:0010332~response to gamma radiation,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010759~positive regulation of macrophage chemotaxis,GO:0014823~response to activity,GO:0016525~negative regulation of angiogenesis,GO:0019079~viral genome replication,GO:0019221~cytokine-mediated signaling pathway,GO:0019725~cellular homeostasis,GO:0030593~neutrophil chemotaxis,GO:0031100~organ regeneration,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032570~response to progesterone,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033552~response to vitamin B3,GO:0034351~negative regulation of glial cell apoptotic process,GO:0035684~helper T cell extravasation,GO:0035690~cellular response to drug,GO:0036006~cellular response to macrophage colony-stimulating factor stimulus,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0036499~PERK-mediated unfolded protein response,GO:0043200~response to amino acid,GO:0043491~protein kinase B signaling,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043615~astrocyte cell migration,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045471~response to ethanol,GO:0046677~response to antibiotic,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0050806~positive regulation of synaptic transmission,GO:0050870~positive regulation of T cell activation,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060135~maternal process involved in female pregnancy,GO:0060137~maternal process involved in parturition,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071300~cellular response to retinoic acid,GO:0071318~cellular response to ATP,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071354~cellular response to interleukin-6,GO:0071356~cellular response to tumor necrosis factor,GO:0071403~cellular response to high density lipoprotein particle stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071549~cellular response to dexamethasone stimulus,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090265~positive regulation of immune complex clearance by monocytes and macrophages,GO:0090280~positive regulation of calcium ion import,GO:0090314~positive regulation of protein targeting to membrane,GO:2000427~positive regulation of apoptotic cell clearance,GO:2000502~negative regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005791~rough endoplasmic reticulum,GO:0030139~endocytic vesicle,GO:0030425~dendrite,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044299~C-fiber,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031727~CCR2 chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05144:Malaria,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05323:Rheumatoid arthritis,	182940~Spina bifida, susceptibility to,607948~Mycobacterium tuberculosis, susceptibility to,609423~HIV-1, resistance to,Coronary artery disease, modifier of~Coronary artery disease, modifier of,		SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Inflammatory response,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,signal peptide,site:Involved in dimerization,site:Involved in dimerization, receptor binding and signaling,site:Involved in GAG binding,site:Involved in GAG binding and receptor binding,strand,
ENSG00000184451	C-C motif chemokine receptor 10(CCR10)	Homo sapiens				GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR005382:CC chemokine receptor 10,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 10,disulfide bond,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000112486	C-C motif chemokine receptor 6(CCR6)	Homo sapiens	14.chemokine_receptor-ligand,		Cell division and chromosome partitioning / Transcription / DNA replication, recombination, and repair,	GO:0002407~dendritic cell chemotaxis,GO:0002523~leukocyte migration involved in inflammatory response,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0010634~positive regulation of epithelial cell migration,GO:0019722~calcium-mediated signaling,GO:0048290~isotype switching to IgA isotypes,GO:0060326~cell chemotaxis,GO:0060474~positive regulation of sperm motility involved in capacitation,GO:0070098~chemokine-mediated signaling pathway,GO:0072676~lymphocyte migration,GO:0072678~T cell migration,GO:0072679~thymocyte migration,GO:1904155~DN2 thymocyte differentiation,GO:1904156~DN3 thymocyte differentiation,GO:2000404~regulation of T cell migration,GO:2000510~positive regulation of dendritic cell chemotaxis,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0036126~sperm flagellum,GO:0097225~sperm midpiece,GO:0097228~sperm principal piece,GO:0097524~sperm plasma membrane,	GO:0004872~receptor activity,GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004067:CC chemokine receptor 6,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 6,chain:Cyclin-L2,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Cyclin-like 1,region of interest:Cyclin-like 2,region of interest:RS,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000186810	C-X-C motif chemokine receptor 3(CXCR3)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,16.Chemokines-rec-T-cells,	h_il12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development,h_mCalpainPathway:mCalpain and friends in Cell motility,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,		GO:0001525~angiogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0002685~regulation of leukocyte migration,GO:0006915~apoptotic process,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008284~positive regulation of cell proliferation,GO:0010818~T cell chemotaxis,GO:0016525~negative regulation of angiogenesis,GO:0019722~calcium-mediated signaling,GO:0030816~positive regulation of cAMP metabolic process,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050921~positive regulation of chemotaxis,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0070098~chemokine-mediated signaling pathway,GO:0071954~chemokine (C-C motif) ligand 11 production,GO:1900118~negative regulation of execution phase of apoptosis,GO:1900119~positive regulation of execution phase of apoptosis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004950~chemokine receptor activity,GO:0016494~C-X-C chemokine receptor activity,GO:0019956~chemokine binding,GO:0019958~C-X-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR004070:CXC chemokine receptor 3,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Alternative splicing,Angiogenesis,Apoptosis,Cell membrane,Chemotaxis,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Sulfation,Transducer,Transmembrane,Transmembrane helix,	chain:C-X-C chemokine receptor type 3,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000198178	C-type lectin domain family 4 member C(CLEC4C)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0045087~innate immune response,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	3D-structure,Adaptive immunity,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Lectin,Membrane,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member C,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000152672	C-type lectin domain family 4 member F(CLEC4F)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006897~endocytosis,	GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	Alternative splicing,Coiled coil,Complete proteome,Endocytosis,Glycoprotein,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member F,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000197992	C-type lectin domain family 9 member A(CLEC9A)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0050715~positive regulation of cytokine secretion,	GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	3D-structure,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 9 member A,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000072195	CAVP-target protein-like(LOC100996693)	Homo sapiens							IPR000048:IQ motif, EF-hand binding site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00015:IQ,SM00408:IGc2,SM00409:IG,	Complete proteome,Reference proteome,
ENSG00000245848	CCAAT/enhancer binding protein alpha(CEBPA)	Homo sapiens		h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000050~urea cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006091~generation of precursor metabolites and energy,GO:0006351~transcription, DNA-templated,GO:0006360~transcription from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0007219~Notch signaling pathway,GO:0008203~cholesterol metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016032~viral process,GO:0019221~cytokine-mediated signaling pathway,GO:0030099~myeloid cell differentiation,GO:0030225~macrophage differentiation,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042593~glucose homeostasis,GO:0045444~fat cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0048469~cell maturation,GO:0048839~inner ear development,GO:0050872~white fat cell differentiation,GO:0050873~brown fat cell differentiation,GO:0055088~lipid homeostasis,GO:0071285~cellular response to lithium ion,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001013~RNA polymerase I regulatory region DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,	hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,	601626~Leukemia, acute myeloid,601626~Leukemia, acute myeloid, somatic,	PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Acetylation,Activator,Alternative initiation,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein alpha,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,sequence conflict,
ENSG00000229140	CCDC26 long non-coding RNA(CCDC26)	Homo sapiens												Coiled coil,Complete proteome,Reference proteome,	chain:Coiled-coil domain-containing protein 26,
ENSG00000177455	CD19 molecule(CD19)	Homo sapiens	78.B_Cell_Development,			GO:0006968~cellular defense response,GO:0007166~cell surface receptor signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0031052~chromosome breakage,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050776~regulation of immune response,GO:0050853~B cell receptor signaling pathway,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04662:B cell receptor signaling pathway,hsa05169:Epstein-Barr virus infection,hsa05340:Primary immunodeficiency,	613493~Immunodeficiency, common variable, 3,		SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:B-lymphocyte antigen CD19,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000116031	CD207 molecule(CD207)	Homo sapiens				GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006898~receptor-mediated endocytosis,GO:0051607~defense response to virus,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030139~endocytic vesicle,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031901~early endosome membrane,	GO:0005537~mannose binding,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,		613393~Birbeck granule deficiency,		SM00034:CLECT,	3D-structure,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:C-type lectin domain family 4 member K,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000139193	CD27 molecule(CD27)	Homo sapiens				GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007420~brain development,GO:0008588~release of cytoplasmic sequestered NF-kappaB,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0016064~immunoglobulin mediated immune response,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0045471~response to ethanol,GO:0045579~positive regulation of B cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0046330~positive regulation of JNK cascade,GO:0070233~negative regulation of T cell apoptotic process,GO:0097191~extrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0043005~neuron projection,GO:0070062~extracellular exosome,	GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022328:Tumour necrosis factor receptor 7,	hsa04060:Cytokine-cytokine receptor interaction,	615122~Lymphoproliferative syndrome 2,		SM00208:TNFR,	Apoptosis,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:CD27 antigen,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000129226	CD68 molecule(CD68)	Homo sapiens	8.MonocytesIFNF_IL4,			GO:0071310~cellular response to organic substance,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR002000:Lysosome-associated membrane glycoprotein,IPR018134:Lysosome-associated membrane glycoprotein, conserved site,	hsa04142:Lysosome,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Macrosialin,compositionally biased region:Pro-rich (hinge),disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:2 X 30 AA tandem repeats,region of interest:Mucin-like,repeat:1,repeat:2,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000105369	CD79a molecule(CD79A)	Homo sapiens	5.B7_CD40_B-cell_activa,79.B_cell_Activation,	h_bcrmolecule:B Cell Receptor Complex,h_bcrPathway:BCR Signaling Pathway,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,		GO:0002250~adaptive immune response,GO:0030183~B cell differentiation,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0050853~B cell receptor signaling pathway,	GO:0005737~cytoplasm,GO:0005771~multivesicular body,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0019815~B cell receptor complex,GO:0045121~membrane raft,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,	IPR003110:Phosphorylated immunoreceptor signaling ITAM,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04662:B cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	613501~Agammaglobulinemia 3,		SM00077:ITAM,SM00408:IGc2,SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:B-cell antigen receptor complex- associated protein alpha chain,disulfide bond,domain:Ig-like C2-type,domain:ITAM,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,signal peptide,site:Required for binding to BLNK,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000010278	CD9 molecule(CD9)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0002576~platelet degranulation,GO:0006928~movement of cell or subcellular component,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007342~fusion of sperm to egg plasma membrane,GO:0007420~brain development,GO:0008285~negative regulation of cell proliferation,GO:0009414~response to water deprivation,GO:0014003~oligodendrocyte development,GO:0030168~platelet activation,GO:0030913~paranodal junction assembly,GO:0031623~receptor internalization,GO:0071404~cellular response to low-density lipoprotein particle stimulus,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031092~platelet alpha granule membrane,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005178~integrin binding,GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04640:Hematopoietic cell lineage,		PIRSF002419:tetraspanin,		Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Fertilization,Glycoprotein,Lipoprotein,Membrane,Palmitate,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CD9 antigen,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000144677	CTD small phosphatase like(CTDSPL)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0006470~protein dephosphorylation,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0004721~phosphoprotein phosphatase activity,GO:0016791~phosphatase activity,GO:0046872~metal ion binding,	IPR004274:NLI interacting factor,IPR011948:Dullard phosphatase domain, eukaryotic,IPR023214:HAD-like domain,				SM00577:CPDc,	3D-structure,Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Nucleus,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	active site:4-aspartylphosphate intermediate,active site:Proton donor,chain:CTD small phosphatase-like protein,domain:FCP1 homology,helix,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,modified residue,sequence variant,site:Transition state stabilizer,splice variant,strand,turn,
ENSG00000183117	CUB and Sushi multiple domains 1(CSMD1)	Homo sapiens				GO:0001964~startle response,GO:0042593~glucose homeostasis,	GO:0016021~integral component of membrane,		IPR000436:Sushi/SCR/CCP,IPR000859:CUB domain,				SM00032:CCP,SM00042:CUB,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:CUB and sushi domain-containing protein 1,disulfide bond,domain:CUB 1,domain:CUB 10,domain:CUB 11,domain:CUB 12,domain:CUB 13,domain:CUB 14,domain:CUB 2,domain:CUB 3,domain:CUB 4,domain:CUB 5,domain:CUB 6,domain:CUB 7,domain:CUB 8,domain:CUB 9,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 21,domain:Sushi 22,domain:Sushi 23,domain:Sushi 24,domain:Sushi 25,domain:Sushi 26,domain:Sushi 27,domain:Sushi 28,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000170456	DENN domain containing 5B(DENND5B)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,GO:0050982~detection of mechanical stimulus,GO:0070588~calcium ion transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005262~calcium channel activity,GO:0017112~Rab guanyl-nucleotide exchange factor activity,	IPR001024:Lipoxygenase, LH2,IPR001194:DENN domain,IPR004012:RUN,IPR005112:dDENN domain,IPR005113:uDENN domain,				SM00593:RUN,SM00799:DENN,SM00800:uDENN,SM00801:dDENN,	Acetylation,Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:DENN domain-containing protein 5B,domain:dDENN,domain:DENN,domain:PLAT,domain:RUN 1,domain:RUN 2,domain:uDENN,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000024526	DEP domain containing 1(DEPDC1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000198:Rho GTPase-activating protein domain,IPR000591:DEP domain,IPR008936:Rho GTPase activation protein,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00049:DEP,	3D-structure,Alternative splicing,Complete proteome,GTPase activation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:DEP domain-containing protein 1A,domain:DEP,domain:Rho-GAP,helix,modified residue,sequence variant,splice variant,strand,
ENSG00000105928	DFNA5, deafness associated tumor suppressor(DFNA5)	Homo sapiens				GO:0007605~sensory perception of sound,GO:0008285~negative regulation of cell proliferation,GO:0012501~programmed cell death,GO:0060113~inner ear receptor cell differentiation,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,		IPR007677:Gasdermin,		600994~Deafness, autosomal dominant 5,			Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Deafness,Disulfide bond,Membrane,Necrosis,Non-syndromic deafness,Polymorphism,Proteomics identification,Reference proteome,Signal,Tumor suppressor,	chain:Non-syndromic hearing impairment protein 5,sequence variant,splice variant,
ENSG00000150764	DIX domain containing 1(DIXDC1)	Homo sapiens			Cell division and chromosome partitioning,	GO:0007049~cell cycle,GO:0016055~Wnt signaling pathway,GO:0021799~cerebral cortex radially oriented cell migration,GO:0021869~forebrain ventricular zone progenitor cell division,GO:0032956~regulation of actin cytoskeleton organization,GO:0045665~negative regulation of neuron differentiation,GO:0060070~canonical Wnt signaling pathway,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0043015~gamma-tubulin binding,	IPR001158:DIX domain,IPR001715:Calponin homology domain,IPR015506:Dishevelled-related protein,				SM00021:DAX,SM00033:CH,	3D-structure,Actin-binding,Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Lipoprotein,Myristate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Wnt signaling pathway,	chain:Dixin,domain:CH,domain:DIX,modified residue,region of interest:Actin-binding,sequence conflict,sequence variant,splice variant,
ENSG00000213221	DNL-type zinc finger(DNLZ)	Homo sapiens				GO:0006457~protein folding,GO:0030150~protein import into mitochondrial matrix,GO:0050821~protein stabilization,	GO:0005739~mitochondrion,	GO:0008270~zinc ion binding,GO:0051087~chaperone binding,	IPR007853:Zinc finger, DNL-type,IPR024158:Mitochondrial import protein TIM15,					Chaperone,Complete proteome,Metal-binding,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,Zinc,Zinc-finger,	chain:DNL-type zinc finger protein,sequence variant,zinc finger region:DNL-type,
ENSG00000163576	EF-hand domain family member B(EFHB)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing family member B,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,sequence variant,splice variant,
ENSG00000241404	EGF like domain multiple 8(EGFL8)	Homo sapiens				GO:0001701~in utero embryonic development,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,	Calcium,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Epidermal growth factor-like protein 8,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EMI,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000177106	EPS8 like 2(EPS8L2)	Homo sapiens				GO:0007266~Rho protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0098609~cell-cell adhesion,GO:1900029~positive regulation of ruffle assembly,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0031982~vesicle,GO:0032587~ruffle membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR013625:Tensin phosphotyrosine-binding domain,				SM00326:SH3,SM00462:PTB,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Epidermal growth factor receptor kinase substrate 8-like protein 2,domain:PID,domain:SH3,helix,modified residue,sequence conflict,splice variant,strand,turn,
ENSG00000127774	ER membrane protein complex subunit 6(EMC6)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0034975~protein folding in endoplasmic reticulum,	GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0072546~ER membrane protein complex,GO:0097631~integral component of omegasome membrane,	GO:0005515~protein binding,	IPR008504:Transmembrane protein 93,					Acetylation,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 93,transmembrane region,
ENSG00000135373	ETS homologous factor(EHF)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0030855~epithelial cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050673~epithelial cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,				SM00251:SAM_PNT,SM00413:ETS,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ETS homologous factor,DNA-binding region:ETS,domain:PNT,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000105672	ETS variant 2(ETV2)	Homo sapiens				GO:0001824~blastocyst development,GO:0001890~placenta development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007219~Notch signaling pathway,GO:0016055~Wnt signaling pathway,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048514~blood vessel morphogenesis,GO:0060803~BMP signaling pathway involved in mesodermal cell fate specification,GO:2000382~positive regulation of mesoderm development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00413:ETS,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,
ENSG00000077800	FK506 binding protein 6(FKBP6)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0007126~meiotic nuclear division,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,GO:0045070~positive regulation of viral genome replication,GO:0061077~chaperone-mediated protein folding,	GO:0000795~synaptonemal complex,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0005528~FK506 binding,GO:0042802~identical protein binding,GO:0051879~Hsp90 protein binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,				SM00028:TPR,	3D-structure,Alternative splicing,Chromosome,Complete proteome,Cytoplasm,Differentiation,Meiosis,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-mediated gene silencing,Spermatogenesis,TPR repeat,Williams-Beuren syndrome,	chain:FK506-binding protein 6,domain:PPIase FKBP-type,helix,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,strand,turn,
ENSG00000198468	FLVCR1 antisense RNA 1 (head to head)(FLVCR1-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein LQK1,
ENSG00000137731	FXYD domain containing ion transport regulator 2(FXYD2)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0001558~regulation of cell growth,GO:0006810~transport,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0042127~regulation of cell proliferation,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016323~basolateral plasma membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005216~ion channel activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0017080~sodium channel regulator activity,	IPR000272:Ion-transport regulator, FXYD motif,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	154020~Hypomagnesemia 2, renal,			3D-structure,Alternative splicing,Complete proteome,Disease mutation,Ion transport,Membrane,Potassium,Potassium transport,Primary hypomagnesemia,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit gamma,sequence variant,splice variant,transmembrane region,
ENSG00000221946	FXYD domain containing ion transport regulator 7(FXYD7)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0043269~regulation of ion transport,GO:1903779~regulation of cardiac conduction,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005216~ion channel activity,GO:0005515~protein binding,GO:0051117~ATPase binding,	IPR000272:Ion-transport regulator, FXYD motif,					Complete proteome,Ion channel,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:FXYD domain-containing ion transport regulator 7,modified residue,transmembrane region,
ENSG00000104921	Fc fragment of IgE receptor II(FCER2)	Homo sapiens	6.CD23_engagement,8.MonocytesIFNF_IL4,			GO:0002925~positive regulation of humoral immune response mediated by circulating immunoglobulin,GO:0007219~Notch signaling pathway,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051712~positive regulation of killing of cells of other organism,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005178~integrin binding,GO:0005515~protein binding,GO:0019863~IgE binding,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04640:Hematopoietic cell lineage,hsa05169:Epstein-Barr virus infection,			SM00034:CLECT,	3D-structure,Calcium,Cell membrane,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,IgE-binding protein,Lectin,Lipoprotein,Membrane,Metal-binding,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin epsilon Fc receptor membrane-bound form,chain:Low affinity immunoglobulin epsilon Fc receptor soluble form,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,site:Cleavage,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000072694	Fc fragment of IgG receptor IIb(FCGR2B)	Homo sapiens		h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,		GO:0006955~immune response,GO:0007165~signal transduction,GO:0016032~viral process,GO:0050776~regulation of immune response,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0019864~IgG binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04662:B cell receptor signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05162:Measles,	152700~Systemic lupus erythematosus, susceptibility to,611162~Malaria, resistance to,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Host-virus interaction,IgG-binding protein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Low affinity immunoglobulin gamma Fc region receptor II-b,chain:Low affinity immunoglobulin gamma Fc region receptor II-c,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000163534	Fc receptor like 1(FCRL1)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,short sequence motif:ITIM motif 5,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000132704	Fc receptor like 2(FCRL2)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0009967~positive regulation of signal transduction,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000143297	Fc receptor like 5(FCRL5)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 5,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000181036	Fc receptor like 6(FCRL6)	Homo sapiens					GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 6,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:ITIM motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000132185	Fc receptor like A(FCRLA)	Homo sapiens				GO:0030154~cell differentiation,	GO:0005737~cytoplasm,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Direct protein sequencing,Disulfide bond,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:Fc receptor-like A,compositionally biased region:Pro-rich,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000162746	Fc receptor like B(FCRLB)	Homo sapiens				GO:0050777~negative regulation of immune response,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,		IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Alternative splicing,Complete proteome,Cytoplasm,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Immunoglobulin domain,Reference proteome,Repeat,Signal,	chain:Fc receptor-like B,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
ENSG00000128266	G protein subunit alpha z(GNAZ)	Homo sapiens				GO:0006457~protein folding,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,	GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005057~receptor signaling protein activity,GO:0005525~GTP binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0046872~metal ion binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04730:Long-term depression,			SM00275:SM00275,	ADP-ribosylation,Complete proteome,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(z) subunit alpha,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,
ENSG00000127920	G protein subunit gamma 11(GNG11)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Coiled coil,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11,lipid moiety-binding region:S-farnesyl cysteine,modified residue,propeptide:Removed in mature form,
ENSG00000180998	G protein-coupled receptor 137C(GPR137C)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Integral membrane protein GPR137C,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000154165	G protein-coupled receptor 15(GPR15)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0072678~T cell migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,				SM01381:SM01381,	Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor 15,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000170412	G protein-coupled receptor class C group 5 member C(GPRC5C)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031982~vesicle,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0004930~G-protein coupled receptor activity,	IPR017978:GPCR, family 3, C-terminal,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasmic vesicle,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor family C group 5 member C,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000111291	G protein-coupled receptor class C group 5 member D(GPRC5D)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR017978:GPCR, family 3, C-terminal,					Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:G-protein coupled receptor family C group 5 member D,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000107485	GATA binding protein 3(GATA3)	Homo sapiens	78.B_Cell_Development,80.T_cell_Activation,89.CD4_T_Cell_Differentiation,	h_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0001806~type IV hypersensitivity,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0002088~lens development in camera-type eye,GO:0002572~pro-T cell differentiation,GO:0003180~aortic valve morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003281~ventricular septum development,GO:0006338~chromatin remodeling,GO:0006366~transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0006959~humoral immune response,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0009615~response to virus,GO:0009653~anatomical structure morphogenesis,GO:0009791~post-embryonic development,GO:0009887~organ morphogenesis,GO:0009967~positive regulation of signal transduction,GO:0010332~response to gamma radiation,GO:0010595~positive regulation of endothelial cell migration,GO:0010975~regulation of neuron projection development,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0030218~erythrocyte differentiation,GO:0031929~TOR signaling,GO:0032689~negative regulation of interferon-gamma production,GO:0032703~negative regulation of interleukin-2 production,GO:0032753~positive regulation of interleukin-4 production,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0035162~embryonic hemopoiesis,GO:0035457~cellular response to interferon-alpha,GO:0035799~ureter maturation,GO:0035898~parathyroid hormone secretion,GO:0042035~regulation of cytokine biosynthetic process,GO:0042421~norepinephrine biosynthetic process,GO:0042472~inner ear morphogenesis,GO:0042493~response to drug,GO:0043370~regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043523~regulation of neuron apoptotic process,GO:0043583~ear development,GO:0043627~response to estrogen,GO:0045061~thymic T cell selection,GO:0045064~T-helper 2 cell differentiation,GO:0045087~innate immune response,GO:0045165~cell fate commitment,GO:0045471~response to ethanol,GO:0045582~positive regulation of T cell differentiation,GO:0045599~negative regulation of fat cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048485~sympathetic nervous system development,GO:0048538~thymus development,GO:0048565~digestive tract development,GO:0048589~developmental growth,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0050728~negative regulation of inflammatory response,GO:0050852~T cell receptor signaling pathway,GO:0051569~regulation of histone H3-K4 methylation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060017~parathyroid gland development,GO:0060037~pharyngeal system development,GO:0060065~uterus development,GO:0060231~mesenchymal to epithelial transition,GO:0060374~mast cell differentiation,GO:0060676~ureteric bud formation,GO:0061085~regulation of histone H3-K27 methylation,GO:0061290~canonical Wnt signaling pathway involved in metanephric kidney development,GO:0071353~cellular response to interleukin-4,GO:0071356~cellular response to tumor necrosis factor,GO:0071442~positive regulation of histone H3-K14 acetylation,GO:0071599~otic vesicle development,GO:0071773~cellular response to BMP stimulus,GO:0072107~positive regulation of ureteric bud formation,GO:0072178~nephric duct morphogenesis,GO:0072179~nephric duct formation,GO:0072182~regulation of nephron tubule epithelial cell differentiation,GO:0072602~interleukin-4 secretion,GO:0072643~interferon-gamma secretion,GO:0072676~lymphocyte migration,GO:0090102~cochlea development,GO:1901536~negative regulation of DNA demethylation,GO:2000114~regulation of establishment of cell polarity,GO:2000146~negative regulation of cell motility,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000607~negative regulation of cell proliferation involved in mesonephros development,GO:2000611~positive regulation of thyroid hormone generation,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000683~regulation of cellular response to X-ray,GO:2000703~negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,GO:2000734~negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005134~interleukin-2 receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,GO:0071837~HMG box domain binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,IPR016374:Transcription factor, GATA-1/2/3,		146255~Hypoparathyroidism, sensorineural deafness, and renal dysplasia,	PIRSF003027:transcription factor, GATA-1/2/3 types,	SM00401:ZnF_GATA,	3D-structure,Activator,Alternative splicing,Complete proteome,Deafness,Disease mutation,DNA-binding,Immunity,Innate immunity,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Trans-acting T-cell-specific transcription factor GATA-3,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
ENSG00000188375	H3 histone family member 3C(H3F3C)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0030307~positive regulation of cell growth,	GO:0000786~nucleosome,GO:0005719~nuclear euchromatin,	GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0046982~protein heterodimerization activity,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,			SM00428:H3,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Histone H3-like,modified residue,sequence conflict,
ENSG00000197568	HERV-H LTR-associating 3(HHLA3)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Reference proteome,	chain:HERV-H LTR-associating protein 3,sequence conflict,splice variant,
ENSG00000109758	HGF activator(HGFAC)	Homo sapiens				GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005791~rough endoplasmic reticulum,	GO:0004252~serine-type endopeptidase activity,GO:0008236~serine-type peptidase activity,	IPR000001:Kringle,IPR000083:Fibronectin, type I,IPR000562:Fibronectin, type II, collagen-binding,IPR000742:Epidermal growth factor-like domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR013032:EGF-like, conserved site,IPR013806:Kringle-like fold,IPR014394:Coagulation factor XIIa/hepatocyte growth factor activator,IPR018056:Kringle, conserved site,IPR018114:Peptidase S1, trypsin family, active site,			PIRSF001146:coagulation factor XII/hepatocyte growth factor activator,	SM00020:Tryp_SPc,SM00058:FN1,SM00059:FN2,SM00130:KR,SM00181:EGF,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Kringle,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Hepatocyte growth factor activator long chain,chain:Hepatocyte growth factor activator short chain,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:Fibronectin type-I,domain:Fibronectin type-II,domain:Kringle,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Removed in mature form,sequence variant,signal peptide,strand,turn,
ENSG00000171476	HOP homeobox(HOPX)	Homo sapiens		h_hopPathway:Hop Pathway in Cardiac Development,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0008016~regulation of heart contraction,GO:0016575~histone deacetylation,GO:0043393~regulation of protein binding,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0045596~negative regulation of cell differentiation,GO:0048286~lung alveolus development,GO:0051155~positive regulation of striated muscle cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,				SM00389:HOX,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Homeobox,Nucleus,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Homeodomain-only protein,DNA-binding region:Homeobox; atypical,sequence conflict,splice variant,
ENSG00000250588	IQCJ-SCHIP1 readthrough(IQCJ-SCHIP1)	Homo sapiens					GO:0005737~cytoplasm,		IPR015649:Schwannomin interacting protein 1,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,
ENSG00000122778	KIAA1549(KIAA1549)	Homo sapiens					GO:0016021~integral component of membrane,		IPR024606:Protein of unknown function DUF3827,					Alternative promoter usage,Alternative splicing,Chromosomal rearrangement,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0606 protein KIAA1549,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000157404	KIT proto-oncogene receptor tyrosine kinase(KIT)	Homo sapiens		h_badPathway:Regulation of BAD phosphorylation,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0001541~ovarian follicle development,GO:0002318~myeloid progenitor cell differentiation,GO:0002320~lymphoid progenitor cell differentiation,GO:0002327~immature B cell differentiation,GO:0002371~dendritic cell cytokine production,GO:0002551~mast cell chemotaxis,GO:0006687~glycosphingolipid metabolic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0008284~positive regulation of cell proliferation,GO:0008354~germ cell migration,GO:0008360~regulation of cell shape,GO:0008542~visual learning,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0010863~positive regulation of phospholipase C activity,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0019827~stem cell population maintenance,GO:0030032~lamellipodium assembly,GO:0030097~hemopoiesis,GO:0030217~T cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030318~melanocyte differentiation,GO:0030335~positive regulation of cell migration,GO:0031274~positive regulation of pseudopodium assembly,GO:0031532~actin cytoskeleton reorganization,GO:0032762~mast cell cytokine production,GO:0035019~somatic stem cell population maintenance,GO:0035162~embryonic hemopoiesis,GO:0035234~ectopic germ cell programmed cell death,GO:0035556~intracellular signal transduction,GO:0035701~hematopoietic stem cell migration,GO:0035855~megakaryocyte development,GO:0038093~Fc receptor signaling pathway,GO:0038109~Kit signaling pathway,GO:0038162~erythropoietin-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0043069~negative regulation of programmed cell death,GO:0043303~mast cell degranulation,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043473~pigmentation,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045747~positive regulation of Notch signaling pathway,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046777~protein autophosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048070~regulation of developmental pigmentation,GO:0048103~somatic stem cell division,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048565~digestive tract development,GO:0048863~stem cell differentiation,GO:0050673~epithelial cell proliferation,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060326~cell chemotaxis,GO:0060374~mast cell differentiation,GO:0070662~mast cell proliferation,GO:0097067~cellular response to thyroid hormone stimulus,GO:0097324~melanocyte migration,GO:0097326~melanocyte adhesion,GO:1905065~positive regulation of vascular smooth muscle cell differentiation,	GO:0001669~acrosomal vesicle,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0009897~external side of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042629~mast cell granule,	GO:0002020~protease binding,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0005020~stem cell factor receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019955~cytokine binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR016243:Tyrosine-protein kinase, CSF-1/PDGF receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR027263:Mast/stem cell growth factor receptor,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,	154800~Mast cell disease,172800~Piebaldism,273300~Germ cell tumors,601626~Leukemia, acute myeloid,606764~Gastrointestinal stromal tumor, familial,	PIRSF000615:tyrosine-protein kinase, CSF-1/PDGF receptor type,PIRSF500951:mast/stem cell growth factor receptor [Parent=PIRSF000615],	SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Mast/stem cell growth factor receptor,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,site:Interaction with APS,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000107821	Kazal type serine peptidase inhibitor domain 1(KAZALD1)	Homo sapiens				GO:0001503~ossification,GO:0001558~regulation of cell growth,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,	GO:0005614~interstitial matrix,	GO:0005520~insulin-like growth factor binding,	IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR002350:Kazal domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011390:Insulin-like growth factor binding protein-related protein (IGFBP-rP), MAC25,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,			PIRSF018239:IGFBP-related protein, MAC25 type,	SM00280:KAZAL,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Immunoglobulin domain,Osteogenesis,Polymorphism,Reference proteome,Secreted,Signal,	chain:Kazal-type serine protease inhibitor domain-containing protein 1,compositionally biased region:Cys-rich,disulfide bond,domain:Ig-like C2-type,domain:IGFBP N-terminal,domain:Kazal-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
ENSG00000162337	LDL receptor related protein 5(LRP5)	Homo sapiens				GO:0001702~gastrulation with mouth forming second,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002076~osteoblast development,GO:0006007~glucose catabolic process,GO:0006897~endocytosis,GO:0008203~cholesterol metabolic process,GO:0008217~regulation of blood pressure,GO:0008284~positive regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0016055~Wnt signaling pathway,GO:0033690~positive regulation of osteoblast proliferation,GO:0035019~somatic stem cell population maintenance,GO:0035426~extracellular matrix-cell signaling,GO:0042074~cell migration involved in gastrulation,GO:0042632~cholesterol homeostasis,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptotic process,GO:0043434~response to peptide hormone,GO:0044332~Wnt signaling pathway involved in dorsal/ventral axis specification,GO:0045600~positive regulation of fat cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045840~positive regulation of mitotic nuclear division,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046849~bone remodeling,GO:0046850~regulation of bone remodeling,GO:0048539~bone marrow development,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060033~anatomical structure regression,GO:0060042~retina morphogenesis in camera-type eye,GO:0060070~canonical Wnt signaling pathway,GO:0060349~bone morphogenesis,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060612~adipose tissue development,GO:0060764~cell-cell signaling involved in mammary gland development,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061304~retinal blood vessel morphogenesis,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:1902262~apoptotic process involved in patterning of blood vessels,GO:1904886~beta-catenin destruction complex disassembly,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:1990851~Wnt-Frizzled-LRP5/6 complex,GO:1990909~Wnt signalosome,	GO:0005515~protein binding,GO:0017147~Wnt-protein binding,GO:0019534~toxin transporter activity,GO:0042813~Wnt-activated receptor activity,GO:0071936~coreceptor activity involved in Wnt signaling pathway,GO:1904928~coreceptor activity involved in canonical Wnt signaling pathway,	IPR000033:LDLR class B repeat,IPR000742:Epidermal growth factor-like domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR011042:Six-bladed beta-propeller, TolB-like,IPR017049:Low density lipoprotein receptor-related protein, 5/6,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa04310:Wnt signaling pathway,	144750~Hyperostosis, endosteal,144750~Osteosclerosis,166710~Osteoporosis,259770~Osteoporosis-pseudoglioma syndrome,601813~Exudative vitreoretinopathy 4,601884~Bone mineral density variability 1,607634~Osteopetrosis, autosomal dominant 1,607636~van Buchem disease, type 2,	PIRSF036314:low density lipoprotein receptor-related protein, 5/6 types,	SM00135:LY,SM00181:EGF,SM00192:LDLa,	Complete proteome,Developmental protein,Disease mutation,Disulfide bond,EGF-like domain,Endocytosis,Endoplasmic reticulum,Glycoprotein,Membrane,Osteogenesis imperfecta,Osteopetrosis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Low-density lipoprotein receptor-related protein 5,compositionally biased region:Pro-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,glycosylation site:N-linked (GlcNAc...),repeat:LDL-receptor class B 1,repeat:LDL-receptor class B 10,repeat:LDL-receptor class B 11,repeat:LDL-receptor class B 12,repeat:LDL-receptor class B 13,repeat:LDL-receptor class B 14,repeat:LDL-receptor class B 15,repeat:LDL-receptor class B 16,repeat:LDL-receptor class B 17,repeat:LDL-receptor class B 18,repeat:LDL-receptor class B 19,repeat:LDL-receptor class B 2,repeat:LDL-receptor class B 20,repeat:LDL-receptor class B 3,repeat:LDL-receptor class B 4,repeat:LDL-receptor class B 5,repeat:LDL-receptor class B 6,repeat:LDL-receptor class B 7,repeat:LDL-receptor class B 8,repeat:LDL-receptor class B 9,repeat:YWTD 1,repeat:YWTD 10,repeat:YWTD 11,repeat:YWTD 2,repeat:YWTD 3,repeat:YWTD 4,repeat:YWTD 5,repeat:YWTD 6,repeat:YWTD 7,repeat:YWTD 8,repeat:YWTD 9,sequence conflict,sequence variant,short sequence motif:PPPSP motif,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000124466	LY6/PLAUR domain containing 3(LYPD3)	Homo sapiens				GO:0007160~cell-matrix adhesion,	GO:0005615~extracellular space,GO:0016021~integral component of membrane,GO:0046658~anchored component of plasma membrane,	GO:0043236~laminin binding,	IPR016054:Ly-6 antigen / uPA receptor -like,				SM00134:LU,	Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Repeat,Signal,	chain:Ly6/PLAUR domain-containing protein 3,domain:UPAR/Ly6 1,domain:UPAR/Ly6 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated cysteine,propeptide:Removed in mature form,signal peptide,
ENSG00000176909	MEF2 activating motif and SAP domain containing transcriptional regulator(MAMSTR)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0010831~positive regulation of myotube differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,	IPR003034:SAP domain,				SM00513:SAP,	Activator,Alternative splicing,Complete proteome,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:MEF2-activating motif and SAP domain- containing transcriptional regulator,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:SAP,region of interest:Transcription activation,sequence conflict,short sequence motif:MEF2-binding,splice variant,
ENSG00000256618	MT-RNR2-like 1(MTRNR2L1)	Homo sapiens					GO:0005576~extracellular region,GO:0005737~cytoplasm,							Complete proteome,Cytoplasm,Reference proteome,Secreted,
ENSG00000073146	Mov10 RISC complex RNA helicase like 1(MOV10L1)	Homo sapiens			DNA replication, recombination, and repair,	GO:0007141~male meiosis I,GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,	GO:0005622~intracellular,GO:0043186~P granule,GO:0071546~pi-body,	GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,	IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Developmental protein,Helicase,Hydrolase,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Putative helicase Mov10l1,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAG box,splice variant,
ENSG00000103154	N-terminal EF-hand calcium binding protein 2(NECAB2)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002048:EF-hand domain,IPR007138:Antibiotic biosynthesis monooxygenase,IPR011008:Dimeric alpha-beta barrel,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Methylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:N-terminal EF-hand calcium-binding protein 2,domain:ABM,domain:EF-hand 1,domain:EF-hand 2,sequence variant,
ENSG00000188039	NACHT and WD repeat domain containing 1(NWD1)	Homo sapiens			Cell motility and secretion,		GO:0005829~cytosol,	GO:0005524~ATP binding,	IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00320:WD40,	Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Nucleotide-binding,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:NACHT and WD repeat domain-containing protein 1,domain:NACHT,nucleotide phosphate-binding region:ATP,repeat:WD 1,repeat:WD 10,repeat:WD 11,repeat:WD 12,repeat:WD 13,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,repeat:WD 8,repeat:WD 9,sequence conflict,sequence variant,splice variant,
ENSG00000022556	NLR family pyrin domain containing 2(NLRP2)	Homo sapiens				GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045087~innate immune response,GO:0050718~positive regulation of interleukin-1 beta secretion,	GO:0000784~nuclear chromosome, telomeric region,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032090~Pyrin domain binding,	IPR001611:Leucine-rich repeat,IPR004020:DAPIN domain,IPR007111:NACHT nucleoside triphosphatase,IPR011029:Death-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM01289:SM01289,	Alternative splicing,Apoptosis,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:NACHT, LRR and PYD domains-containing protein 2,compositionally biased region:Poly-Glu,domain:DAPIN,domain:NACHT,nucleotide phosphate-binding region:ATP,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,splice variant,
ENSG00000198435	NOTCH-regulated ankyrin repeat protein(NRARP)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001569~patterning of blood vessels,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:0007219~Notch signaling pathway,GO:0032525~somite rostral/caudal axis specification,GO:0045581~negative regulation of T cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902367~negative regulation of Notch signaling pathway involved in somitogenesis,			IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Developmental protein,Reference proteome,Repeat,	chain:Notch-regulated ankyrin repeat-containing protein,repeat:ANK 1,repeat:ANK 2,
ENSG00000102471	Nedd4 family interacting protein 2(NDFIP2)	Homo sapiens				GO:0007034~vacuolar transport,GO:0007165~signal transduction,GO:0010629~negative regulation of gene expression,GO:0030001~metal ion transport,GO:0031398~positive regulation of protein ubiquitination,GO:0032410~negative regulation of transporter activity,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0051224~negative regulation of protein transport,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0032585~multivesicular body membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0050699~WW domain binding,	IPR019325:NEDD4/BSD2,					Complete proteome,Endosome,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:NEDD4 family-interacting protein 2,region of interest:Interaction with NEDD4,sequence variant,transmembrane region,
ENSG00000185630	PBX homeobox 1(PBX1)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0006694~steroid biosynthetic process,GO:0007548~sex differentiation,GO:0008284~positive regulation of cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0030278~regulation of ossification,GO:0030325~adrenal gland development,GO:0030326~embryonic limb morphogenesis,GO:0035019~somatic stem cell population maintenance,GO:0035162~embryonic hemopoiesis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045665~negative regulation of neuron differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048706~embryonic skeletal system development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR005542:PBX,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,	hsa05202:Transcriptional misregulation in cancer,	Leukemia, acute pre-B-cell~Leukemia, acute pre-B-cell,		SM00389:HOX,	3D-structure,Activator,Alternative splicing,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,DNA-binding,Homeobox,Nucleus,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Sexual differentiation,Steroidogenesis,Transcription,Transcription regulation,	chain:Pre-B-cell leukemia transcription factor 1,compositionally biased region:Poly-Ala,DNA-binding region:Homeobox; TALE-type,helix,site:Breakpoint for translocation to form CAA67062A-PBX1 oncogene,splice variant,turn,
ENSG00000107438	PDZ and LIM domain 1(PDLIM1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006355~regulation of transcription, DNA-templated,GO:0006979~response to oxidative stress,GO:0098609~cell-cell adhesion,	GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,	GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001478:PDZ domain,IPR001781:Zinc finger, LIM-type,IPR006643:ZASP,				SM00132:LIM,SM00228:PDZ,SM00735:ZM,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,LIM domain,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Zinc,	chain:PDZ and LIM domain protein 1,domain:LIM zinc-binding,domain:PDZ,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,sequence conflict,sequence variant,strand,turn,
ENSG00000140451	PIF1 5'-to-3' DNA helicase(PIF1)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000002~mitochondrial genome maintenance,GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0032204~regulation of telomere maintenance,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032508~DNA duplex unwinding,GO:0044806~G-quadruplex DNA unwinding,GO:0051974~negative regulation of telomerase activity,	GO:0000784~nuclear chromosome, telomeric region,GO:0005657~replication fork,GO:0005739~mitochondrion,	GO:0000287~magnesium ion binding,GO:0003678~DNA helicase activity,GO:0005524~ATP binding,GO:0010521~telomerase inhibitor activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0033682~ATP-dependent 5'-3' DNA/RNA helicase activity,GO:0042162~telomeric DNA binding,GO:0043141~ATP-dependent 5'-3' DNA helicase activity,GO:0051880~G-quadruplex DNA binding,	IPR003840:DNA helicase,IPR010285:DNA helicase PIF1, ATP-dependent,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Alternative initiation,Alternative splicing,ATP-binding,Complete proteome,DNA damage,DNA recombination,DNA repair,DNA-binding,Helicase,Hydrolase,Mitochondrion,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:ATP-dependent DNA helicase PIF1,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Hydrolyzes ATP in the presence of both magnesium and single-stranded DNA; weak activity in the presence of RNA or double-stranded DNA; No unwinding activity,sequence variant,splice variant,
ENSG00000110777	POU class 2 associating factor 1(POU2AF1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006959~humoral immune response,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR015389:POU, class 2, associating factor 1,					3D-structure,Chromosomal rearrangement,Complete proteome,Direct protein sequencing,Nucleus,Polymorphism,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:POU domain class 2-associating factor 1,helix,sequence variant,
ENSG00000258388	PPT2-EGFL8 readthrough (NMD candidate)(PPT2-EGFL8)	Homo sapiens						GO:0008474~palmitoyl-(protein) hydrolase activity,	IPR002472:Palmitoyl protein thioesterase,					Complete proteome,Proteomics identification,Reference proteome,
ENSG00000177380	PTPRF interacting protein alpha 3(PPFIA3)	Homo sapiens				GO:0007269~neurotransmitter secretion,GO:0014047~glutamate secretion,GO:0048172~regulation of short-term neuronal synaptic plasticity,	GO:0001669~acrosomal vesicle,GO:0005829~cytosol,GO:0048786~presynaptic active zone,GO:0098875~epididymosome,	GO:0005515~protein binding,	IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Liprin-alpha-3,domain:SAM 1,domain:SAM 2,domain:SAM 3,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000143847	PTPRF interacting protein alpha 4(PPFIA4)	Homo sapiens				GO:0007269~neurotransmitter secretion,GO:0014047~glutamate secretion,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0009986~cell surface,GO:0045202~synapse,GO:0048786~presynaptic active zone,	GO:0005515~protein binding,	IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Liprin-alpha-4,domain:SAM 1,domain:SAM 2,domain:SAM 3,sequence conflict,splice variant,
ENSG00000188060	RAB42, member RAS oncogene family(RAB42)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0016020~membrane,	GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Reference proteome,	chain:Putative Ras-related protein Rab-42,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,
ENSG00000254389	RHPN1 antisense RNA 1 (head to head)(RHPN1-AS1)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C8orf51,
ENSG00000128408	RIB43A domain with coiled-coils 2(RIBC2)	Homo sapiens					GO:0005634~nucleus,	GO:0005515~protein binding,	IPR008805:RIB43A,					Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:RIB43A-like with coiled-coils protein 2,sequence variant,
ENSG00000166592	RRAD, Ras related glycolysis inhibitor and calcium channel regulator(RRAD)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR017358:Small GTPase superfamily, GEM/REM/Rad,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF038017:GTP-binding protein, GEM type,		3D-structure,Calmodulin-binding,Cell membrane,Complete proteome,GTP-binding,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:GTP-binding protein RAD,helix,nucleotide phosphate-binding region:GTP,region of interest:Calmodulin-binding,sequence variant,strand,turn,
ENSG00000058335	Ras protein specific guanine nucleotide releasing factor 1(RASGRF1)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007616~long-term memory,GO:0008283~cell proliferation,GO:0031175~neuron projection development,GO:0035020~regulation of Rac protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0090630~activation of GTPase activity,GO:2000310~regulation of N-methyl-D-aspartate selective glutamate receptor activity,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030426~growth cone,GO:0043005~neuron projection,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0035254~glutamate receptor binding,	IPR000048:IQ motif, EF-hand binding site,IPR000219:Dbl homology (DH) domain,IPR000651:Ras-like guanine nucleotide exchange factor, N-terminal,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR001849:Pleckstrin homology domain,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR011993:Pleckstrin homology-like domain,IPR019804:Ras guanine-nucleotide exchange factor, conserved site,IPR023578:Ras guanine nucleotide exchange factor, domain,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04510:Focal adhesion,			SM00147:RasGEF,SM00229:RasGEFN,SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Coiled coil,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Reference proteome,Repeat,Ubl conjugation,	chain:Ras-specific guanine nucleotide-releasing factor 1,domain:DH,domain:IQ,domain:N-terminal Ras-GEF,domain:PH 1,domain:PH 2,domain:Ras-GEF,modified residue,sequence conflict,splice variant,
ENSG00000175643	RecQ mediated genome instability 2(RMI2)	Homo sapiens				GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,		hsa03460:Fanconi anemia pathway,				3D-structure,Acetylation,Alternative splicing,Complete proteome,DNA replication,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:RecQ-mediated genome instability protein 2,DNA-binding region:OB,mutagenesis site,splice variant,
ENSG00000187010	Rh blood group D antigen(RHD)	Homo sapiens				GO:0015695~organic cation transport,GO:0019740~nitrogen utilization,GO:0072488~ammonium transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008519~ammonium transmembrane transporter activity,	IPR001905:Ammonium transporter,IPR002229:Blood group Rhesus C/E/D polypeptide,IPR024041:Ammonium transporter AmtB-like domain,		Rh-negative blood type~Rh-negative blood type,			Alternative splicing,Blood group antigen,Complete proteome,Direct protein sequencing,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Blood group Rh(D) polypeptide,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000147799	Rho GTPase activating protein 39(ARHGAP39)	Homo sapiens			RNA processing and modification,	GO:0007165~signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005856~cytoskeleton,	GO:0005096~GTPase activator activity,	IPR000198:Rho GTPase-activating protein domain,IPR000857:MyTH4 domain,IPR001202:WW domain,IPR008936:Rho GTPase activation protein,				SM00139:MyTH4,SM00324:RhoGAP,SM00456:WW,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Reference proteome,Repeat,	chain:Uncharacterized protein KIAA1688,compositionally biased region:Pro-rich,domain:MyTH4,domain:Rho-GAP,domain:WW 1,domain:WW 2,modified residue,
ENSG00000165895	Rho GTPase activating protein 42(ARHGAP42)	Homo sapiens				GO:0003085~negative regulation of systemic arterial blood pressure,GO:0007165~signal transduction,GO:0035024~negative regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:1904694~negative regulation of vascular smooth muscle contraction,		GO:0005096~GTPase activator activity,	IPR000198:Rho GTPase-activating protein domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00324:RhoGAP,SM00326:SH3,	Coiled coil,Complete proteome,GTPase activation,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Rho GTPase-activating protein FLJ32810,compositionally biased region:Ser-rich,domain:Rho-GAP,domain:SH3,modified residue,sequence conflict,splice variant,
ENSG00000172602	Rho family GTPase 1(RND1)	Homo sapiens				GO:0007015~actin filament organization,GO:0007162~negative regulation of cell adhesion,GO:0007264~small GTPase mediated signal transduction,GO:0016322~neuron remodeling,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,	GO:0003924~GTPase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04360:Axon guidance,				3D-structure,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Polymorphism,Prenylation,Reference proteome,	chain:Rho-related GTP-binding protein Rho6,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence variant,short sequence motif:Effector region,strand,turn,
ENSG00000110237	Rho guanine nucleotide exchange factor 17(ARHGEF17)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR011993:Pleckstrin homology-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00325:RhoGEF,	Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rho guanine nucleotide exchange factor 17,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:DH,modified residue,sequence conflict,sequence variant,
ENSG00000183111	Rho guanine nucleotide exchange factor 37(ARHGEF37)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001452:Src homology-3 domain,IPR004148:BAR domain,IPR011511:Variant SH3,IPR027267:Arfaptin homology (AH) domain/BAR domain,				SM00325:RhoGEF,SM00326:SH3,SM00721:BAR,	Complete proteome,Guanine-nucleotide releasing factor,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Probable guanine nucleotide exchange factor FLJ41603,domain:BAR,domain:DH,domain:SH3 1,domain:SH3 2,sequence variant,
ENSG00000196754	S100 calcium binding protein A2(S100A2)	Homo sapiens				GO:0043542~endothelial cell migration,		GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM01394:SM01394,	3D-structure,Calcium,Complete proteome,Direct protein sequencing,Metal-binding,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-A2,domain:EF-hand 1,domain:EF-hand 2,helix,sequence conflict,strand,turn,
ENSG00000160307	S100 calcium binding protein B(S100B)	Homo sapiens				GO:0007409~axonogenesis,GO:0007417~central nervous system development,GO:0007611~learning or memory,GO:0007613~memory,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048708~astrocyte differentiation,GO:0051384~response to glucocorticoid,GO:0051597~response to methylmercury,GO:0060291~long-term synaptic potentiation,GO:0071456~cellular response to hypoxia,GO:2001015~negative regulation of skeletal muscle cell differentiation,	GO:0001726~ruffle,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044548~S100 protein binding,GO:0048156~tau protein binding,GO:0048306~calcium-dependent protein binding,GO:0050786~RAGE receptor binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,SM01394:SM01394,	3D-structure,Acetylation,Calcium,Complete proteome,Cytoplasm,Direct protein sequencing,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Zinc,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-B,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,strand,turn,
ENSG00000104611	SH2 domain containing 4A(SH2D4A)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0019902~phosphatase binding,	IPR000980:SH2 domain,				SM00252:SH2,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:SH2 domain-containing protein 4A,compositionally biased region:Poly-Ser,domain:SH2,modified residue,sequence conflict,sequence variant,
ENSG00000158714	SLAM family member 8(SLAMF8)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,					Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:SLAM family member 8,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000162723	SLAM family member 9(SLAMF9)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,					Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:SLAM family member 9,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000161888	SPC24, NDC80 kinetochore complex component(SPC24)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0031262~Ndc80 complex,	GO:0005515~protein binding,	IPR013252:Kinetochore-Ndc80 subunit Spc24,					3D-structure,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,Kinetochore,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Kinetochore protein Spc24,helix,modified residue,region of interest:Interaction with the C-terminus of SPBC25,region of interest:Interaction with the N-terminus of SPBC25,region of interest:Interaction with the NDC80-CDCA1 subcomplex,turn,
ENSG00000100721	T-cell leukemia/lymphoma 1A(TCL1A)	Homo sapiens				GO:0007275~multicellular organism development,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR004832:TCL1/MTCP1,	hsa04151:PI3K-Akt signaling pathway,	Leukemia/lymphoma, T-cell~Leukemia/lymphoma, T-cell,			3D-structure,Chromosomal rearrangement,Complete proteome,Cytoplasm,Endoplasmic reticulum,Microsome,Nucleus,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:T-cell leukemia/lymphoma protein 1A,helix,mutagenesis site,sequence conflict,sequence variant,strand,turn,
ENSG00000257949	TEN1, CST complex subunit(TEN1)	Homo sapiens				GO:0051974~negative regulation of telomerase activity,GO:1904356~regulation of telomere maintenance via telomere lengthening,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:1990879~CST complex,	GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0010521~telomerase inhibitor activity,GO:0042162~telomeric DNA binding,						3D-structure,Chromosome,Complete proteome,DNA-binding,Nucleus,Proteomics identification,Reference proteome,Telomere,	chain:Uncharacterized protein FLJ39785,
ENSG00000141655	TNF receptor superfamily member 11a(TNFRSF11A)	Homo sapiens		h_ranklPathway:Bone Remodelling,		GO:0001503~ossification,GO:0002250~adaptive immune response,GO:0002548~monocyte chemotaxis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0009314~response to radiation,GO:0030316~osteoclast differentiation,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034097~response to cytokine,GO:0034612~response to tumor necrosis factor,GO:0042981~regulation of apoptotic process,GO:0043507~positive regulation of JUN kinase activity,GO:0048535~lymph node development,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060086~circadian temperature homeostasis,GO:0060749~mammary gland alveolus development,GO:0070555~response to interleukin-1,GO:0071812~positive regulation of fever generation by positive regulation of prostaglandin secretion,GO:0071847~TNFSF11-mediated signaling pathway,GO:0071848~positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,GO:0097190~apoptotic signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0019955~cytokine binding,GO:0046872~metal ion binding,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022323:Tumour necrosis factor receptor 11,IPR022361:Tumour necrosis factor receptor 11A,	hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04917:Prolactin signaling pathway,hsa05323:Rheumatoid arthritis,	174810~Osteolysis, familial expansile,602080~Paget disease of bone 2, early-onset,612301~Osteopetrosis, autosomal recessive 7,		SM00208:TNFR,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Deafness,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Metal-binding,Osteopetrosis,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Sodium,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 11A,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000186827	TNF receptor superfamily member 4(TNFRSF4)	Homo sapiens		h_ox40Pathway:OX40 Signaling Pathway,		GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007275~multicellular organism development,GO:0030890~positive regulation of B cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042098~T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046718~viral entry into host cell,GO:0051024~positive regulation of immunoglobulin secretion,GO:0097190~apoptotic signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,	GO:0001618~virus receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,	IPR001368:TNFR/NGFR cysteine-rich region,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR020445:Tumour necrosis factor receptor 4,	hsa04060:Cytokine-cytokine receptor interaction,	615593~Immunodeficiency 16,		SM00208:TNFR,SM01411:SM01411,	3D-structure,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3; truncated,repeat:TNFR-Cys 4,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000162543	UBX domain protein 10(UBXN10)	Homo sapiens							IPR001012:UBX,				SM00166:UBX,	Complete proteome,Phosphoprotein,Reference proteome,	chain:UBX domain-containing protein 10,domain:UBX,
ENSG00000156966	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7(B3GNT7)	Homo sapiens				GO:0016266~O-glycan processing,GO:0018146~keratan sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0008532~N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00533:Glycosaminoglycan biosynthesis - keratan sulfate,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 7,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000101842	V-set and immunoglobulin domain containing 1(VSIG1)	Homo sapiens				GO:0003382~epithelial cell morphogenesis,GO:0030277~maintenance of gastrointestinal epithelium,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR000920:Myelin P0 protein,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:V-set and immunoglobulin domain- containing protein 1,disulfide bond,domain:Ig-like C2-type 2,domain:Ig-like V-type 1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000165238	WNK lysine deficient protein kinase 2(WNK2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:2000021~regulation of ion homeostasis,GO:2000651~positive regulation of sodium ion transmembrane transporter activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR024678:Serine/threonine-protein kinase OSR1/WNK, CCT domain,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Kinase,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase WNK2,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
ENSG00000251359	WWC2 antisense RNA 2(WWC2-AS2)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000165171	Williams Beuren syndrome chromosome region 27(WBSCR27)	Homo sapiens				GO:0032259~methylation,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,						Complete proteome,Polymorphism,Reference proteome,Williams-Beuren syndrome,	chain:Williams-Beuren syndrome chromosomal region 27 protein,sequence variant,
ENSG00000085741	Wnt family member 11(WNT11)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0001837~epithelial to mesenchymal transition,GO:0003151~outflow tract morphogenesis,GO:0003402~planar cell polarity pathway involved in axis elongation,GO:0006468~protein phosphorylation,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007275~multicellular organism development,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0030282~bone mineralization,GO:0030308~negative regulation of cell growth,GO:0030325~adrenal gland development,GO:0030335~positive regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0031667~response to nutrient levels,GO:0032147~activation of protein kinase activity,GO:0032915~positive regulation of transforming growth factor beta2 production,GO:0034394~protein localization to cell surface,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045165~cell fate commitment,GO:0045199~maintenance of epithelial cell apical/basal polarity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048341~paraxial mesoderm formation,GO:0048570~notochord morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048844~artery morphogenesis,GO:0051496~positive regulation of stress fiber assembly,GO:0060021~palate development,GO:0060028~convergent extension involved in axis elongation,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060197~cloacal septation,GO:0060412~ventricular septum morphogenesis,GO:0060484~lung-associated mesenchyme development,GO:0060548~negative regulation of cell death,GO:0060675~ureteric bud morphogenesis,GO:0060775~planar cell polarity pathway involved in gastrula mediolateral intercalation,GO:0061037~negative regulation of cartilage development,GO:0061053~somite development,GO:0061101~neuroendocrine cell differentiation,GO:0070830~bicellular tight junction assembly,GO:0071300~cellular response to retinoic acid,GO:0072177~mesonephric duct development,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0090037~positive regulation of protein kinase C signaling,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090272~negative regulation of fibroblast growth factor production,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0005096~GTPase activator activity,GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0030295~protein kinase activator activity,GO:0044212~transcription regulatory region DNA binding,	IPR005817:Wnt,IPR018161:Wnt protein, conserved site,IPR026536:Wnt-11 protein,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,			SM00097:WNT1,	Complete proteome,Developmental protein,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-11,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
ENSG00000115596	Wnt family member 6(WNT6)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0007275~multicellular organism development,GO:0009798~axis specification,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045165~cell fate commitment,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060684~epithelial-mesenchymal cell signaling,GO:0061303~cornea development in camera-type eye,GO:0070172~positive regulation of tooth mineralization,GO:0071300~cellular response to retinoic acid,GO:0072079~nephron tubule formation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030666~endocytic vesicle membrane,GO:0070062~extracellular exosome,	GO:0005109~frizzled binding,	IPR005817:Wnt,IPR009143:Wnt-6 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,			SM00097:WNT1,	Complete proteome,Developmental protein,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-6,glycosylation site:N-linked (GlcNAc...),signal peptide,
ENSG00000229807	X inactive specific transcript (non-protein coding)(XIST)	Homo sapiens									300087~X-inactivation, familial skewed,
ENSG00000173578	X-C motif chemokine receptor 1(XCR1)	Homo sapiens				GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004950~chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005393:XC chemokine receptor 1,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Chemokine XC receptor 1,disulfide bond,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000122121	X-prolyl aminopeptidase 2(XPNPEP2)	Homo sapiens				GO:0006508~proteolysis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0004177~aminopeptidase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000587:Creatinase,IPR000994:Peptidase M24, structural domain,IPR001131:Peptidase M24B, X-Pro dipeptidase/aminopeptidase P, conserved site,	hsa04974:Protein digestion and absorption,	300909~Angioedema induced by ACE inhibitors, susceptibility to,			Aminopeptidase,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Manganese,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,	chain:Xaa-Pro aminopeptidase 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated alanine,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,propeptide:Removed in mature form,sequence conflict,signal peptide,
ENSG00000173210	actin binding LIM protein family member 3(ABLIM3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007010~cytoskeleton organization,GO:0030032~lamellipodium assembly,GO:0030036~actin cytoskeleton organization,GO:0042384~cilium assembly,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0030027~lamellipodium,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR003128:Villin headpiece,	hsa04360:Axon guidance,			SM00132:LIM,SM00153:VHP,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,LIM domain,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:Actin-binding LIM protein 3,domain:HP,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,helix,modified residue,sequence conflict,sequence variant,splice variant,turn,
ENSG00000107796	actin, alpha 2, smooth muscle, aorta(ACTA2)	Homo sapiens				GO:0006936~muscle contraction,GO:0008217~regulation of blood pressure,GO:0009615~response to virus,GO:0010628~positive regulation of gene expression,GO:0014829~vascular smooth muscle contraction,GO:0072144~glomerular mesangial cell development,GO:0090131~mesenchyme migration,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030485~smooth muscle contractile fiber,GO:0043234~protein complex,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,	hsa04270:Vascular smooth muscle contraction,	611788~Aortic aneurysm, familial thoracic 6,613834~Multisystemic smooth muscle dysfunction syndrome,614042~Moyamoya disease 5,		SM00268:ACTIN,	Acetylation,Aortic aneurysm,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Isopeptide bond,Methylation,Muscle protein,Nucleotide-binding,Oxidation,Polymorphism,Proteomics identification,Reference proteome,	chain:Actin, aortic smooth muscle,modified residue,propeptide:Removed in mature form,sequence conflict,sequence variant,
ENSG00000198576	activity regulated cytoskeleton associated protein(ARC)	Homo sapiens				GO:0006897~endocytosis,GO:0007010~cytoskeleton organization,GO:0007492~endoderm development,GO:0007612~learning,GO:0009952~anterior/posterior pattern specification,GO:0016477~cell migration,GO:0022604~regulation of cell morphogenesis,GO:0048168~regulation of neuronal synaptic plasticity,GO:2000969~positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,	GO:0001669~acrosomal vesicle,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0043197~dendritic spine,GO:0045211~postsynaptic membrane,		IPR023263:Activity-regulated cytoskeleton-associated protein,	hsa05031:Amphetamine addiction,				Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Developmental protein,Endocytosis,Endosome,Membrane,Postsynaptic cell membrane,Reference proteome,Synapse,	chain:Activity-regulated cytoskeleton- associated protein,region of interest:Binds SH3GL1 or SH3GL3,region of interest:Required for binding DNM2,
ENSG00000240303	acyl-CoA dehydrogenase family member 11(ACAD11)	Homo sapiens			General function prediction only,Lipid metabolism,	GO:0006635~fatty acid beta-oxidation,GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0055088~lipid homeostasis,	GO:0005634~nucleus,GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0031966~mitochondrial membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0004466~long-chain-acyl-CoA dehydrogenase activity,GO:0009055~electron carrier activity,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0017099~very-long-chain-acyl-CoA dehydrogenase activity,GO:0050660~flavin adenine dinucleotide binding,GO:0052890~oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,GO:0070991~medium-chain-acyl-CoA dehydrogenase activity,	IPR002575:Aminoglycoside phosphotransferase,IPR006091:Acyl-CoA oxidase/dehydrogenase, central domain,IPR009075:Acyl-CoA dehydrogenase/oxidase C-terminal,IPR009100:Acyl-CoA dehydrogenase/oxidase,IPR011009:Protein kinase-like domain,IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal,					3D-structure,Acetylation,Alternative splicing,Complete proteome,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	binding site:FAD,binding site:FAD; shared with dimeric partner,binding site:Substrate; via amide nitrogen,binding site:Substrate; via carbonyl oxygen,chain:Acyl-CoA dehydrogenase family member 11,chain:Nephrocystin-3,helix,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:FAD; shared with dimeric partner,region of interest:Substrate binging,repeat:TPR 1,repeat:TPR 10,repeat:TPR 11,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,repeat:TPR 9,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000163485	adenosine A1 receptor(ADORA1)	Homo sapiens				GO:0000186~activation of MAPKK activity,GO:0001659~temperature homeostasis,GO:0001666~response to hypoxia,GO:0001973~adenosine receptor signaling pathway,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0002674~negative regulation of acute inflammatory response,GO:0002686~negative regulation of leukocyte migration,GO:0002793~positive regulation of peptide secretion,GO:0003093~regulation of glomerular filtration,GO:0006612~protein targeting to membrane,GO:0006909~phagocytosis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0014050~negative regulation of glutamate secretion,GO:0016042~lipid catabolic process,GO:0032229~negative regulation of synaptic transmission, GABAergic,GO:0032244~positive regulation of nucleoside transport,GO:0032900~negative regulation of neurotrophin production,GO:0035307~positive regulation of protein dephosphorylation,GO:0035814~negative regulation of renal sodium excretion,GO:0042323~negative regulation of circadian sleep/wake cycle, non-REM sleep,GO:0043066~negative regulation of apoptotic process,GO:0043268~positive regulation of potassium ion transport,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045776~negative regulation of blood pressure,GO:0045777~positive regulation of blood pressure,GO:0045908~negative regulation of vasodilation,GO:0046888~negative regulation of hormone secretion,GO:0050890~cognition,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,GO:0050995~negative regulation of lipid catabolic process,GO:0051930~regulation of sensory perception of pain,GO:0051967~negative regulation of synaptic transmission, glutamatergic,GO:0055118~negative regulation of cardiac muscle contraction,GO:0060079~excitatory postsynaptic potential,GO:0060087~relaxation of vascular smooth muscle,GO:0070256~negative regulation of mucus secretion,GO:0097190~apoptotic signaling pathway,GO:1900453~negative regulation of long term synaptic depression,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030673~axolemma,GO:0032279~asymmetric synapse,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0043197~dendritic spine,GO:0045211~postsynaptic membrane,GO:0048786~presynaptic active zone,	GO:0001609~G-protein coupled adenosine receptor activity,GO:0001664~G-protein coupled receptor binding,GO:0001883~purine nucleoside binding,GO:0004629~phospholipase C activity,GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0032795~heterotrimeric G-protein binding,GO:0046982~protein heterodimerization activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001068:Adenosine A1 receptor,IPR001634:Adenosine receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa05032:Morphine addiction,			SM01381:SM01381,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Adenosine receptor A1,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000213638	adenosine deaminase, tRNA specific 3(ADAT3)	Homo sapiens				GO:0006400~tRNA modification,GO:0009451~RNA modification,	GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0008270~zinc ion binding,GO:0019239~deaminase activity,	IPR002125:CMP/dCMP deaminase, zinc-binding,IPR016193:Cytidine deaminase-like,		615286~Mental retardation, autosomal recessive 36,			Acetylation,Complete proteome,Disease mutation,Mental retardation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,tRNA processing,Zinc,	chain:tRNA-specific adenosine deaminase-like protein 3,metal ion-binding site:Zinc,modified residue,sequence variant,
ENSG00000165695	adenylate kinase 8(AK8)	Homo sapiens				GO:0006165~nucleoside diphosphate phosphorylation,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0021591~ventricular system development,	GO:0005829~cytosol,GO:0005930~axoneme,GO:0036126~sperm flagellum,	GO:0004017~adenylate kinase activity,GO:0004127~cytidylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019206~nucleoside kinase activity,	IPR000850:Adenylate kinase,IPR007862:Adenylate kinase, active site lid domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,				Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Polymorphism,Reference proteome,Transferase,	chain:Putative adenylate kinase-like protein C9orf98,nucleotide phosphate-binding region:ATP,region of interest:Adenylate kinase,sequence variant,splice variant,
ENSG00000135298	adhesion G protein-coupled receptor B3(ADGRB3)	Homo sapiens			Function unknown,	GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007520~myoblast fusion,GO:0016322~neuron remodeling,GO:0016525~negative regulation of angiogenesis,GO:0043547~positive regulation of GTPase activity,GO:0048814~regulation of dendrite morphogenesis,GO:0051965~positive regulation of synapse assembly,GO:0061743~motor learning,GO:0099558~maintenance of synapse structure,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043083~synaptic cleft,GO:0098794~postsynapse,	GO:0004930~G-protein coupled receptor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR000859:CUB domain,IPR000884:Thrombospondin, type 1 repeat,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR008077:GPCR, family 2, brain-specific angiogenesis inhibitor,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,				SM00008:HormR,SM00209:TSP1,SM00303:GPS,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Brain-specific angiogenesis inhibitor 3,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,disulfide bond,domain:CUB,domain:GPS,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000112414	adhesion G protein-coupled receptor G6(ADGRG6)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0014037~Schwann cell differentiation,GO:0019933~cAMP-mediated signaling,GO:0022011~myelination in peripheral nervous system,GO:0042552~myelination,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005518~collagen binding,GO:0043236~laminin binding,GO:0050840~extracellular matrix binding,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR000859:CUB domain,IPR001759:Pentaxin,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,		616503~Lethal congenital contracture syndrome 9,		SM00042:CUB,SM00159:PTX,SM00303:GPS,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 126,compositionally biased region:Ser-rich,disulfide bond,domain:CUB,domain:GPS,domain:Pentaxin,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000129474	ajuba LIM protein(AJUBA)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007010~cytoskeleton organization,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0030032~lamellipodium assembly,GO:0030334~regulation of cell migration,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031334~positive regulation of protein complex assembly,GO:0033673~negative regulation of kinase activity,GO:0034613~cellular protein localization,GO:0035195~gene silencing by miRNA,GO:0035313~wound healing, spreading of epidermal cells,GO:0035331~negative regulation of hippo signaling,GO:0043087~regulation of GTPase activity,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0046474~glycerophospholipid biosynthetic process,GO:0048041~focal adhesion assembly,GO:1900037~regulation of cellular response to hypoxia,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005925~focal adhesion,GO:0030027~lamellipodium,	GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0045294~alpha-catenin binding,GO:0051015~actin filament binding,	IPR001781:Zinc finger, LIM-type,	hsa04390:Hippo signaling pathway,			SM00132:LIM,	Alternative splicing,Cell adhesion,Cell cycle,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,LIM domain,Membrane,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-mediated gene silencing,Transcription,Transcription regulation,Zinc,	chain:Protein ajuba,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,modified residue,region of interest:PreLIM,short sequence motif:Nuclear localization signal,
ENSG00000164904	aldehyde dehydrogenase 7 family member A1(ALDH7A1)	Homo sapiens				GO:0006081~cellular aldehyde metabolic process,GO:0006554~lysine catabolic process,GO:0007605~sensory perception of sound,GO:0019285~glycine betaine biosynthetic process from choline,GO:0042426~choline catabolic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0004043~L-aminoadipate-semialdehyde dehydrogenase activity,GO:0005515~protein binding,GO:0008802~betaine-aldehyde dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,	IPR015590:Aldehyde dehydrogenase domain,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa00053:Ascorbate and aldarate metabolism,hsa00071:Fatty acid degradation,hsa00260:Glycine, serine and threonine metabolism,hsa00280:Valine, leucine and isoleucine degradation,hsa00300:Lysine biosynthesis,hsa00310:Lysine degradation,hsa00330:Arginine and proline metabolism,hsa00340:Histidine metabolism,hsa00380:Tryptophan metabolism,hsa00410:beta-Alanine metabolism,hsa00561:Glycerolipid metabolism,hsa00620:Pyruvate metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,	266100~Epilepsy, pyridoxine-dependent,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Epilepsy,Mitochondrion,NAD,Nucleus,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	active site:Nucleophile,active site:Proton acceptor,chain:Alpha-aminoadipic semialdehyde dehydrogenase,helix,nucleotide phosphate-binding region:NAD,sequence variant,site:Transition state stabilizer,strand,turn,
ENSG00000121410	alpha-1-B glycoprotein(A1BG)	Homo sapiens				GO:0002576~platelet degranulation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR016332:Alpha-1B-glycoprotein/leukocyte immunoglobulin-like receptor,			PIRSF001979:alpha-1B-glycoprotein,	SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Alpha-1B-glycoprotein,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,domain:Ig-like V-type 3,domain:Ig-like V-type 4,domain:Ig-like V-type 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000163697	amyloid beta precursor protein binding family B member 2(APBB2)	Homo sapiens				GO:0001764~neuron migration,GO:0006355~regulation of transcription, DNA-templated,GO:0007050~cell cycle arrest,GO:0007411~axon guidance,GO:0030198~extracellular matrix organization,GO:0030308~negative regulation of cell growth,GO:0035556~intracellular signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030027~lamellipodium,GO:0030426~growth cone,GO:0045202~synapse,	GO:0001540~beta-amyloid binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,	IPR001202:WW domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,		104300~Alzheimer disease, late-onset,		SM00456:WW,SM00462:PTB,	Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Amyloid beta A4 precursor protein-binding family B member 2,domain:PID 1,domain:PID 2,domain:WW,modified residue,sequence conflict,splice variant,
ENSG00000029534	ankyrin 1(ANK1)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,	General function prediction only,	GO:0006887~exocytosis,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0010638~positive regulation of organelle organization,GO:0045199~maintenance of epithelial cell apical/basal polarity,GO:0072661~protein targeting to plasma membrane,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014731~spectrin-associated cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0016529~sarcoplasmic reticulum,GO:0030018~Z disc,GO:0030673~axolemma,GO:0031430~M band,GO:0042383~sarcolemma,GO:0045211~postsynaptic membrane,	GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0019899~enzyme binding,GO:0030507~spectrin binding,GO:0051117~ATPase binding,	IPR000488:Death domain,IPR000906:ZU5,IPR002110:Ankyrin repeat,IPR011029:Death-like domain,IPR020683:Ankyrin repeat-containing domain,	hsa05205:Proteoglycans in cancer,	182900~Spherocytosis, type 1,		SM00005:DEATH,SM00218:ZU5,SM00248:ANK,	3D-structure,Alternative promoter usage,Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Elliptocytosis,Hereditary hemolytic anemia,Hydroxylation,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sarcoplasmic reticulum,Signal,	chain:Ankyrin-1,domain:Death,domain:ZU5,helix,modified residue,mutagenesis site,region of interest:55 kDa regulatory domain,region of interest:89 kDa domain,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 12,repeat:ANK 13,repeat:ANK 14,repeat:ANK 15,repeat:ANK 16,repeat:ANK 17,repeat:ANK 18,repeat:ANK 19,repeat:ANK 2,repeat:ANK 20,repeat:ANK 21,repeat:ANK 22,repeat:ANK 23,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000118137	apolipoprotein A1(APOA1)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),		GO:0001523~retinoid metabolic process,GO:0001932~regulation of protein phosphorylation,GO:0001935~endothelial cell proliferation,GO:0002576~platelet degranulation,GO:0002740~negative regulation of cytokine secretion involved in immune response,GO:0006644~phospholipid metabolic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0006869~lipid transport,GO:0006898~receptor-mediated endocytosis,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007584~response to nutrient,GO:0008203~cholesterol metabolic process,GO:0008211~glucocorticoid metabolic process,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0010873~positive regulation of cholesterol esterification,GO:0010898~positive regulation of triglyceride catabolic process,GO:0010903~negative regulation of very-low-density lipoprotein particle remodeling,GO:0014012~peripheral nervous system axon regeneration,GO:0018158~protein oxidation,GO:0018206~peptidyl-methionine modification,GO:0019433~triglyceride catabolic process,GO:0019915~lipid storage,GO:0030300~regulation of intestinal cholesterol absorption,GO:0030301~cholesterol transport,GO:0030325~adrenal gland development,GO:0031100~organ regeneration,GO:0031102~neuron projection regeneration,GO:0032489~regulation of Cdc42 protein signal transduction,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0034375~high-density lipoprotein particle remodeling,GO:0034380~high-density lipoprotein particle assembly,GO:0034384~high-density lipoprotein particle clearance,GO:0035025~positive regulation of Rho protein signal transduction,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0043534~blood vessel endothelial cell migration,GO:0043627~response to estrogen,GO:0043691~reverse cholesterol transport,GO:0044267~cellular protein metabolic process,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0050713~negative regulation of interleukin-1 beta secretion,GO:0050728~negative regulation of inflammatory response,GO:0050821~protein stabilization,GO:0050919~negative chemotaxis,GO:0051006~positive regulation of lipoprotein lipase activity,GO:0051180~vitamin transport,GO:0051345~positive regulation of hydrolase activity,GO:0051496~positive regulation of stress fiber assembly,GO:0055085~transmembrane transport,GO:0055091~phospholipid homeostasis,GO:0060192~negative regulation of lipase activity,GO:0060354~negative regulation of cell adhesion molecule production,GO:0060761~negative regulation of response to cytokine stimulus,GO:0070328~triglyceride homeostasis,GO:0070371~ERK1 and ERK2 cascade,GO:0070508~cholesterol import,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030139~endocytic vesicle,GO:0031410~cytoplasmic vesicle,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0034365~discoidal high-density lipoprotein particle,GO:0034366~spherical high-density lipoprotein particle,GO:0034774~secretory granule lumen,GO:0042627~chylomicron,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,	GO:0001540~beta-amyloid binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0005548~phospholipid transporter activity,GO:0008035~high-density lipoprotein particle binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0017127~cholesterol transporter activity,GO:0019899~enzyme binding,GO:0031210~phosphatidylcholine binding,GO:0034190~apolipoprotein receptor binding,GO:0034191~apolipoprotein A-I receptor binding,GO:0042802~identical protein binding,GO:0045499~chemorepellent activity,GO:0055102~lipase inhibitor activity,GO:0060228~phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0070653~high-density lipoprotein particle receptor binding,	IPR000074:Apolipoprotein A1/A4/E,	hsa03320:PPAR signaling pathway,hsa04975:Fat digestion and absorption,hsa04977:Vitamin digestion and absorption,hsa05143:African trypanosomiasis,	105200~Amyloidosis, 3 or more types,604091~Hypoalphalipoproteinemia,ApoA-I and apoC-III deficiency, combined~ApoA-I and apoC-III deficiency, combined,Corneal clouding, autosomal recessive~Corneal clouding, autosomal recessive,			3D-structure,Amyloid,Amyloidosis,Atherosclerosis,Cholesterol metabolism,Complete proteome,Direct protein sequencing,Disease mutation,Glycation,Glycoprotein,HDL,Lipid metabolism,Lipid transport,Lipoprotein,Neuropathy,Oxidation,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Steroid metabolism,Sterol metabolism,Transport,	chain:Apolipoprotein A-I,chain:Apolipoprotein A-I(1-242),glycosylation site:N-linked (Glc) (glycation),helix,modified residue,region of interest:10 X approximate tandem repeats,repeat:1,repeat:10,repeat:2,repeat:3; half-length,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9; half-length,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000100298	apolipoprotein B mRNA editing enzyme catalytic subunit 3H(APOBEC3H)	Homo sapiens				GO:0009972~cytidine deamination,GO:0010529~negative regulation of transposition,GO:0045087~innate immune response,GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0048525~negative regulation of viral process,GO:0051607~defense response to virus,GO:0070383~DNA cytosine deamination,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004126~cytidine deaminase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016814~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,	IPR002125:CMP/dCMP deaminase, zinc-binding,IPR013158:APOBEC-like, N-terminal,IPR016192:APOBEC/CMP deaminase, zinc-binding,IPR016193:Cytidine deaminase-like,					Alternative splicing,Antiviral defense,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Immunity,Innate immunity,Lipoprotein,Metal-binding,Nucleus,Polymorphism,Reference proteome,Zinc,	active site:Proton donor,chain:DNA dC->dU-editing enzyme APOBEC-3H,metal ion-binding site:Zinc,sequence conflict,sequence variant,splice variant,
ENSG00000130203	apolipoprotein E(APOE)	Homo sapiens				GO:0000302~response to reactive oxygen species,GO:0001523~retinoid metabolic process,GO:0001937~negative regulation of endothelial cell proliferation,GO:0002021~response to dietary excess,GO:0006641~triglyceride metabolic process,GO:0006707~cholesterol catabolic process,GO:0006869~lipid transport,GO:0006874~cellular calcium ion homeostasis,GO:0006898~receptor-mediated endocytosis,GO:0006979~response to oxidative stress,GO:0007010~cytoskeleton organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007263~nitric oxide mediated signal transduction,GO:0007271~synaptic transmission, cholinergic,GO:0008203~cholesterol metabolic process,GO:0010468~regulation of gene expression,GO:0010544~negative regulation of platelet activation,GO:0010873~positive regulation of cholesterol esterification,GO:0010875~positive regulation of cholesterol efflux,GO:0010877~lipid transport involved in lipid storage,GO:0015909~long-chain fatty acid transport,GO:0017038~protein import,GO:0019068~virion assembly,GO:0019433~triglyceride catabolic process,GO:0019934~cGMP-mediated signaling,GO:0030195~negative regulation of blood coagulation,GO:0030516~regulation of axon extension,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0031102~neuron projection regeneration,GO:0032489~regulation of Cdc42 protein signal transduction,GO:0032805~positive regulation of low-density lipoprotein particle receptor catabolic process,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034372~very-low-density lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0034375~high-density lipoprotein particle remodeling,GO:0034380~high-density lipoprotein particle assembly,GO:0034382~chylomicron remnant clearance,GO:0034384~high-density lipoprotein particle clearance,GO:0034447~very-low-density lipoprotein particle clearance,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042159~lipoprotein catabolic process,GO:0042311~vasodilation,GO:0042632~cholesterol homeostasis,GO:0043407~negative regulation of MAP kinase activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0043691~reverse cholesterol transport,GO:0044794~positive regulation by host of viral process,GO:0045541~negative regulation of cholesterol biosynthetic process,GO:0046889~positive regulation of lipid biosynthetic process,GO:0046907~intracellular transport,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048844~artery morphogenesis,GO:0050728~negative regulation of inflammatory response,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051044~positive regulation of membrane protein ectodomain proteolysis,GO:0051055~negative regulation of lipid biosynthetic process,GO:0051651~maintenance of location in cell,GO:0055089~fatty acid homeostasis,GO:0060999~positive regulation of dendritic spine development,GO:0061000~negative regulation of dendritic spine development,GO:0070328~triglyceride homeostasis,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090370~negative regulation of cholesterol efflux,GO:0097113~AMPA glutamate receptor clustering,GO:0097114~NMDA glutamate receptor clustering,GO:0098869~cellular oxidant detoxification,GO:1900221~regulation of beta-amyloid clearance,GO:1901214~regulation of neuron death,GO:1901215~negative regulation of neuron death,GO:1901216~positive regulation of neuron death,GO:1901627~negative regulation of postsynaptic membrane organization,GO:1901628~positive regulation of postsynaptic membrane organization,GO:1901630~negative regulation of presynaptic membrane organization,GO:1901631~positive regulation of presynaptic membrane organization,GO:1902004~positive regulation of beta-amyloid formation,GO:1902430~negative regulation of beta-amyloid formation,GO:1902947~regulation of tau-protein kinase activity,GO:1902951~negative regulation of dendritic spine maintenance,GO:1902952~positive regulation of dendritic spine maintenance,GO:1902995~positive regulation of phospholipid efflux,GO:1902998~positive regulation of neurofibrillary tangle assembly,GO:1902999~negative regulation of phospholipid efflux,GO:1903001~negative regulation of lipid transport across blood brain barrier,GO:1903002~positive regulation of lipid transport across blood brain barrier,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0034361~very-low-density lipoprotein particle,GO:0034362~low-density lipoprotein particle,GO:0034363~intermediate-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0042627~chylomicron,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,	GO:0001540~beta-amyloid binding,GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008201~heparin binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0016209~antioxidant activity,GO:0017127~cholesterol transporter activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046911~metal chelating activity,GO:0048156~tau protein binding,GO:0050750~low-density lipoprotein particle receptor binding,GO:0060228~phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0070326~very-low-density lipoprotein particle receptor binding,GO:0071813~lipoprotein particle binding,	IPR000074:Apolipoprotein A1/A4/E,	hsa05010:Alzheimer's disease,	104310~Alzheimer disease-2,269600~Sea-blue histiocyte disease,603075~Macular degeneration, age-related,611771~Lipoprotein glomerulopathy,Hyperlipoproteinemia, type III~Hyperlipoproteinemia, type III,Myocardial infarction susceptibility~Myocardial infarction susceptibility,			3D-structure,Alzheimer disease,Amyloidosis,Cholesterol metabolism,Chylomicron,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Glycation,Glycoprotein,HDL,Heparin-binding,Hyperlipidemia,Lipid metabolism,Lipid transport,Lipoprotein,Neurodegeneration,Oxidation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Steroid metabolism,Sterol metabolism,Transport,VLDL,	chain:Apolipoprotein E,glycosylation site:N-linked (Glc) (glycation),glycosylation site:O-linked (GalNAc...),helix,modified residue,region of interest:8 X 22 AA approximate tandem repeats,region of interest:Heparin-binding,region of interest:LDL receptor binding,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,sequence variant,signal peptide,strand,turn,
ENSG00000165272	aquaporin 3 (Gill blood group)(AQP3)	Homo sapiens				GO:0002684~positive regulation of immune system process,GO:0003091~renal water homeostasis,GO:0006810~transport,GO:0006833~water transport,GO:0007588~excretion,GO:0009992~cellular water homeostasis,GO:0015793~glycerol transport,GO:0032526~response to retinoic acid,GO:0033280~response to vitamin D,GO:0034220~ion transmembrane transport,GO:0042476~odontogenesis,GO:0045616~regulation of keratinocyte differentiation,GO:0051592~response to calcium ion,GO:0070295~renal water absorption,GO:0071918~urea transmembrane transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,	GO:0005215~transporter activity,GO:0015204~urea transmembrane transporter activity,GO:0015250~water channel activity,GO:0015254~glycerol channel activity,	IPR000425:Major intrinsic protein,IPR022357:Major intrinsic protein, conserved site,IPR023271:Aquaporin-like,IPR023275:Aquaporin 3,	hsa04962:Vasopressin-regulated water reabsorption,	607457~Blood group GIL,			Alternative splicing,Blood group antigen,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Aquaporin-3,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:NPA 1,short sequence motif:NPA 2,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000157399	arylsulfatase E (chondrodysplasia punctata 1)(ARSE)	Homo sapiens				GO:0001501~skeletal system development,GO:0006687~glycosphingolipid metabolic process,GO:0008152~metabolic process,GO:0043687~post-translational protein modification,	GO:0005788~endoplasmic reticulum lumen,GO:0005795~Golgi stack,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004065~arylsulfatase activity,GO:0008484~sulfuric ester hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR024607:Sulfatase, conserved site,		302950~Chondrodysplasia punctata, X-linked recessive,			Calcium,Complete proteome,Disease mutation,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Metal-binding,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	binding site:Substrate,chain:Arylsulfatase E,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via 3-oxoalanine,modified residue,sequence conflict,sequence variant,signal peptide,
ENSG00000148219	astrotactin 2(ASTN2)	Homo sapiens				GO:0015031~protein transport,GO:2000009~negative regulation of protein localization to cell surface,	GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005938~cell cortex,GO:0016021~integral component of membrane,GO:0030136~clathrin-coated vesicle,GO:0043204~perikaryon,GO:0060187~cell pole,	GO:0005509~calcium ion binding,GO:0043533~inositol 1,3,4,5 tetrakisphosphate binding,	IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR020864:Membrane attack complex component/perforin (MACPF) domain,IPR026995:Astrotactin,				SM00457:MACPF,	3D-structure,Alternative splicing,Calcium,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Disulfide bond,EGF-like domain,Endosome,Glycoprotein,Membrane,Metal-binding,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Astrotactin-2,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Fibronectin type-III,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000168874	atonal bHLH transcription factor 8(ATOH8)	Homo sapiens				GO:0001704~formation of primary germ layer,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006351~transcription, DNA-templated,GO:0007399~nervous system development,GO:0010595~positive regulation of endothelial cell migration,GO:0030154~cell differentiation,GO:0035148~tube formation,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051450~myoblast proliferation,GO:0060395~SMAD protein signal transduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0033613~activating transcription factor binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Neurogenesis,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Protein atonal homolog 8,compositionally biased region:Pro-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence variant,splice variant,
ENSG00000144648	atypical chemokine receptor 2(ACKR2)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0070098~chemokine-mediated signaling pathway,	GO:0005769~early endosome,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0055037~recycling endosome,	GO:0004950~chemokine receptor activity,GO:0005044~scavenger receptor activity,GO:0016493~C-C chemokine receptor activity,GO:0019957~C-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR001277:CXC chemokine receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Inflammatory response,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Chemokine-binding protein 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000181652	autophagy related 9B(ATG9B)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0000422~mitophagy,GO:0034497~protein localization to pre-autophagosomal structure,GO:0034727~piecemeal microautophagy of nucleus,GO:0044805~late nucleophagy,	GO:0000407~pre-autophagosomal structure,GO:0000421~autophagosome membrane,GO:0005776~autophagosome,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,		IPR007241:Autophagy-related protein 9,					Alternative splicing,Autophagy,Complete proteome,Cytoplasmic vesicle,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Autophagy-related protein 9B,compositionally biased region:Pro-rich,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000089685	baculoviral IAP repeat containing 5(BIRC5)	Homo sapiens		h_bcellsurvivalPathway:B Cell Survival Pathway,		GO:0000086~G2/M transition of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0000910~cytokinesis,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007346~regulation of mitotic cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0009966~regulation of signal transduction,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0031503~protein complex localization,GO:0031536~positive regulation of exit from mitosis,GO:0031577~spindle checkpoint,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0051301~cell division,GO:0051303~establishment of chromosome localization,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061469~regulation of type B pancreatic cell proliferation,GO:0090307~mitotic spindle assembly,GO:1990001~inhibition of cysteine-type endopeptidase activity involved in apoptotic process,	GO:0000228~nuclear chromosome,GO:0000775~chromosome, centromeric region,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005819~spindle,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0030496~midbody,GO:0031021~interphase microtubule organizing center,GO:0032133~chromosome passenger complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0008536~Ran GTPase binding,GO:0015631~tubulin binding,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0048037~cofactor binding,GO:0050897~cobalt ion binding,GO:0051087~chaperone binding,	IPR001370:Baculoviral inhibition of apoptosis protein repeat,	hsa04390:Hippo signaling pathway,hsa05161:Hepatitis B,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,			SM00238:BIR,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Kinetochore,Metal-binding,Microtubule,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repressor,Thiol protease inhibitor,Transcription,Transcription regulation,Ubl conjugation,Zinc,	chain:Baculoviral IAP repeat-containing protein 5,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,repeat:BIR,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000123095	basic helix-loop-helix family member e41(BHLHE41)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008283~cell proliferation,GO:0009887~organ morphogenesis,GO:0010832~negative regulation of myotube differentiation,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0030154~cell differentiation,GO:0032922~circadian regulation of gene expression,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0043425~bHLH transcription factor binding,GO:0043426~MRF binding,GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR003650:Orange,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04710:Circadian rhythm,	612975~Short sleeper,		SM00353:HLH,SM00511:ORANGE,	Biological rhythms,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Class E basic helix-loop-helix protein 41,compositionally biased region:Ala/Gly-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,
ENSG00000100024	beta-ureidopropionase 1(UPB1)	Homo sapiens			General function prediction only,	GO:0006807~nitrogen compound metabolic process,GO:0019483~beta-alanine biosynthetic process,GO:0046135~pyrimidine nucleoside catabolic process,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003837~beta-ureidopropionase activity,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,GO:0046872~metal ion binding,	IPR003010:Carbon-nitrogen hydrolase,	hsa00240:Pyrimidine metabolism,hsa00410:beta-Alanine metabolism,hsa00770:Pantothenate and CoA biosynthesis,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,	613161~Beta-ureidopropionase deficiency,			Allosteric enzyme,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:Beta-ureidopropionase,domain:CN hydrolase,metal ion-binding site:Zinc,sequence conflict,sequence variant,
ENSG00000169627	bolA family member 2B(BOLA2B)	Homo sapiens					GO:0070062~extracellular exosome,		IPR002634:BolA protein,			PIRSF003113:Stress-induced morphoprotein, BolA type,		Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Proteomics identification,Reference proteome,	chain:BolA-like protein 2,modified residue,splice variant,
ENSG00000133134	brain expressed X-linked 2(BEX2)	Homo sapiens				GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0042981~regulation of apoptotic process,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR007623:Brain-expressed X-linked protein,IPR021156:Transcription elongation factor A-like/Brain expressed X-linked-like,			PIRSF008633:brain-expressed X-linked protein,		Alternative splicing,Apoptosis,Cell cycle,Complete proteome,Cytoplasm,Methylation,Nucleus,Reference proteome,	chain:Protein BEX2,
ENSG00000136717	bridging integrator 1(BIN1)	Homo sapiens	62.G1-phase_progression_by_Myc,			GO:0006897~endocytosis,GO:0006997~nucleus organization,GO:0008283~cell proliferation,GO:0016032~viral process,GO:0030100~regulation of endocytosis,GO:0042692~muscle cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0045664~regulation of neuron differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0051647~nucleus localization,GO:0060988~lipid tube assembly,GO:0071156~regulation of cell cycle arrest,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0030424~axon,GO:0031674~I band,GO:0033268~node of Ranvier,GO:0043194~axon initial segment,GO:0060987~lipid tube,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0048156~tau protein binding,GO:0051015~actin filament binding,GO:0070063~RNA polymerase binding,	IPR001452:Src homology-3 domain,IPR003005:Amphiphysin,IPR003023:Amphiphysin, isoform 2,IPR004148:BAR domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,	255200~Myopathy, centronuclear, autosomal recessive,		SM00326:SH3,SM00721:BAR,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,Endocytosis,Host-virus interaction,Nucleus,Phosphoprotein,Reference proteome,SH3 domain,Tumor suppressor,	chain:Myc box-dependent-interacting protein 1,domain:BAR,domain:SH3,helix,modified residue,region of interest:Clathrin-binding,region of interest:Interaction with BIN2,sequence conflict,sequence variant,splice variant,strand,
ENSG00000128536	cadherin related family member 3(CDHR3)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0046718~viral entry into host cell,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0001618~virus receptor activity,GO:0005509~calcium ion binding,	IPR002126:Cadherin,IPR015919:Cadherin-like,				SM00112:CA,	Alternative splicing,Asthma,Calcium,Cell adhesion,Cell membrane,Complete proteome,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-like protein 28,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000187492	cadherin related family member 4(CDHR4)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,	IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,				SM00112:CA,	Alternative splicing,Calcium,Cell adhesion,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-like protein 29,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000164304	cancer antigen 1(CAGE1)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Cancer-associated gene 1 protein,sequence conflict,sequence variant,splice variant,
ENSG00000119865	cannabinoid receptor interacting protein 1(CNRIP1)	Homo sapiens					GO:0043209~myelin sheath,							Alternative splicing,Complete proteome,Direct protein sequencing,Proteomics identification,Reference proteome,	chain:CB1 cannabinoid receptor-interacting protein 1,sequence conflict,splice variant,
ENSG00000254598	casein kinase 2 alpha 3(CSNK2A3)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0008284~positive regulation of cell proliferation,GO:0030307~positive regulation of cell growth,GO:0045732~positive regulation of protein catabolic process,		GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Casein kinase II subunit alpha,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,strand,turn,
ENSG00000119326	catenin alpha like 1(CTNNAL1)	Homo sapiens				GO:0007155~cell adhesion,GO:0007266~Rho protein signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0045296~cadherin binding,GO:0051015~actin filament binding,	IPR001033:Alpha-catenin,IPR006077:Vinculin/alpha-catenin,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Alpha-catulin,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000152705	cation channel sperm associated 3(CATSPER3)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006816~calcium ion transport,GO:0007275~multicellular organism development,GO:0030317~sperm motility,GO:0032570~response to progesterone,GO:0034220~ion transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0035036~sperm-egg recognition,GO:0048240~sperm capacitation,GO:0070588~calcium ion transmembrane transport,GO:0086010~membrane depolarization during action potential,	GO:0001669~acrosomal vesicle,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0031514~motile cilium,GO:0036128~CatSper complex,	GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,	IPR005821:Ion transport domain,					Calcium,Calcium channel,Calcium transport,Cell membrane,Cell projection,Cilium,Complete proteome,Developmental protein,Differentiation,Flagellum,Ion channel,Ion transport,Membrane,Polymorphism,Reference proteome,Spermatogenesis,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Cation channel sperm-associated protein 3,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,topological domain:Pore forming,transmembrane region,
ENSG00000111665	cell division cycle associated 3(CDCA3)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0016567~protein ubiquitination,GO:0051301~cell division,	GO:0005829~cytosol,GO:0005911~cell-cell junction,	GO:0005515~protein binding,						Cell cycle,Cell division,Complete proteome,Cytoplasm,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,	chain:Cell division cycle-associated protein 3,modified residue,region of interest:F-box-like,short sequence motif:KEN box,
ENSG00000138028	cell growth regulator with EF-hand domain 1(CGREF1)	Homo sapiens				GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0007155~cell adhesion,GO:0008285~negative regulation of cell proliferation,	GO:0005576~extracellular region,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,					Alternative splicing,Calcium,Cell adhesion,Cell cycle,Complete proteome,Growth arrest,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	calcium-binding region:1,calcium-binding region:2,chain:Cell growth regulator with EF hand domain protein 1,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,sequence variant,signal peptide,
ENSG00000169583	chloride intracellular channel 3(CLIC3)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0006821~chloride transport,GO:0007165~signal transduction,GO:0034765~regulation of ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0034707~chloride channel complex,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0005244~voltage-gated ion channel activity,GO:0005254~chloride channel activity,GO:0005515~protein binding,	IPR002946:Intracellular chloride channel,IPR004045:Glutathione S-transferase, N-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,					3D-structure,Chloride,Chloride channel,Complete proteome,Cytoplasm,Disulfide bond,Ion channel,Ion transport,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Chloride intracellular channel protein 3,domain:GST C-terminal,domain:GST N-terminal,helix,region of interest:Required for insertion into the membrane,sequence variant,strand,transmembrane region,
ENSG00000188037	chloride voltage-gated channel 1(CLCN1)	Homo sapiens			Signal transduction mechanisms,	GO:0006936~muscle contraction,GO:0019227~neuronal action potential propagation,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0034707~chloride channel complex,GO:0042383~sarcolemma,	GO:0005247~voltage-gated chloride channel activity,GO:0005515~protein binding,GO:0031404~chloride ion binding,GO:0042803~protein homodimerization activity,	IPR000644:Cystathionine beta-synthase, core,IPR001807:Chloride channel, voltage gated,IPR002243:Chloride channel ClC-1,IPR014743:Chloride channel, core,		160800~Myotonia congenita, dominant,255700~Myotonia congenita, recessive,Myotonia levior, recessive~Myotonia levior, recessive,			CBS domain,Cell membrane,Chloride,Chloride channel,Complete proteome,Disease mutation,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	binding site:Chloride,binding site:Chloride; via amide nitrogen,chain:Chloride channel protein 1,domain:CBS 1,domain:CBS 2,region of interest:In-membrane helix,region of interest:In-membrane loop between two helices,sequence conflict,sequence variant,short sequence motif:Selectivity filter part_1,short sequence motif:Selectivity filter part_2,short sequence motif:Selectivity filter part_3,topological domain:Cytoplasmic,transmembrane region,
ENSG00000138135	cholesterol 25-hydroxylase(CH25H)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006699~bile acid biosynthetic process,GO:0008203~cholesterol metabolic process,GO:0016126~sterol biosynthetic process,GO:0035754~B cell chemotaxis,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0000254~C-4 methylsterol oxidase activity,GO:0001567~cholesterol 25-hydroxylase activity,GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,	IPR006694:Fatty acid hydroxylase,	hsa00120:Primary bile acid biosynthesis,				Complete proteome,Endoplasmic reticulum,Glycoprotein,Iron,Lipid biosynthesis,Lipid metabolism,Membrane,Metal-binding,Monooxygenase,Oxidoreductase,Polymorphism,Reference proteome,Steroid biosynthesis,Steroid metabolism,Sterol biosynthesis,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:Cholesterol 25-hydroxylase,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Histidine box-1,short sequence motif:Histidine box-2,short sequence motif:Histidine box-3,transmembrane region,
ENSG00000090539	chordin(CHRD)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,		GO:0001501~skeletal system development,GO:0001649~osteoblast differentiation,GO:0001702~gastrulation with mouth forming second,GO:0001707~mesoderm formation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0007275~multicellular organism development,GO:0021919~BMP signaling pathway involved in spinal cord dorsal/ventral patterning,GO:0030336~negative regulation of cell migration,GO:0030514~negative regulation of BMP signaling pathway,GO:0030900~forebrain development,GO:0033504~floor plate development,GO:0045668~negative regulation of osteoblast differentiation,GO:0045785~positive regulation of cell adhesion,	GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0008201~heparin binding,GO:0019955~cytokine binding,GO:0045545~syndecan binding,	IPR001007:von Willebrand factor, type C,IPR010895:CHRD,IPR016353:Chordin,	hsa04350:TGF-beta signaling pathway,		PIRSF002496:chordin,	SM00214:VWC,SM00754:CHRD,	Alternative splicing,Complete proteome,Developmental protein,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Chordin,domain:CHRD 1,domain:CHRD 2,domain:CHRD 3,domain:CHRD 4,domain:VWFC 1,domain:VWFC 2,domain:VWFC 3,domain:VWFC 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000215910	chromosome 1 open reading frame 167(C1orf167)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf167,compositionally biased region:Gln-rich,sequence variant,splice variant,
ENSG00000188004	chromosome 1 open reading frame 204(C1orf204)	Homo sapiens					GO:0005622~intracellular,GO:0016021~integral component of membrane,	GO:0044822~poly(A) RNA binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Immunoglobulin domain,Membrane,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:V-set and immunoglobulin domain- containing protein 8,compositionally biased region:Poly-Cys,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000116667	chromosome 1 open reading frame 21(C1orf21)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein C1orf21,modified residue,
ENSG00000222047	chromosome 10 open reading frame 55(C10orf55)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein C10orf55,
ENSG00000187479	chromosome 11 open reading frame 96(C11orf96)	Homo sapiens												Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein Ag2 homolog,compositionally biased region:Pro-rich,modified residue,sequence variant,
ENSG00000162062	chromosome 16 open reading frame 59(C16orf59)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C16orf59,sequence variant,splice variant,
ENSG00000260456	chromosome 16 open reading frame 95(C16orf95)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000228300	chromosome 19 open reading frame 24(C19orf24)	Homo sapiens					GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,		IPR009565:Protein of unknown function DUF1180,					Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C19orf24,sequence conflict,
ENSG00000198723	chromosome 19 open reading frame 45(C19orf45)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C19orf45,sequence conflict,sequence variant,
ENSG00000221916	chromosome 19 open reading frame 73(C19orf73)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C19orf73,sequence variant,
ENSG00000205856	chromosome 22 open reading frame 42(C22orf42)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C22orf42,sequence variant,
ENSG00000114529	chromosome 3 open reading frame 52(C3orf52)	Homo sapiens					GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Alternative splicing,Complete proteome,Endoplasmic reticulum,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:TPA-induced transmembrane protein,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000243449	chromosome 4 open reading frame 48(C4orf48)	Homo sapiens					GO:0005576~extracellular region,							Alternative splicing,Complete proteome,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C4orf48,compositionally biased region:Poly-Leu,compositionally biased region:Pro-rich,
ENSG00000164241	chromosome 5 open reading frame 63(C5orf63)	Homo sapiens				GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,		IPR008554:Glutaredoxin-like,IPR012336:Thioredoxin-like fold,					Alternative splicing,Complete proteome,Disulfide bond,Electron transport,Proteomics identification,Reference proteome,Transport,	chain:Glutaredoxin-like protein YDR286C homolog,disulfide bond,
ENSG00000177335	chromosome 8 open reading frame 31(C8orf31)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C8orf31,sequence conflict,sequence variant,splice variant,
ENSG00000253250	chromosome 8 open reading frame 88(C8orf88)	Homo sapiens				GO:0045947~negative regulation of translational initiation,	GO:0005737~cytoplasm,	GO:0008190~eukaryotic initiation factor 4E binding,						Complete proteome,Reference proteome,
ENSG00000164972	chromosome 9 open reading frame 24(C9orf24)	Homo sapiens				GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0043623~cellular protein complex assembly,	GO:0002177~manchette,GO:0005634~nucleus,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0043014~alpha-tubulin binding,						Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Spermatogenesis,	chain:Uncharacterized protein C9orf24,sequence variant,splice variant,
ENSG00000139610	chymotrypsin like elastase family member 1(CELA1)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006508~proteolysis,GO:0006954~inflammatory response,GO:0009791~post-embryonic development,GO:0016055~Wnt signaling pathway,GO:0031017~exocrine pancreas development,GO:0035264~multicellular organism growth,GO:0042127~regulation of cell proliferation,GO:0045595~regulation of cell differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048771~tissue remodeling,GO:0060309~elastin catabolic process,GO:0061113~pancreas morphogenesis,	GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,GO:0046872~metal ion binding,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	Calcium,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Metal-binding,Polymorphism,Protease,Reference proteome,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Chymotrypsin-like elastase family member 1,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,
ENSG00000141086	chymotrypsin like(CTRL)	Homo sapiens				GO:0006508~proteolysis,GO:0007586~digestion,	GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00020:Tryp_SPc,	Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Chymotrypsin-like protease CTRL-1,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),propeptide:Activation peptide,sequence variant,signal peptide,
ENSG00000160318	claudin domain containing 2(CLDND2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR004031:PMP-22/EMP/MP20/Claudin,IPR004032:PMP-22/EMP/MP20,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Claudin domain-containing protein 2,transmembrane region,
ENSG00000159884	coiled-coil domain containing 107(CCDC107)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Coiled coil,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Coiled-coil domain-containing protein 107,sequence variant,signal peptide,splice variant,transmembrane region,
ENSG00000170160	coiled-coil domain containing 144A(CCDC144A)	Homo sapiens			Cell division and chromosome partitioning,				IPR021885:Protein of unknown function DUF3496,					Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Reference proteome,	chain:Coiled-coil domain-containing protein 144A,chain:Coiled-coil domain-containing protein 144B,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),sequence conflict,splice variant,
ENSG00000198003	coiled-coil domain containing 151(CCDC151)	Homo sapiens			Cell division and chromosome partitioning,	GO:0003341~cilium movement,GO:0007368~determination of left/right symmetry,GO:0036158~outer dynein arm assembly,GO:0070286~axonemal dynein complex assembly,GO:1902017~regulation of cilium assembly,	GO:0005814~centriole,GO:0005929~cilium,GO:0005930~axoneme,GO:0036064~ciliary basal body,	GO:0005515~protein binding,			616037~Ciliary dyskinesia, primary, 30,			Alternative splicing,Cell projection,Ciliopathy,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Primary ciliary dyskinesia,Proteomics identification,Reference proteome,	chain:Coiled-coil domain-containing protein 151,sequence conflict,sequence variant,
ENSG00000198865	coiled-coil domain containing 152(CCDC152)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,Signal,	chain:Coiled-coil domain-containing protein 152,sequence variant,
ENSG00000197816	coiled-coil domain containing 180(CCDC180)	Homo sapiens					GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR026701:Uncharacterised protein C9orf174,					Alternative splicing,Coiled coil,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,
ENSG00000177875	coiled-coil domain containing 184(CCDC184)	Homo sapiens					GO:0005737~cytoplasm,	GO:0005515~protein binding,						Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C12orf68,compositionally biased region:Poly-Glu,sequence conflict,sequence variant,
ENSG00000109881	coiled-coil domain containing 34(CCDC34)	Homo sapiens												Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 34,compositionally biased region:Asp-rich,sequence conflict,sequence variant,splice variant,
ENSG00000175602	coiled-coil domain containing 85B(CCDC85B)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0045599~negative regulation of fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0005515~protein binding,	IPR019359:Protein of unknown function DUF2216, coiled-coil,					Acetylation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Growth regulation,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Coiled-coil domain-containing protein 85B,mutagenesis site,sequence conflict,
ENSG00000092758	collagen type IX alpha 3 chain(COL9A3)	Homo sapiens				GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0030198~extracellular matrix organization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005594~collagen type IX trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0030020~extracellular matrix structural constituent conferring tensile strength,	IPR008160:Collagen triple helix repeat,	hsa04974:Protein digestion and absorption,	600969~Epiphyseal dysplasia, multiple, 3,603932~Intervertebral disc disease, susceptibility to,Epiphyseal dysplasia, multiple, with myopathy~Epiphyseal dysplasia, multiple, with myopathy,			3D-structure,Collagen,Complete proteome,Disease mutation,Dwarfism,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-3(IX) chain,glycosylation site:N-linked (GlcNAc...),region of interest:Nonhelical region 1 (NC1),region of interest:Nonhelical region 2 (NC2),region of interest:Nonhelical region 3 (NC3),region of interest:Triple-helical region 1 (COL1),region of interest:Triple-helical region 2 (COL2),region of interest:Triple-helical region 3 (COL3),sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,
ENSG00000173372	complement C1q A chain(C1QA)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,		GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0007267~cell-cell signaling,GO:0010039~response to iron ion,GO:0045087~innate immune response,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005602~complement component C1 complex,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	613652~C1q deficiency,		SM00110:C1Q,	3D-structure,Collagen,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit A,disulfide bond,domain:C1q,domain:Collagen-like,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Gal...),modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000173369	complement C1q B chain(C1QB)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,		GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,GO:0048839~inner ear development,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005602~complement component C1 complex,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	613652~C1q deficiency,		SM00110:C1Q,	3D-structure,Collagen,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit B,disulfide bond,domain:C1q,domain:Collagen-like,glycosylation site:O-linked (Gal...),modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000159189	complement C1q C chain(C1QC)	Homo sapiens		h_classicPathway:Classical Complement Pathway,h_compPathway:Complement Pathway,		GO:0006508~proteolysis,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0030853~negative regulation of granulocyte differentiation,GO:0045087~innate immune response,GO:0045650~negative regulation of macrophage differentiation,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,	IPR001073:Complement C1q protein,IPR008160:Collagen triple helix repeat,IPR008983:Tumour necrosis factor-like domain,	hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,	613652~C1q deficiency,		SM00110:C1Q,	3D-structure,Collagen,Complement pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Reference proteome,Repeat,Secreted,Signal,	chain:Complement C1q subcomponent subunit C,disulfide bond,domain:C1q,domain:Collagen-like,glycosylation site:O-linked (Gal...),modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000105427	cornifelin(CNFN)	Homo sapiens				GO:0031424~keratinization,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,		IPR006461:Uncharacterised protein family Cys-rich,					Complete proteome,Cytoplasm,Direct protein sequencing,Keratinization,Reference proteome,	chain:Cornifelin,compositionally biased region:Cys-rich,
ENSG00000077063	cortactin binding protein 2(CTTNBP2)	Homo sapiens				GO:0007420~brain development,	GO:0005938~cell cortex,GO:0008021~synaptic vesicle,GO:0043197~dendritic spine,	GO:0017124~SH3 domain binding,	IPR002110:Ankyrin repeat,IPR019131:Cortactin-binding protein-2, N-terminal,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Cortactin-binding protein 2,compositionally biased region:Pro-rich,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,sequence variant,
ENSG00000241563	cortistatin(CORT)	Homo sapiens				GO:0000712~resolution of meiotic recombination intermediates,GO:0006312~mitotic recombination,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0031297~replication fork processing,GO:0036297~interstrand cross-link repair,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0043240~Fanconi anaemia nuclear complex,GO:0071821~FANCM-MHF complex,	GO:0001664~G-protein coupled receptor binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0005184~neuropeptide hormone activity,	IPR004250:Somatostatin,IPR018142:Somatostatin/Cortistatin, C-terminal,			PIRSF001814:somatostatin,		Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Hormone,Reference proteome,Secreted,Signal,	chain:Centromere protein S,disulfide bond,peptide:Cortistatin-17,peptide:Cortistatin-29,signal peptide,splice variant,
ENSG00000100122	crystallin beta B1(CRYBB1)	Homo sapiens				GO:0007601~visual perception,		GO:0005212~structural constituent of eye lens,GO:0005515~protein binding,	IPR001064:Beta/gamma crystallin,IPR011024:Gamma-crystallin-related,		611544~Cataract 17, multiple types,		SM00247:XTALbg,	3D-structure,Acetylation,Cataract,Complete proteome,Direct protein sequencing,Disease mutation,Eye lens protein,Reference proteome,Repeat,	chain:Beta-crystallin B1,domain:Beta/gamma crystallin 'Greek key' 1,domain:Beta/gamma crystallin 'Greek key' 2,domain:Beta/gamma crystallin 'Greek key' 3,domain:Beta/gamma crystallin 'Greek key' 4,helix,modified residue,region of interest:C-terminal arm,region of interest:Connecting peptide,region of interest:N-terminal arm,site:Susceptible to oxidation,strand,turn,
ENSG00000110092	cyclin D1(CCND1)	Homo sapiens		h_btg2Pathway:BTG family proteins and cell cycle regulation,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_g1Pathway:Cell Cycle: G1/S Check Point ,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_p53Pathway:p53 Signaling Pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_wntPathway:WNT Signaling Pathway,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000320~re-entry into mitotic cell cycle,GO:0001934~positive regulation of protein phosphorylation,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007595~lactation,GO:0010039~response to iron ion,GO:0010165~response to X-ray,GO:0010243~response to organonitrogen compound,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030857~negative regulation of epithelial cell differentiation,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032026~response to magnesium ion,GO:0032355~response to estradiol,GO:0033197~response to vitamin E,GO:0033327~Leydig cell differentiation,GO:0033598~mammary gland epithelial cell proliferation,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0042493~response to drug,GO:0043627~response to estrogen,GO:0044321~response to leptin,GO:0045444~fat cell differentiation,GO:0045471~response to ethanol,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045787~positive regulation of cell cycle,GO:0051301~cell division,GO:0051412~response to corticosterone,GO:0051592~response to calcium ion,GO:0060070~canonical Wnt signaling pathway,GO:0060749~mammary gland alveolus development,GO:0070141~response to UV-A,GO:0071157~negative regulation of cell cycle arrest,GO:0097421~liver regeneration,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0017053~transcriptional repressor complex,	GO:0003714~transcription corepressor activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0032403~protein complex binding,GO:0042826~histone deacetylase binding,GO:0070064~proline-rich region binding,	IPR004367:Cyclin, C-terminal domain,IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,IPR015451:Cyclin D,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04510:Focal adhesion,hsa04630:Jak-STAT signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05161:Hepatitis B,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05416:Viral myocarditis,	114500~Colorectal cancer, susceptibility to,193300~von Hippel-Lindau syndrome, modifier of,254500~Multiple myeloma, susceptibility to,		SM00385:CYCLIN,SM01332:SM01332,	3D-structure,Cell cycle,Cell division,Chromosomal rearrangement,Complete proteome,Cyclin,Cytoplasm,DNA damage,Isopeptide bond,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:G1/S-specific cyclin-D1,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
ENSG00000170312	cyclin dependent kinase 1(CDK1)	Homo sapiens	1.RBphosphoE2F,157.14-3-3_Cell_Cycle,26.cyclin-CDK_complexes,4.cyclins_&_p27_cell_cycle,	h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics,h_akapcentrosomePathway:Protein Kinase A at the Centrosome,H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_sam68Pathway:Regulation of Splicing through Sam68,h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000187~activation of MAPK activity,GO:0000226~microtubule cytoskeleton organization,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007067~mitotic nuclear division,GO:0007077~mitotic nuclear envelope disassembly,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007098~centrosome cycle,GO:0007344~pronuclear fusion,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0009636~response to toxic substance,GO:0010628~positive regulation of gene expression,GO:0014038~regulation of Schwann cell differentiation,GO:0014070~response to organic cyclic compound,GO:0014075~response to amine,GO:0014823~response to activity,GO:0016477~cell migration,GO:0016572~histone phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0030261~chromosome condensation,GO:0030855~epithelial cell differentiation,GO:0031100~organ regeneration,GO:0031145~anaphase-promoting complex-dependent catabolic process,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0034501~protein localization to kinetochore,GO:0042493~response to drug,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045471~response to ethanol,GO:0045740~positive regulation of DNA replication,GO:0045931~positive regulation of mitotic cell cycle,GO:0045995~regulation of embryonic development,GO:0046686~response to cadmium ion,GO:0046688~response to copper ion,GO:0048678~response to axon injury,GO:0051301~cell division,GO:0051436~negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,GO:0051439~regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,GO:0055015~ventricular cardiac muscle cell development,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0070301~cellular response to hydrogen peroxide,GO:0090166~Golgi disassembly,GO:1900182~positive regulation of protein localization to nucleus,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0016020~membrane,GO:0030496~midbody,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,	GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0030332~cyclin binding,GO:0030544~Hsp70 protein binding,GO:0035173~histone kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04115:p53 signaling pathway,hsa04540:Gap junction,hsa04914:Progesterone-mediated oocyte maturation,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,			SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Kinase,Mitochondrion,Mitosis,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Cell division control protein 2 homolog,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,strand,turn,
ENSG00000147889	cyclin dependent kinase inhibitor 2A(CDKN2A)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0000422~mitophagy,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0016925~protein sumoylation,GO:0030308~negative regulation of cell growth,GO:0030889~negative regulation of B cell proliferation,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033235~positive regulation of protein sumoylation,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0042326~negative regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046825~regulation of protein export from nucleus,GO:0048103~somatic stem cell division,GO:0050821~protein stabilization,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051882~mitochondrial depolarization,GO:0070534~protein K63-linked ubiquitination,GO:0071158~positive regulation of cell cycle arrest,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:1900182~positive regulation of protein localization to nucleus,GO:1901798~positive regulation of signal transduction by p53 class mediator,GO:1902510~regulation of apoptotic DNA fragmentation,GO:1903051~negative regulation of proteolysis involved in cellular protein catabolic process,GO:1903214~regulation of protein targeting to mitochondrion,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000774~positive regulation of cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0035985~senescence-associated heterochromatin focus,GO:0043234~protein complex,	GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0019789~SUMO transferase activity,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,GO:0055105~ubiquitin-protein transferase inhibitor activity,GO:0097371~MDM2/MDM4 family protein binding,	IPR010868:Cyclin-dependent kinase inhibitor 2A,IPR020683:Ankyrin repeat-containing domain,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05223:Non-small cell lung cancer,	155601~Melanoma, cutaneous malignant, 2,155755~Melanoma and neural system tumor syndrome,606719~Pancreatic cancer/melanoma syndrome,Orolaryngeal cancer, multiple,~Orolaryngeal cancer, multiple,,			3D-structure,Acetylation,Alternative splicing,ANK repeat,Apoptosis,Cell cycle,Complete proteome,Cyclin,Cytoplasm,Disease mutation,DNA-binding,Kinase,Li-Fraumeni syndrome,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,rRNA processing,Transcription,Transcription regulation,Transferase,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,	chain:Cyclin-dependent kinase inhibitor 2A, isoform 4,chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000182809	cysteine rich protein 2(CRIP2)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0030097~hemopoiesis,	GO:0005938~cell cortex,GO:0031012~extracellular matrix,	GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,LIM domain,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:Cysteine-rich protein 2,compositionally biased region:Gly-rich,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,helix,modified residue,strand,turn,
ENSG00000169607	cytoskeleton associated protein 2 like(CKAP2L)	Homo sapiens					GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,		IPR026165:Cytoskeleton-associated protein 2 family,		272440~Filippi syndrome,			Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Cytoskeleton-associated protein 2-like,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000168350	delta 4-desaturase, sphingolipid 2(DEGS2)	Homo sapiens				GO:0006667~sphinganine metabolic process,GO:0030148~sphingolipid biosynthetic process,GO:0046513~ceramide biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0000170~sphingosine hydroxylase activity,GO:0042284~sphingolipid delta-4 desaturase activity,	IPR005804:Fatty acid desaturase, type 1,IPR011388:Sphingolipid delta4-desaturase,IPR013866:Sphingolipid delta4-desaturase, N-terminal,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,hsa04071:Sphingolipid signaling pathway,		PIRSF017228:sphingolipid Delta-4 desaturase,	SM01269:SM01269,	Complete proteome,Endoplasmic reticulum,Lipid biosynthesis,Lipid metabolism,Lipoprotein,Membrane,Myristate,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sphingolipid delta(4)-desaturase/C4- hydroxylase DES2,lipid moiety-binding region:N-myristoyl glycine,region of interest:Required for C4-hydroxylase activity,sequence variant,transmembrane region,
ENSG00000164935	dendrocyte expressed seven transmembrane protein(DCSTAMP)	Homo sapiens				GO:0030308~negative regulation of cell growth,GO:0030316~osteoclast differentiation,GO:0034241~positive regulation of macrophage fusion,GO:0036006~cellular response to macrophage colony-stimulating factor stimulus,GO:0043011~myeloid dendritic cell differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045780~positive regulation of bone resorption,GO:0061025~membrane fusion,GO:0071353~cellular response to interleukin-4,GO:0071356~cellular response to tumor necrosis factor,GO:0072675~osteoclast fusion,	GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0005515~protein binding,	IPR012858:Dendritic cell-specific transmembrane protein-like,					Alternative splicing,Cell membrane,Complete proteome,Differentiation,Endoplasmic reticulum,Endosome,Immunity,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane 7 superfamily member 4,compositionally biased region:Poly-Ala,sequence variant,topological domain:Cytoplasmic,transmembrane region,
ENSG00000163687	deoxyribonuclease 1 like 3(DNASE1L3)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0006308~DNA catabolic process,GO:0006309~apoptotic DNA fragmentation,GO:0010623~programmed cell death involved in cell development,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,	GO:0003677~DNA binding,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0004536~deoxyribonuclease activity,GO:0005509~calcium ion binding,	IPR005135:Endonuclease/exonuclease/phosphatase,IPR016202:Deoxyribonuclease I-like,IPR018057:Deoxyribonuclease I, active site,		614420~Systemic lupus erythematosus 16,	PIRSF000988:deoxyribonuclease I,	SM00476:DNaseIc,	ADP-ribosylation,Alternative splicing,Apoptosis,Calcium,Complete proteome,Disulfide bond,Endonuclease,Endoplasmic reticulum,Hydrolase,Necrosis,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Systemic lupus erythematosus,	chain:Deoxyribonuclease gamma,disulfide bond,sequence variant,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear localization signal,signal peptide,
ENSG00000171451	dermatan sulfate epimerase-like(DSEL)	Homo sapiens				GO:0030204~chondroitin sulfate metabolic process,GO:0030208~dermatan sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008146~sulfotransferase activity,GO:0047757~chondroitin-glucuronate 5-epimerase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Glycoprotein,Isomerase,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Dermatan-sulfate epimerase-like protein,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,transmembrane region,
ENSG00000132837	dimethylglycine dehydrogenase(DMGDH)	Homo sapiens			Amino acid transport and metabolism,	GO:0006544~glycine metabolic process,GO:0006579~amino-acid betaine catabolic process,GO:0019695~choline metabolic process,GO:0042426~choline catabolic process,GO:0055114~oxidation-reduction process,	GO:0005759~mitochondrial matrix,	GO:0009055~electron carrier activity,GO:0016491~oxidoreductase activity,GO:0044822~poly(A) RNA binding,GO:0047865~dimethylglycine dehydrogenase activity,	IPR006076:FAD dependent oxidoreductase,IPR006222:Glycine cleavage T-protein, N-terminal,IPR013977:Glycine cleavage T-protein, C-terminal barrel,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,IPR027266:GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1,	hsa00260:Glycine, serine and threonine metabolism,hsa01100:Metabolic pathways,	605850~Dimethylglycine dehydrogenase deficiency,			3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Dimethylglycine dehydrogenase, mitochondrial,modified residue,sequence variant,transit peptide:Mitochondrion,
ENSG00000197635	dipeptidyl peptidase 4(DPP4)	Homo sapiens				GO:0001662~behavioral fear response,GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0008284~positive regulation of cell proliferation,GO:0010716~negative regulation of extracellular matrix disassembly,GO:0031295~T cell costimulation,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0035641~locomotory exploration behavior,GO:0036343~psychomotor behavior,GO:0042110~T cell activation,GO:0043542~endothelial cell migration,GO:0046718~viral entry into host cell,	GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030027~lamellipodium,GO:0030139~endocytic vesicle,GO:0031258~lamellipodium membrane,GO:0045121~membrane raft,GO:0046581~intercellular canaliculus,GO:0070062~extracellular exosome,GO:0071438~invadopodium membrane,	GO:0001618~virus receptor activity,GO:0002020~protease binding,GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR001375:Peptidase S9, prolyl oligopeptidase, catalytic domain,IPR002469:Peptidase S9B, dipeptidylpeptidase IV N-terminal,IPR002471:Peptidase S9, serine active site,	hsa04974:Protein digestion and absorption,				3D-structure,Aminopeptidase,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Protease,Proteomics identification,Receptor,Reference proteome,Secreted,Serine protease,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Charge relay system,chain:Dipeptidyl peptidase 4 membrane form,chain:Dipeptidyl peptidase 4 soluble form,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000082458	discs large MAGUK scaffold protein 3(DLG3)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,		GO:0001736~establishment of planar polarity,GO:0007268~chemical synaptic transmission,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0010923~negative regulation of phosphatase activity,GO:0034220~ion transmembrane transport,GO:0043113~receptor clustering,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0046037~GMP metabolic process,GO:0046710~GDP metabolic process,GO:0097120~receptor localization to synapse,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0008328~ionotropic glutamate receptor complex,GO:0014069~postsynaptic density,GO:0016323~basolateral plasma membrane,GO:0030426~growth cone,GO:0032281~AMPA glutamate receptor complex,GO:0043025~neuronal cell body,GO:0043198~dendritic shaft,GO:0045211~postsynaptic membrane,	GO:0004385~guanylate kinase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0015276~ligand-gated ion channel activity,GO:0019900~kinase binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030165~PDZ domain binding,GO:0031625~ubiquitin protein ligase binding,GO:0035255~ionotropic glutamate receptor binding,	IPR001452:Src homology-3 domain,IPR001478:PDZ domain,IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR016313:Membrane-associated guanylate kinase (MAGUK) scaffold protein,IPR019583:PDZ-associated domain of NMDA receptors,IPR019590:Membrane-associated guanylate kinase (MAGUK), PEST domain, N-terminal,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04390:Hippo signaling pathway,	300850~Mental retardation, X-linked 90,	PIRSF001741:membrane-associated guanylate kinase (MAGUK) scaffold protein,	SM00072:GuKc,SM00228:PDZ,SM00326:SH3,SM01277:SM01277,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Disks large homolog 3,domain:Guanylate kinase-like,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,
ENSG00000197380	dishevelled binding antagonist of beta catenin 3(DACT3)	Homo sapiens				GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0035414~negative regulation of catenin import into nucleus,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,	GO:0005080~protein kinase C binding,GO:0008013~beta-catenin binding,GO:0042802~identical protein binding,GO:0051018~protein kinase A binding,GO:0070097~delta-catenin binding,	IPR024843:Dapper,IPR024844:Dact3,					Coiled coil,Complete proteome,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Wnt signaling pathway,	chain:Dapper homolog 3,compositionally biased region:Arg-rich,compositionally biased region:Poly-Arg,short sequence motif:PDZ-binding,
ENSG00000120875	dual specificity phosphatase 4(DUSP4)	Homo sapiens		h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,		GO:0000188~inactivation of MAPK activity,GO:0001706~endoderm formation,GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035970~peptidyl-threonine dephosphorylation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:1990439~MAP kinase threonine phosphatase activity,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001763:Rhodanese-like domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR008343:Mitogen-activated protein (MAP) kinase phosphatase,IPR016130:Protein-tyrosine phosphatase, active site,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,	hsa04010:MAPK signaling pathway,		PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase),	SM00195:DSPc,SM00404:PTPc_motif,SM00450:RHOD,	3D-structure,Alternative splicing,Complete proteome,Hydrolase,Nucleus,Phosphoprotein,Protein phosphatase,Reference proteome,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 4,domain:Rhodanese,domain:Tyrosine-protein phosphatase,helix,sequence conflict,strand,turn,
ENSG00000184545	dual specificity phosphatase 8(DUSP8)	Homo sapiens		h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,		GO:0000188~inactivation of MAPK activity,GO:0016311~dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001763:Rhodanese-like domain,IPR008343:Mitogen-activated protein (MAP) kinase phosphatase,IPR016130:Protein-tyrosine phosphatase, active site,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,	hsa04010:MAPK signaling pathway,			SM00195:DSPc,SM00450:RHOD,	3D-structure,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Protein phosphatase,Reference proteome,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 8,chain:Putative uncharacterized protein C11orf81,compositionally biased region:Pro-rich,domain:Rhodanese,domain:Tyrosine-protein phosphatase,modified residue,sequence conflict,splice variant,
ENSG00000154099	dynein axonemal assembly factor 1(DNAAF1)	Homo sapiens				GO:0001947~heart looping,GO:0003341~cilium movement,GO:0003356~regulation of cilium beat frequency,GO:0030324~lung development,GO:0035469~determination of pancreatic left/right asymmetry,GO:0036158~outer dynein arm assembly,GO:0036159~inner dynein arm assembly,GO:0044458~motile cilium assembly,GO:0060271~cilium morphogenesis,GO:0060287~epithelial cilium movement involved in determination of left/right asymmetry,GO:0060972~left/right pattern formation,GO:0070286~axonemal dynein complex assembly,GO:0071907~determination of digestive tract left/right asymmetry,GO:0071910~determination of liver left/right asymmetry,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005930~axoneme,	GO:0045502~dynein binding,	IPR001611:Leucine-rich repeat,		613193~Ciliary dyskinesia, primary, 13,			Alternative splicing,Cell projection,Ciliopathy,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Leucine-rich repeat,Phosphoprotein,Polymorphism,Primary ciliary dyskinesia,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-rich repeat-containing protein 50,compositionally biased region:Pro-rich,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,sequence conflict,sequence variant,splice variant,
ENSG00000129521	egl-9 family hypoxia inducible factor 3(EGLN3)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0018126~protein hydroxylation,GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline,GO:0042127~regulation of cell proliferation,GO:0043523~regulation of neuron apoptotic process,GO:0055114~oxidation-reduction process,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0031418~L-ascorbic acid binding,GO:0031545~peptidyl-proline 4-dioxygenase activity,	IPR005123:Oxoglutarate/iron-dependent dioxygenase,IPR006620:Prolyl 4-hydroxylase, alpha subunit,	hsa04066:HIF-1 signaling pathway,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,			SM00702:P4Hc,	Apoptosis,Complete proteome,Cytoplasm,Dioxygenase,DNA damage,Iron,Metal-binding,Nucleus,Oxidoreductase,Polymorphism,Reference proteome,Vitamin C,	binding site:2-oxoglutarate,chain:Egl nine homolog 3,domain:Fe2OG dioxygenase,metal ion-binding site:Iron,mutagenesis site,sequence variant,
ENSG00000197561	elastase, neutrophil expressed(ELANE)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001878~response to yeast,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0002523~leukocyte migration involved in inflammatory response,GO:0006508~proteolysis,GO:0006874~cellular calcium ion homeostasis,GO:0006909~phagocytosis,GO:0009411~response to UV,GO:0022617~extracellular matrix disassembly,GO:0030163~protein catabolic process,GO:0032496~response to lipopolysaccharide,GO:0042742~defense response to bacterium,GO:0043406~positive regulation of MAP kinase activity,GO:0044130~negative regulation of growth of symbiont in host,GO:0045079~negative regulation of chemokine biosynthetic process,GO:0045415~negative regulation of interleukin-8 biosynthetic process,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0050778~positive regulation of immune response,GO:0050922~negative regulation of chemotaxis,GO:0070947~neutrophil mediated killing of fungus,GO:1903238~positive regulation of leukocyte tethering or rolling,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0017053~transcriptional repressor complex,GO:0030141~secretory granule,GO:0070062~extracellular exosome,	GO:0001106~RNA polymerase II transcription corepressor activity,GO:0002020~protease binding,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0019955~cytokine binding,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,	162800~Neutropenia, cyclic,202700~Neutropenia, severe congenital 1, autosomal dominant,		SM00020:Tryp_SPc,	3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Neutrophil elastase,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,
ENSG00000167136	endonuclease G(ENDOG)	Homo sapiens		h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		GO:0001701~in utero embryonic development,GO:0006309~apoptotic DNA fragmentation,GO:0006310~DNA recombination,GO:0007568~aging,GO:0009612~response to mechanical stimulus,GO:0032355~response to estradiol,GO:0034612~response to tumor necrosis factor,GO:0036475~neuron death in response to oxidative stress,GO:0046677~response to antibiotic,GO:0071277~cellular response to calcium ion,GO:0071333~cellular response to glucose stimulus,GO:0071456~cellular response to hypoxia,GO:1901300~positive regulation of hydrogen peroxide-mediated programmed cell death,GO:1902512~positive regulation of apoptotic DNA fragmentation,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0043204~perikaryon,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004536~deoxyribonuclease activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001604:DNA/RNA non-specific endonuclease,IPR018524:DNA/RNA non-specific endonuclease, active site,IPR020821:Extracellular Endonuclease, subunit A,	hsa04210:Apoptosis,			SM00477:NUC,SM00892:SM00892,	Complete proteome,Endonuclease,Hydrolase,Magnesium,Manganese,Metal-binding,Mitochondrion,Nuclease,Polymorphism,Reference proteome,Transit peptide,	active site:Proton acceptor,chain:Endonuclease G, mitochondrial,metal ion-binding site:Magnesium or manganese; catalytic,sequence conflict,sequence variant,transit peptide:Mitochondrion,
ENSG00000111405	endonuclease, poly(U) specific(ENDOU)	Homo sapiens				GO:0006508~proteolysis,GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0007565~female pregnancy,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0003723~RNA binding,GO:0004521~endoribonuclease activity,GO:0005044~scavenger receptor activity,GO:0008083~growth factor activity,GO:0008236~serine-type peptidase activity,GO:0030145~manganese ion binding,GO:0030247~polysaccharide binding,	IPR001212:Somatomedin B domain,IPR018998:Endoribonuclease XendoU,IPR020436:Somatomedin B, chordata,				SM00201:SO,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Endonuclease,Hydrolase,Manganese,Metal-binding,Nuclease,Polymorphism,Reference proteome,Repeat,RNA-binding,Secreted,Signal,	chain:Placental protein 11,disulfide bond,domain:SMB,sequence variant,signal peptide,
ENSG00000168913	energy homeostasis associated(ENHO)	Homo sapiens					GO:0005576~extracellular region,							Alternative splicing,Complete proteome,Reference proteome,Secreted,Signal,	chain:Adropin,signal peptide,splice variant,
ENSG00000253626	eukaryotic translation initiation factor 5A-like 1(EIF5AL1)	Homo sapiens				GO:0006452~translational frameshifting,GO:0015031~protein transport,GO:0045901~positive regulation of translational elongation,GO:0045905~positive regulation of translational termination,GO:0051028~mRNA transport,	GO:0005643~nuclear pore,GO:0005789~endoplasmic reticulum membrane,	GO:0003746~translation elongation factor activity,GO:0043022~ribosome binding,	IPR001884:Translation elongation factor IF5A,IPR008991:Translation protein SH3-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014722:Ribosomal protein L2 domain 2,IPR019769:Translation elongation factor, IF5A, hypusine site,IPR020189:Translation elongation factor, IF5A C-terminal,			PIRSF003025:translation initiation factor eIF-5A,	SM01376:SM01376,	Complete proteome,Cytoplasm,Elongation factor,Endoplasmic reticulum,Hypusine,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Protein biosynthesis,Protein transport,Reference proteome,RNA-binding,Translocation,Transport,	chain:Eukaryotic translation initiation factor 5A-1,chain:Eukaryotic translation initiation factor 5A-1-like,helix,modified residue,mutagenesis site,region of interest:DOHH-binding,sequence conflict,splice variant,strand,turn,
ENSG00000111879	family with sequence similarity 184 member A(FAM184A)	Homo sapiens					GO:0005615~extracellular space,	GO:0005515~protein binding,						Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein FAM184A,sequence conflict,sequence variant,splice variant,
ENSG00000144649	family with sequence similarity 198 member A(FAM198A)	Homo sapiens					GO:0005576~extracellular region,							Complete proteome,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C3orf41,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
ENSG00000204930	family with sequence similarity 221 member B(FAM221B)	Homo sapiens							IPR026755:Protein FAM221A,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C9orf128,sequence variant,splice variant,
ENSG00000184949	family with sequence similarity 227 member A(FAM227A)	Homo sapiens												Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Putative uncharacterized protein LOC388900,compositionally biased region:Poly-Ser,modified residue,
ENSG00000203778	family with sequence similarity 229 member B(FAM229B)	Homo sapiens												Complete proteome,Reference proteome,	chain:UPF0731 protein C6orf225,
ENSG00000213185	family with sequence similarity 24 member B(FAM24B)	Homo sapiens					GO:0005576~extracellular region,							Complete proteome,Polymorphism,Reference proteome,Secreted,Signal,	chain:Protein FAM24B,sequence variant,signal peptide,
ENSG00000226777	family with sequence similarity 30, member A(FAM30A)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000189157	family with sequence similarity 47 member E(FAM47E)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Reference proteome,	chain:Protein FAM47E,sequence conflict,splice variant,
ENSG00000172717	family with sequence similarity 71 member D(FAM71D)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,		IPR022168:Protein of unknown function DUF3699,					Alternative splicing,Complete proteome,Reference proteome,	chain:Protein FAM71D,sequence conflict,splice variant,
ENSG00000101447	family with sequence similarity 83 member D(FAM83D)	Homo sapiens				GO:0001837~epithelial to mesenchymal transition,GO:0007067~mitotic nuclear division,GO:0008283~cell proliferation,GO:0016477~cell migration,GO:0032006~regulation of TOR signaling,GO:0042176~regulation of protein catabolic process,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:1902480~protein localization to mitotic spindle,GO:1902808~positive regulation of cell cycle G1/S phase transition,	GO:0005737~cytoplasm,GO:0097431~mitotic spindle pole,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0019894~kinesin binding,GO:0019901~protein kinase binding,	IPR012461:Protein of unknown function DUF1669,					3D-structure,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Mitosis,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Protein FAM83D,compositionally biased region:Poly-Ala,compositionally biased region:Ser-rich,modified residue,sequence conflict,splice variant,
ENSG00000171847	family with sequence similarity 90 member A1(FAM90A1)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM90A1,sequence conflict,sequence variant,
ENSG00000134824	fatty acid desaturase 2(FADS2)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0036109~alpha-linolenic acid metabolic process,GO:0043651~linoleic acid metabolic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004768~stearoyl-CoA 9-desaturase activity,GO:0016213~linoleoyl-CoA desaturase activity,	IPR001199:Cytochrome b5-like heme/steroid binding domain,IPR005804:Fatty acid desaturase, type 1,IPR012171:Fatty acid/sphingolipid desaturase,	hsa00592:alpha-Linolenic acid metabolism,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,		PIRSF015921:fatty acid desaturase/sphingolipid desaturase,	SM01117:SM01117,	Alternative splicing,Complete proteome,Electron transport,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Membrane,Oxidoreductase,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Fatty acid desaturase 2,domain:Cytochrome b5 heme-binding,sequence conflict,short sequence motif:Histidine box-1,short sequence motif:Histidine box-2,short sequence motif:Histidine box-3,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000137441	fibroblast growth factor binding protein 2(FGFBP2)	Homo sapiens					GO:0005615~extracellular space,	GO:0019838~growth factor binding,	IPR010510:FGF binding 1,					Complete proteome,Disulfide bond,Growth factor binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Fibroblast growth factor-binding protein 2,disulfide bond,sequence variant,signal peptide,
ENSG00000160339	ficolin 2(FCN2)	Homo sapiens				GO:0001867~complement activation, lectin pathway,GO:0006508~proteolysis,GO:0006956~complement activation,GO:0008228~opsonization,GO:0043654~recognition of apoptotic cell,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,	GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0003823~antigen binding,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0043394~proteoglycan binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,GO:2001065~mannan binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR008160:Collagen triple helix repeat,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,				SM00186:FBG,	3D-structure,Alternative splicing,Calcium,Collagen,Complement activation lectin pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydroxylation,Immunity,Innate immunity,Lectin,Metal-binding,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Ficolin-2,domain:Collagen-like,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
ENSG00000162458	filamin binding LIM protein 1(FBLIM1)	Homo sapiens				GO:0008360~regulation of cell shape,GO:0016337~single organismal cell-cell adhesion,GO:0033623~regulation of integrin activation,GO:0034329~cell junction assembly,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0005938~cell cortex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031005~filamin binding,	IPR001781:Zinc finger, LIM-type,				SM00132:LIM,	3D-structure,Alternative splicing,Cell adhesion,Cell junction,Cell shape,Complete proteome,Cytoplasm,Cytoskeleton,LIM domain,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:Filamin-binding LIM protein 1,compositionally biased region:Pro-rich,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,mutagenesis site,region of interest:Filamin-binding,region of interest:PLEKHC1-binding,sequence variant,splice variant,strand,
ENSG00000110203	folate receptor 3(FOLR3)	Homo sapiens				GO:0015884~folic acid transport,	GO:0005576~extracellular region,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,	GO:0005542~folic acid binding,	IPR004269:Folate receptor,IPR018143:Folate receptor-like,	hsa04144:Endocytosis,				Alternative splicing,Complete proteome,Disulfide bond,Folate-binding,Glycoprotein,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,	chain:Folate receptor gamma,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,
ENSG00000185897	free fatty acid receptor 3(FFAR3)	Homo sapiens				GO:0002385~mucosal immune response,GO:0002720~positive regulation of cytokine production involved in immune response,GO:0002879~positive regulation of acute inflammatory response to non-antigenic stimulus,GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0014061~regulation of norepinephrine secretion,GO:0032722~positive regulation of chemokine production,GO:0045776~negative regulation of blood pressure,GO:0046885~regulation of hormone biosynthetic process,GO:0071398~cellular response to fatty acid,GO:0090276~regulation of peptide hormone secretion,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0008289~lipid binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR013312:G protein-coupled receptor 40-related receptor,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Immunity,Inflammatory response,Lipid-binding,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Free fatty acid receptor 3,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000163288	gamma-aminobutyric acid type A receptor beta1 subunit(GABRB1)	Homo sapiens				GO:0006810~transport,GO:0006811~ion transport,GO:0007165~signal transduction,GO:0009636~response to toxic substance,GO:0021954~central nervous system neuron development,GO:0032570~response to progesterone,GO:0034220~ion transmembrane transport,GO:0042698~ovulation cycle,GO:0071420~cellular response to histamine,GO:1902476~chloride transmembrane transport,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0034707~chloride channel complex,GO:0045211~postsynaptic membrane,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022851~GABA-gated chloride ion channel activity,GO:0050811~GABA receptor binding,	IPR002289:Gamma-aminobutyric-acid A receptor, beta subunit,IPR006028:Gamma-aminobutyric acid A receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04723:Retrograde endocannabinoid signaling,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,				Alternative splicing,Cell junction,Cell membrane,Chloride,Chloride channel,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Gamma-aminobutyric acid receptor subunit beta-1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000099998	gamma-glutamyltransferase 5(GGT5)	Homo sapiens				GO:0006508~proteolysis,GO:0006520~cellular amino acid metabolic process,GO:0006691~leukotriene metabolic process,GO:0006749~glutathione metabolic process,GO:0006750~glutathione biosynthetic process,GO:0006954~inflammatory response,GO:0019370~leukotriene biosynthetic process,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031362~anchored component of external side of plasma membrane,	GO:0003840~gamma-glutamyltransferase activity,GO:0036374~glutathione hydrolase activity,	IPR000101:Gamma-glutamyltranspeptidase,	hsa00430:Taurine and hypotaurine metabolism,hsa00460:Cyanoamino acid metabolism,hsa00480:Glutathione metabolism,hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,				Acyltransferase,Alternative splicing,Complete proteome,Glutathione biosynthesis,Glycoprotein,Hydrolase,Leukotriene biosynthesis,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,Zymogen,	chain:Gamma-glutamyltransferase 5 heavy chain,chain:Gamma-glutamyltransferase 5 light chain,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000165474	gap junction protein beta 2(GJB2)	Homo sapiens				GO:0006810~transport,GO:0007154~cell communication,GO:0007267~cell-cell signaling,GO:0007605~sensory perception of sound,GO:0016264~gap junction assembly,GO:0030539~male genitalia development,GO:0032355~response to estradiol,GO:0032570~response to progesterone,GO:0034599~cellular response to oxidative stress,GO:0044752~response to human chorionic gonadotropin,GO:0046697~decidualization,GO:0055085~transmembrane transport,	GO:0005737~cytoplasm,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0005922~connexon complex,GO:0016021~integral component of membrane,GO:0016328~lateral plasma membrane,	GO:0005243~gap junction channel activity,	IPR000500:Connexin,IPR002268:Gap junction beta-2 protein (Cx26),IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,		124500~Vohwinkel syndrome,148210~Keratitis-ichthyosis-deafness syndrome,148350~Keratoderma, palmoplantar, with deafness,149200~Bart-Pumphrey syndrome,220290~Deafness, autosomal recessive 1A,601544~Deafness, autosomal dominant 3A,602540~Hystrix-like ichthyosis with deafness,		SM00037:CNX,SM01089:SM01089,	3D-structure,Cell junction,Cell membrane,Complete proteome,Deafness,Disease mutation,Disulfide bond,Ectodermal dysplasia,Gap junction,Hearing,Ichthyosis,Membrane,Non-syndromic deafness,Palmoplantar keratoderma,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction beta-2 protein,helix,sequence conflict,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000213780	general transcription factor IIH subunit 4(GTF2H4)	Homo sapiens				GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0033683~nucleotide-excision repair, DNA incision,GO:0070816~phosphorylation of RNA polymerase II C-terminal domain,GO:0070911~global genome nucleotide-excision repair,	GO:0000439~core TFIIH complex,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005675~holo TFIIH complex,	GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,	IPR004598:Transcription factor TFIIH subunit p52/Tfb2,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,hsa05203:Viral carcinogenesis,				3D-structure,Alternative splicing,Complete proteome,DNA damage,DNA repair,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:General transcription factor IIH subunit 4,sequence variant,
ENSG00000174500	germinal center associated signaling and motility(GCSAM)	Homo sapiens				GO:0050855~regulation of B cell receptor signaling pathway,GO:2000401~regulation of lymphocyte migration,GO:2000402~negative regulation of lymphocyte migration,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0045159~myosin II binding,						Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Germinal center B-cell-expressed transcript 2 protein,modified residue,
ENSG00000116032	glutamate ionotropic receptor NMDA type subunit 3B(GRIN3B)	Homo sapiens				GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0051205~protein insertion into membrane,GO:0051924~regulation of calcium ion transport,GO:0070588~calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0017146~NMDA selective glutamate receptor complex,GO:0030054~cell junction,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0004972~NMDA glutamate receptor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0016594~glycine binding,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05033:Nicotine addiction,hsa05034:Alcoholism,			SM00079:PBPe,SM00918:SM00918,	Calcium,Cell junction,Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Magnesium,Membrane,Polymorphism,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Glutamate [NMDA] receptor subunit 3B,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000170899	glutathione S-transferase alpha 4(GSTA4)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008152~metabolic process,GO:1901687~glutathione derivative biosynthetic process,	GO:0005829~cytosol,	GO:0004364~glutathione transferase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003080:Glutathione S-transferase, alpha class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase A4,domain:GST C-terminal,domain:GST N-terminal,helix,sequence variant,strand,turn,
ENSG00000134202	glutathione S-transferase mu 3(GSTM3)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0008065~establishment of blood-nerve barrier,GO:0008152~metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:0043627~response to estrogen,GO:0070458~cellular detoxification of nitrogen compound,GO:1901687~glutathione derivative biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0035686~sperm fibrous sheath,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 3,domain:GST C-terminal,domain:GST N-terminal,helix,sequence conflict,sequence variant,strand,
ENSG00000168765	glutathione S-transferase mu 4(GSTM4)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0008152~metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:1901687~glutathione derivative biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004364~glutathione transferase activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 4,domain:GST C-terminal,domain:GST N-terminal,helix,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000186281	glycerol-3-phosphate acyltransferase 2, mitochondrial(GPAT2)	Homo sapiens			Lipid metabolism,	GO:0006072~glycerol-3-phosphate metabolic process,GO:0006654~phosphatidic acid biosynthetic process,GO:0016024~CDP-diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,GO:0044255~cellular lipid metabolic process,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,	GO:0004366~glycerol-3-phosphate O-acyltransferase activity,GO:0008374~O-acyltransferase activity,	IPR002123:Phospholipid/glycerol acyltransferase,IPR022284:Glycerol-3-phosphate O-acyltransferase,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,			SM00563:PlsC,	Acyltransferase,Alternative splicing,Complete proteome,Lipid biosynthesis,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion outer membrane,Phospholipid biosynthesis,Phospholipid metabolism,Phosphoprotein,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:Glycerol-3-phosphate acyltransferase 2, mitochondrial,region of interest:Acyltransferase,sequence conflict,short sequence motif:HXXXXD motif,splice variant,transmembrane region,
ENSG00000100116	glycine C-acetyltransferase(GCAT)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006520~cellular amino acid metabolic process,GO:0006567~threonine catabolic process,GO:0009058~biosynthetic process,GO:0019518~L-threonine catabolic process to glycine,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0003824~catalytic activity,GO:0008890~glycine C-acetyltransferase activity,GO:0016874~ligase activity,GO:0030170~pyridoxal phosphate binding,	IPR001917:Aminotransferase, class-II, pyridoxal-phosphate binding site,IPR004839:Aminotransferase, class I/classII,IPR011282:2-amino-3-ketobutyrate coenzyme A ligase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,	hsa00260:Glycine, serine and threonine metabolism,				Acetylation,Acyltransferase,Alternative splicing,Complete proteome,Ligase,Mitochondrion,Nucleus,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,Transit peptide,	chain:2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial,modified residue,sequence conflict,sequence variant,transit peptide:Mitochondrion,
ENSG00000115523	granulysin(GNLY)	Homo sapiens				GO:0006968~cellular defense response,GO:0031640~killing of cells of other organism,GO:0042742~defense response to bacterium,GO:0050832~defense response to fungus,	GO:0005615~extracellular space,		IPR008138:Saposin-like type B, 2,IPR008139:Saposin B,IPR011001:Saposin-like,				SM00741:SapB,	3D-structure,Alternative splicing,Antibiotic,Antimicrobial,Complete proteome,Disulfide bond,Fungicide,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Granulysin,disulfide bond,domain:Saposin B-type,helix,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000100453	granzyme B(GZMB)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_ctlPathway:CTL mediated immune response against target cells ,h_d4gdiPathway:D4-GDI Signaling Pathway,h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_setPathway:Granzyme A mediated Apoptosis Pathway,		GO:0006915~apoptotic process,GO:0016485~protein processing,GO:0019835~cytolysis,GO:0042267~natural killer cell mediated cytotoxicity,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04650:Natural killer cell mediated cytotoxicity,hsa04940:Type I diabetes mellitus,hsa05202:Transcriptional misregulation in cancer,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,			SM00020:Tryp_SPc,	3D-structure,Apoptosis,Complete proteome,Cytolysis,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Granzyme B,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000100450	granzyme H(GZMH)	Homo sapiens				GO:0006915~apoptotic process,GO:0006955~immune response,GO:0016485~protein processing,GO:0019835~cytolysis,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	3D-structure,Alternative splicing,Complete proteome,Cytolysis,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Granzyme H,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence variant,signal peptide,strand,turn,
ENSG00000197540	granzyme M(GZMM)	Homo sapiens				GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0008219~cell death,GO:0019835~cytolysis,GO:0045087~innate immune response,	GO:0005576~extracellular region,GO:0016020~membrane,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	3D-structure,Apoptosis,Complete proteome,Cytolysis,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Innate immunity,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Granzyme M,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence variant,signal peptide,strand,turn,
ENSG00000257017	haptoglobin(HP)	Homo sapiens				GO:0002376~immune system process,GO:0006898~receptor-mediated endocytosis,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0010942~positive regulation of cell death,GO:0042542~response to hydrogen peroxide,GO:0042742~defense response to bacterium,GO:0051354~negative regulation of oxidoreductase activity,GO:0098869~cellular oxidant detoxification,GO:2000296~negative regulation of hydrogen peroxide catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031838~haptoglobin-hemoglobin complex,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0016209~antioxidant activity,GO:0030492~hemoglobin binding,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR008292:Haptoglobin,IPR009003:Trypsin-like cysteine/serine peptidase domain,		614081~Anhaptoglobinemia,614081~Hypohaptoglobinemia,	PIRSF001137:haptoglobin,	SM00020:Tryp_SPc,SM00032:CCP,	3D-structure,Acute phase,Alternative splicing,Antibiotic,Antimicrobial,Antioxidant,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemoglobin-binding,Immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease homolog,Signal,Sushi,	chain:Haptoglobin,chain:Haptoglobin alpha chain,chain:Haptoglobin beta chain,chain:Haptoglobin-related protein,disulfide bond,domain:Peptidase S1,domain:Sushi,domain:Sushi 1,domain:Sushi 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000163106	hematopoietic prostaglandin D synthase(HPGDS)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006693~prostaglandin metabolic process,GO:0007165~signal transduction,GO:0007626~locomotory behavior,GO:0019371~cyclooxygenase pathway,GO:1901687~glutathione derivative biosynthetic process,GO:2000255~negative regulation of male germ cell proliferation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004364~glutathione transferase activity,GO:0004667~prostaglandin-D synthase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,				3D-structure,Calcium,Complete proteome,Cytoplasm,Fatty acid biosynthesis,Fatty acid metabolism,Isomerase,Lipid biosynthesis,Lipid metabolism,Magnesium,Metal-binding,Prostaglandin biosynthesis,Prostaglandin metabolism,Reference proteome,Transferase,	active site:Nucleophile,chain:Hematopoietic prostaglandin D synthase,chain:Prostaglandin-H2 D-isomerase,disulfide bond,domain:GST C-terminal,domain:GST N-terminal,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000136929	hemogen(HEMGN)	Homo sapiens				GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0045667~regulation of osteoblast differentiation,	GO:0005654~nucleoplasm,	GO:0005515~protein binding,						Complete proteome,Developmental protein,Differentiation,Nucleus,Phosphoprotein,Reference proteome,	chain:Hemogen,region of interest:Necessary for nuclear localization,sequence conflict,
ENSG00000002587	heparan sulfate-glucosamine 3-sulfotransferase 1(HS3ST1)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,	GO:0005796~Golgi lumen,GO:0016021~integral component of membrane,	GO:0008146~sulfotransferase activity,GO:0008467~[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,				3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Polymorphism,Reference proteome,Signal,Transferase,	binding site:PAPS,chain:Heparan sulfate glucosamine 3-O- sulfotransferase 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,nucleotide phosphate-binding region:PAPS,sequence variant,signal peptide,strand,turn,
ENSG00000114315	hes family bHLH transcription factor 1(HES1)	Homo sapiens		h_hesPathway:Segmentation Clock,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0003143~embryonic heart tube morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003266~regulation of secondary heart field cardioblast proliferation,GO:0003281~ventricular septum development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006461~protein complex assembly,GO:0007155~cell adhesion,GO:0007219~Notch signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007262~STAT protein import into nucleus,GO:0007399~nervous system development,GO:0008284~positive regulation of cell proliferation,GO:0016477~cell migration,GO:0021537~telencephalon development,GO:0021555~midbrain-hindbrain boundary morphogenesis,GO:0021557~oculomotor nerve development,GO:0021558~trochlear nerve development,GO:0021575~hindbrain morphogenesis,GO:0021861~forebrain radial glial cell differentiation,GO:0021984~adenohypophysis development,GO:0030324~lung development,GO:0030513~positive regulation of BMP signaling pathway,GO:0030901~midbrain development,GO:0031016~pancreas development,GO:0035019~somatic stem cell population maintenance,GO:0035910~ascending aorta morphogenesis,GO:0042102~positive regulation of T cell proliferation,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042668~auditory receptor cell fate determination,GO:0043388~positive regulation of DNA binding,GO:0045598~regulation of fat cell differentiation,GO:0045608~negative regulation of auditory receptor cell differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045977~positive regulation of mitotic cell cycle, embryonic,GO:0046331~lateral inhibition,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048469~cell maturation,GO:0048538~thymus development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0048844~artery morphogenesis,GO:0050678~regulation of epithelial cell proliferation,GO:0060122~inner ear receptor stereocilium organization,GO:0060164~regulation of timing of neuron differentiation,GO:0060253~negative regulation of glial cell proliferation,GO:0060412~ventricular septum morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0060716~labyrinthine layer blood vessel development,GO:0061009~common bile duct development,GO:0061106~negative regulation of stomach neuroendocrine cell differentiation,GO:0061309~cardiac neural crest cell development involved in outflow tract morphogenesis,GO:0061626~pharyngeal arch artery morphogenesis,GO:0072012~glomerulus vasculature development,GO:0072049~comma-shaped body morphogenesis,GO:0072050~S-shaped body morphogenesis,GO:0072141~renal interstitial fibroblast development,GO:0072282~metanephric nephron tubule morphogenesis,GO:0090102~cochlea development,GO:0090162~establishment of epithelial cell polarity,GO:0097084~vascular smooth muscle cell development,GO:0097150~neuronal stem cell population maintenance,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000227~negative regulation of pancreatic A cell differentiation,GO:2000737~negative regulation of stem cell differentiation,GO:2000974~negative regulation of pro-B cell differentiation,GO:2000978~negative regulation of forebrain neuron differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0051087~chaperone binding,GO:0071820~N-box binding,	IPR003650:Orange,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa03460:Fanconi anemia pathway,hsa04330:Notch signaling pathway,hsa04950:Maturity onset diabetes of the young,			SM00353:HLH,SM00511:ORANGE,	3D-structure,Complete proteome,DNA-binding,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor HES-1,compositionally biased region:Pro-rich,compositionally biased region:Ser/Thr-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,modified residue,short sequence motif:WRPW motif,
ENSG00000078399	homeobox A9(HOXA9)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007338~single fertilization,GO:0008584~male gonad development,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0030879~mammary gland development,GO:0035115~embryonic forelimb morphogenesis,GO:0042118~endothelial cell activation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0048706~embryonic skeletal system development,GO:0060065~uterus development,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR006711:Hox9, N-terminal activation domain,IPR009057:Homeodomain-like,IPR017112:Homeobox protein Hox9,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,			PIRSF037109:homeobox protein, Hox9 type,	SM00389:HOX,	Chromosomal rearrangement,Complete proteome,Developmental protein,DNA-binding,Homeobox,Methylation,Nucleus,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-A9,DNA-binding region:Homeobox,sequence conflict,site:Breakpoint for translocation to form MSI2/HOXA9 fusion protein,
ENSG00000173917	homeobox B2(HOXB2)	Homo sapiens				GO:0002011~morphogenesis of an epithelial sheet,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008015~blood circulation,GO:0009952~anterior/posterior pattern specification,GO:0009953~dorsal/ventral pattern formation,GO:0021569~rhombomere 3 development,GO:0021570~rhombomere 4 development,GO:0021612~facial nerve structural organization,GO:0048704~embryonic skeletal system morphogenesis,GO:0048857~neural nucleus development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001827:Homeobox protein, antennapedia type, conserved site,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-B2,DNA-binding region:Homeobox,modified residue,sequence conflict,short sequence motif:Antp-type hexapeptide,
ENSG00000182742	homeobox B4(HOXB4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002011~morphogenesis of an epithelial sheet,GO:0006351~transcription, DNA-templated,GO:0008283~cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048103~somatic stem cell division,GO:0048536~spleen development,GO:0048539~bone marrow development,GO:0048704~embryonic skeletal system morphogenesis,GO:0060216~definitive hemopoiesis,GO:0060218~hematopoietic stem cell differentiation,GO:2000738~positive regulation of stem cell differentiation,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001827:Homeobox protein, antennapedia type, conserved site,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR017995:Homeobox protein, antennapedia type,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-B4,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich (part of the transcriptional activation domain),DNA-binding region:Homeobox,short sequence motif:Antp-type hexapeptide,
ENSG00000164120	hydroxyprostaglandin dehydrogenase 15-(NAD)(HPGD)	Homo sapiens				GO:0006693~prostaglandin metabolic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007565~female pregnancy,GO:0007567~parturition,GO:0019372~lipoxygenase pathway,GO:0030728~ovulation,GO:0045786~negative regulation of cell cycle,GO:0055114~oxidation-reduction process,GO:0070493~thrombin receptor signaling pathway,GO:0097070~ductus arteriosus closure,GO:2001300~lipoxin metabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004957~prostaglandin E receptor activity,GO:0016404~15-hydroxyprostaglandin dehydrogenase (NAD+) activity,GO:0016491~oxidoreductase activity,GO:0042803~protein homodimerization activity,GO:0051287~NAD binding,GO:0070403~NAD+ binding,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa05202:Transcriptional misregulation in cancer,	119900~Digital clubbing, isolated congenital,259100~Cranioosteoarthropathy,259100~Hypertrophic osteoarthropathy, primary, autosomal recessive 1,			3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Fatty acid metabolism,Lipid metabolism,NAD,Oxidoreductase,Polymorphism,Prostaglandin metabolism,Proteomics identification,Reference proteome,Tumor suppressor,	active site:Proton acceptor,binding site:NAD; via carbonyl oxygen,binding site:Substrate,chain:15-hydroxyprostaglandin dehydrogenase [NAD+],helix,mutagenesis site,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,strand,turn,
ENSG00000099822	hyperpolarization activated cyclic nucleotide gated potassium channel 2(HCN2)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0060078~regulation of postsynaptic membrane potential,GO:0071320~cellular response to cAMP,GO:0071321~cellular response to cGMP,GO:0071805~potassium ion transmembrane transport,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0098719~sodium ion import across plasma membrane,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0098855~HCN channel complex,	GO:0005222~intracellular cAMP activated cation channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0030552~cAMP binding,GO:0042802~identical protein binding,	IPR000595:Cyclic nucleotide-binding domain,IPR003938:Potassium channel, voltage-dependent, EAG/ELK/ERG,IPR005821:Ion transport domain,IPR013621:Ion transport N-terminal,IPR014710:RmlC-like jelly roll fold,IPR018488:Cyclic nucleotide-binding, conserved site,IPR018490:Cyclic nucleotide-binding-like,	hsa04024:cAMP signaling pathway,			SM00100:cNMP,	3D-structure,cAMP,cAMP-binding,Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium/sodium hyperpolarization- activated cyclic nucleotide-gated channel 2,compositionally biased region:Pro-rich,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:cAMP,region of interest:Involved in subunit assembly,sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,
ENSG00000152580	immunoglobulin superfamily member 10(IGSF10)	Homo sapiens			Function unknown,	GO:0001503~ossification,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,	GO:0005576~extracellular region,		IPR000372:Leucine-rich repeat-containing N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Leucine-rich repeat,Osteogenesis,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Immunoglobulin superfamily member 10,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 10,domain:Ig-like C2-type 11,domain:Ig-like C2-type 12,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,domain:Ig-like C2-type 9,domain:LRRNT,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000216588	immunoglobulin superfamily member 23(IGSF23)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,					Complete proteome,Glycoprotein,Immunoglobulin domain,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,
ENSG00000085552	immunoglobulin superfamily member 9(IGSF9)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0016358~dendrite development,GO:0050807~regulation of synapse organization,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0060077~inhibitory synapse,	GO:0098632~protein binding involved in cell-cell adhesion,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Protein turtle homolog A,compositionally biased region:Pro-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:PDZ-binding,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000080854	immunoglobulin superfamily member 9B(IGSF9B)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007399~nervous system development,GO:0097151~positive regulation of inhibitory postsynaptic potential,	GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,	GO:0019900~kinase binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Methylation,Neurogenesis,Phosphoprotein,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Protein turtle homolog B,compositionally biased region:Pro-rich,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000131203	indoleamine 2,3-dioxygenase 1(IDO1)	Homo sapiens				GO:0002376~immune system process,GO:0002534~cytokine production involved in inflammatory response,GO:0002666~positive regulation of T cell tolerance induction,GO:0002678~positive regulation of chronic inflammatory response,GO:0002830~positive regulation of type 2 immune response,GO:0006569~tryptophan catabolic process,GO:0007565~female pregnancy,GO:0019441~tryptophan catabolic process to kynurenine,GO:0032496~response to lipopolysaccharide,GO:0032693~negative regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0033555~multicellular organismal response to stress,GO:0034276~kynurenic acid biosynthetic process,GO:0036269~swimming behavior,GO:0042130~negative regulation of T cell proliferation,GO:0046006~regulation of activated T cell proliferation,GO:0055114~oxidation-reduction process,GO:0070233~negative regulation of T cell apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,	GO:0005829~cytosol,GO:0030485~smooth muscle contractile fiber,GO:0032421~stereocilium bundle,	GO:0004833~tryptophan 2,3-dioxygenase activity,GO:0009055~electron carrier activity,GO:0020037~heme binding,GO:0033754~indoleamine 2,3-dioxygenase activity,GO:0046872~metal ion binding,	IPR000898:Indoleamine 2,3-dioxygenase,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,hsa05143:African trypanosomiasis,				3D-structure,Complete proteome,Cytoplasm,Dioxygenase,Direct protein sequencing,Heme,Immunity,Iron,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Tryptophan catabolism,	chain:Indoleamine 2,3-dioxygenase 1,helix,metal ion-binding site:Iron (heme proximal ligand),sequence variant,strand,turn,
ENSG00000188676	indoleamine 2,3-dioxygenase 2(IDO2)	Homo sapiens				GO:0002376~immune system process,GO:0006569~tryptophan catabolic process,GO:0019441~tryptophan catabolic process to kynurenine,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,	GO:0004833~tryptophan 2,3-dioxygenase activity,GO:0020037~heme binding,GO:0033754~indoleamine 2,3-dioxygenase activity,GO:0046872~metal ion binding,	IPR000898:Indoleamine 2,3-dioxygenase,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,hsa05143:African trypanosomiasis,				Alternative splicing,Complete proteome,Dioxygenase,Heme,Immunity,Iron,Membrane,Metal-binding,Oxidoreductase,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Tryptophan catabolism,	chain:Indoleamine 2,3-dioxygenase 2,metal ion-binding site:Iron (heme proximal ligand),sequence variant,splice variant,
ENSG00000163083	inhibin beta B subunit(INHBB)	Homo sapiens				GO:0001541~ovarian follicle development,GO:0006952~defense response,GO:0009267~cellular response to starvation,GO:0009612~response to mechanical stimulus,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0030154~cell differentiation,GO:0032869~cellular response to insulin stimulus,GO:0032924~activin receptor signaling pathway,GO:0040007~growth,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0044320~cellular response to leptin stimulus,GO:0044764~multi-organism cellular process,GO:0045444~fat cell differentiation,GO:0046676~negative regulation of insulin secretion,GO:0046881~positive regulation of follicle-stimulating hormone secretion,GO:0046882~negative regulation of follicle-stimulating hormone secretion,GO:0048178~negative regulation of hepatocyte growth factor biosynthetic process,GO:0048468~cell development,GO:0048599~oocyte development,GO:0060279~positive regulation of ovulation,GO:0060395~SMAD protein signal transduction,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0048471~perinuclear region of cytoplasm,GO:0071944~cell periphery,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0042803~protein homodimerization activity,GO:0046789~host cell surface receptor binding,	IPR000381:Inhibin, beta B subunit,IPR001111:Transforming growth factor-beta, N-terminal,IPR001839:Transforming growth factor-beta, C-terminal,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00204:TGFB,	Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Hormone,Reference proteome,Secreted,Signal,	chain:Inhibin beta B chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
ENSG00000163453	insulin like growth factor binding protein 7(IGFBP7)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0007155~cell adhesion,GO:0007566~embryo implantation,GO:0008285~negative regulation of cell proliferation,GO:0009408~response to heat,GO:0032526~response to retinoic acid,GO:0032870~cellular response to hormone stimulus,GO:0050810~regulation of steroid biosynthetic process,GO:0051414~response to cortisol,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005520~insulin-like growth factor binding,	IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR002350:Kazal domain,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011390:Insulin-like growth factor binding protein-related protein (IGFBP-rP), MAC25,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,		614224~Retinal arterial macroaneurysm with supravalvular pulmonic stenosis,	PIRSF018239:IGFBP-related protein, MAC25 type,	SM00121:IB,SM00280:KAZAL,SM00409:IG,	Alternative splicing,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor binding,Immunoglobulin domain,Phosphoprotein,Polymorphism,Reference proteome,RNA editing,Secreted,Signal,	chain:Insulin-like growth factor-binding protein 7,disulfide bond,domain:Ig-like C2-type,domain:IGFBP N-terminal,domain:Kazal-like,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000099769	insulin like growth factor binding protein acid labile subunit(IGFALS)	Homo sapiens		h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,		GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0044267~cellular protein metabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0042567~insulin-like growth factor ternary complex,GO:0070062~extracellular exosome,	GO:0005520~insulin-like growth factor binding,	IPR000372:Leucine-rich repeat-containing N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,		615961~Acid-labile subunit, deficiency of,		SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,	Alternative splicing,Cell adhesion,Complete proteome,Direct protein sequencing,Disease mutation,Glycoprotein,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Insulin-like growth factor-binding protein complex acid labile subunit,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 18,repeat:LRR 19,repeat:LRR 2,repeat:LRR 20,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,signal peptide,
ENSG00000165949	interferon alpha inducible protein 27(IFI27)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0032355~response to estradiol,GO:0034097~response to cytokine,GO:0046825~regulation of protein export from nucleus,GO:0060135~maternal process involved in female pregnancy,GO:0060337~type I interferon signaling pathway,GO:0097190~apoptotic signaling pathway,	GO:0005637~nuclear inner membrane,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0005521~lamin binding,	IPR009311:Interferon-induced 6-16,					Apoptosis,Complete proteome,Membrane,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Signal,Transit peptide,Transmembrane,Transmembrane helix,	chain:Interferon alpha-inducible protein 27,modified residue,sequence conflict,sequence variant,transmembrane region,
ENSG00000182393	interferon lambda 1(IFNL1)	Homo sapiens				GO:0002829~negative regulation of type 2 immune response,GO:0007259~JAK-STAT cascade,GO:0008285~negative regulation of cell proliferation,GO:0032696~negative regulation of interleukin-13 production,GO:0032714~negative regulation of interleukin-5 production,GO:0032729~positive regulation of interferon-gamma production,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0043381~negative regulation of memory T cell differentiation,GO:0045087~innate immune response,GO:0045345~positive regulation of MHC class I biosynthetic process,GO:0045581~negative regulation of T cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046427~positive regulation of JAK-STAT cascade,GO:0050778~positive regulation of immune response,GO:0051607~defense response to virus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0032002~interleukin-28 receptor complex,	GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0032003~interleukin-28 receptor binding,		hsa04630:Jak-STAT signaling pathway,				3D-structure,Antiviral defense,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Interleukin-29,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
ENSG00000163701	interleukin 17 receptor E(IL17RE)	Homo sapiens				GO:0006954~inflammatory response,GO:0019221~cytokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0030368~interleukin-17 receptor activity,	IPR013568:SEFIR,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Glycoprotein,Inflammatory response,Membrane,Polymorphism,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor E,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000100385	interleukin 2 receptor subunit beta(IL2RB)	Homo sapiens		h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0000165~MAPK cascade,GO:0006461~protein complex assembly,GO:0007165~signal transduction,GO:0016032~viral process,GO:0019221~cytokine-mediated signaling pathway,GO:0038110~interleukin-2-mediated signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016020~membrane,	GO:0004911~interleukin-2 receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0019976~interleukin-2 binding,	IPR003531:Short hematopoietin receptor, family 1, conserved site,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04144:Endocytosis,hsa04151:PI3K-Akt signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,			SM00060:FN3,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Host-virus interaction,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-2 receptor subunit beta,disulfide bond,domain:Fibronectin type-III,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000008517	interleukin 32(IL32)	Homo sapiens				GO:0006952~defense response,GO:0006955~immune response,GO:0007155~cell adhesion,	GO:0005615~extracellular space,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005125~cytokine activity,GO:0005515~protein binding,						Alternative splicing,Complete proteome,Cytokine,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Interleukin-32,sequence variant,signal peptide,splice variant,
ENSG00000136244	interleukin 6(IL6)	Homo sapiens	11.IL-6_gp130-Jak-STAT,110.CRHandLC-NA,114.Genomic_reformatting_Brain_Ischemia,12.IL-6_type_cytok-signal-transduct,15.T-cell_polarization-chemokine_receptors,18.Cytokine_astocytes,19.Cytokine_microglia,20.Cytokine_oligodendrocytes,21.Cytokine_neurons,22.Cytokine-chemokine_CNS,56.Macrophage_regulation_of_CD4+T_cells,58.(CD40L)_immnosurveillance,7.IL17_hematopoesis,80.T_cell_Activation,97.Immune_injury_MS-lesions_MS_antigen,	h_cytokinePathway:Cytokine Network,h_erythPathway:Erythrocyte Differentiation Pathway,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_il17Pathway:IL 17 Signaling Pathway,h_il1rPathway:Signal transduction through IL1R,h_il5Pathway:IL 5 Signaling Pathway,h_il6Pathway:IL 6 signaling pathway,h_inflamPathway:Cytokines and Inflammatory Response,h_LairPathway:Cells and Molecules involved in local acute inflammatory response,h_LDLpathway:Low-density lipoprotein (LDL) pathway during atherogenesis,h_stemPathway:Regulation of hematopoiesis by cytokines,		GO:0001781~neutrophil apoptotic process,GO:0001878~response to yeast,GO:0002384~hepatic immune response,GO:0002446~neutrophil mediated immunity,GO:0002526~acute inflammatory response,GO:0002548~monocyte chemotaxis,GO:0002675~positive regulation of acute inflammatory response,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006469~negative regulation of protein kinase activity,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0009408~response to heat,GO:0009409~response to cold,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0010888~negative regulation of lipid storage,GO:0010976~positive regulation of neuron projection development,GO:0010996~response to auditory stimulus,GO:0016049~cell growth,GO:0019221~cytokine-mediated signaling pathway,GO:0030168~platelet activation,GO:0031000~response to caffeine,GO:0031018~endocrine pancreas development,GO:0031175~neuron projection development,GO:0031669~cellular response to nutrient levels,GO:0032494~response to peptidoglycan,GO:0032722~positive regulation of chemokine production,GO:0032755~positive regulation of interleukin-6 production,GO:0032868~response to insulin,GO:0032966~negative regulation of collagen biosynthetic process,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0042060~wound healing,GO:0042102~positive regulation of T cell proliferation,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042593~glucose homeostasis,GO:0042832~defense response to protozoan,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043200~response to amino acid,GO:0043410~positive regulation of MAPK cascade,GO:0045079~negative regulation of chemokine biosynthetic process,GO:0045188~regulation of circadian sleep/wake cycle, non-REM sleep,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045454~cell redox homeostasis,GO:0045599~negative regulation of fat cell differentiation,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045721~negative regulation of gluconeogenesis,GO:0045727~positive regulation of translation,GO:0045740~positive regulation of DNA replication,GO:0045765~regulation of angiogenesis,GO:0045779~negative regulation of bone resorption,GO:0045837~negative regulation of membrane potential,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046677~response to antibiotic,GO:0046716~muscle cell cellular homeostasis,GO:0046849~bone remodeling,GO:0046888~negative regulation of hormone secretion,GO:0048635~negative regulation of muscle organ development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050710~negative regulation of cytokine secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0050871~positive regulation of B cell activation,GO:0051024~positive regulation of immunoglobulin secretion,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051384~response to glucocorticoid,GO:0051592~response to calcium ion,GO:0051602~response to electrical stimulus,GO:0051607~defense response to virus,GO:0051897~positive regulation of protein kinase B signaling,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060445~branching involved in salivary gland morphogenesis,GO:0060664~epithelial cell proliferation involved in salivary gland morphogenesis,GO:0070091~glucagon secretion,GO:0070102~interleukin-6-mediated signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071392~cellular response to estradiol stimulus,GO:0071549~cellular response to dexamethasone stimulus,GO:0071864~positive regulation of cell proliferation in bone marrow,GO:0072540~T-helper 17 cell lineage commitment,GO:1901215~negative regulation of neuron death,GO:1990646~cellular response to prolactin,GO:2000366~positive regulation of STAT protein import into nucleus,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000660~negative regulation of interleukin-1-mediated signaling pathway,GO:2000676~positive regulation of type B pancreatic cell apoptotic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005896~interleukin-6 receptor complex,GO:0009897~external side of plasma membrane,	GO:0005125~cytokine activity,GO:0005138~interleukin-6 receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR003574:Interleukin-6,IPR009079:Four-helical cytokine-like, core,IPR012351:Four-helical cytokine, core,	hsa04060:Cytokine-cytokine receptor interaction,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04668:TNF signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05020:Prion diseases,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,hsa05332:Graft-versus-host disease,hsa05410:Hypertrophic cardiomyopathy (HCM),	108010~Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to,125853~Diabetes, susceptibility to, 222100,148000~Kaposi sarcoma, susceptibility to,266600~Crohn disease-associated growth failure,604302~Rheumatoid arthritis, systemic juvenile,	PIRSF001935:interleukin-6,	SM00126:IL6,	3D-structure,Acute phase,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Interleukin-6,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence variant,signal peptide,strand,
ENSG00000132465	joining chain of multimeric IgA and IgM(JCHAIN)	Homo sapiens				GO:0001895~retina homeostasis,GO:0002250~adaptive immune response,GO:0003094~glomerular filtration,GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0019731~antibacterial humoral response,GO:0032461~positive regulation of protein oligomerization,GO:0045087~innate immune response,GO:0060267~positive regulation of respiratory burst,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0071748~monomeric IgA immunoglobulin complex,GO:0071750~dimeric IgA immunoglobulin complex,GO:0071751~secretory IgA immunoglobulin complex,GO:0071752~secretory dimeric IgA immunoglobulin complex,GO:0071756~pentameric IgM immunoglobulin complex,GO:0071757~hexameric IgM immunoglobulin complex,GO:0072562~blood microparticle,	GO:0003697~single-stranded DNA binding,GO:0003823~antigen binding,GO:0019862~IgA binding,GO:0031210~phosphatidylcholine binding,GO:0034987~immunoglobulin receptor binding,GO:0042803~protein homodimerization activity,GO:0042834~peptidoglycan binding,	IPR024110:Immunoglobulin J chain,					Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:Immunoglobulin J chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,signal peptide,
ENSG00000111057	keratin 18(KRT18)	Homo sapiens				GO:0007049~cell cycle,GO:0009653~anatomical structure morphogenesis,GO:0016032~viral process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0043000~Golgi to plasma membrane CFTR protein transport,GO:0043066~negative regulation of apoptotic process,GO:0045104~intermediate filament cytoskeleton organization,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097284~hepatocyte apoptotic process,GO:0098609~cell-cell adhesion,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005882~intermediate filament,GO:0005913~cell-cell adherens junction,GO:0034451~centriolar satellite,GO:0045095~keratin filament,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0097110~scaffold protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001664:Intermediate filament protein,IPR002957:Keratin, type I,IPR018039:Intermediate filament protein, conserved site,		215600~Cirrhosis, cryptogenic,215600~Cirrhosis, noncryptogenic, susceptibility to,		SM01391:SM01391,	Acetylation,Cell cycle,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Glycoprotein,Host-virus interaction,Intermediate filament,Isopeptide bond,Keratin,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Keratin, type I cytoskeletal 18,glycosylation site:O-linked (GlcNAc),modified residue,mutagenesis site,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Interaction with DNAJB6,region of interest:Interaction with TRADD,region of interest:Linker 1,region of interest:Linker 12,region of interest:Necessary for interaction with PNN,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,site:Cleavage; by caspase-3, caspase-6 or caspase-7,site:Stutter,
ENSG00000135480	keratin 7(KRT7)	Homo sapiens				GO:0016032~viral process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005882~intermediate filament,GO:0045095~keratin filament,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001664:Intermediate filament protein,IPR003054:Type II keratin,IPR009053:Prefoldin,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	3D-structure,Acetylation,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Host-virus interaction,Intermediate filament,Isopeptide bond,Keratin,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Keratin, type II cytoskeletal 7,modified residue,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Interaction with HPV16 E7,region of interest:Linker 1,region of interest:Linker 12,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,site:Stutter,
ENSG00000170421	keratin 8(KRT8)	Homo sapiens				GO:0016032~viral process,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0045214~sarcomere organization,GO:0051599~response to hydrostatic pressure,GO:0051707~response to other organism,GO:0060706~cell differentiation involved in embryonic placenta development,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097284~hepatocyte apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005882~intermediate filament,GO:0005911~cell-cell junction,GO:0016010~dystrophin-associated glycoprotein complex,GO:0016363~nuclear matrix,GO:0030018~Z disc,GO:0042383~sarcolemma,GO:0043034~costamere,GO:0045095~keratin filament,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0097110~scaffold protein binding,	IPR001664:Intermediate filament protein,IPR003054:Type II keratin,IPR009053:Prefoldin,IPR018039:Intermediate filament protein, conserved site,		215600~Cirrhosis, cryptogenic,215600~Cirrhosis, noncryptogenic, susceptibility to,		SM01391:SM01391,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Glycoprotein,Host-virus interaction,Intermediate filament,Isopeptide bond,Keratin,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Keratin, type II cytoskeletal 8,compositionally biased region:Ser-rich,modified residue,mutagenesis site,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Necessary for interaction with PNN,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,site:Stutter,
ENSG00000134545	killer cell lectin like receptor C1(KLRC1)	Homo sapiens		h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,		GO:0007166~cell surface receptor signaling pathway,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0023024~MHC class I protein complex binding,GO:0030246~carbohydrate binding,GO:1990405~protein antigen binding,	IPR001304:C-type lectin,IPR008646:Herpesvirus UL45-like,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04612:Antigen processing and presentation,			SM00034:CLECT,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:NKG2-A/NKG2-B type II integral membrane protein,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000134539	killer cell lectin like receptor D1(KLRD1)	Homo sapiens		h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,		GO:0002228~natural killer cell mediated immunity,GO:0007166~cell surface receptor signaling pathway,GO:0045087~innate immune response,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0023024~MHC class I protein complex binding,GO:0023030~MHC class Ib protein binding, via antigen binding groove,GO:0030246~carbohydrate binding,GO:1990405~protein antigen binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04612:Antigen processing and presentation,hsa04650:Natural killer cell mediated cytotoxicity,			SM00034:CLECT,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Natural killer cells antigen CD94,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000213809	killer cell lectin like receptor K1(KLRK1)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0002250~adaptive immune response,GO:0007165~signal transduction,GO:0030101~natural killer cell activation,GO:0030154~cell differentiation,GO:0031295~T cell costimulation,GO:0032729~positive regulation of interferon-gamma production,GO:0034260~negative regulation of GTPase activity,GO:0045087~innate immune response,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0050776~regulation of immune response,GO:0050830~defense response to Gram-positive bacterium,GO:0071222~cellular response to lipopolysaccharide,GO:2000502~negative regulation of natural killer cell chemotaxis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0032394~MHC class Ib receptor activity,GO:0042288~MHC class I protein binding,GO:0042803~protein homodimerization activity,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04650:Natural killer cell mediated cytotoxicity,hsa05144:Malaria,			SM00034:CLECT,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Differentiation,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Lectin,Membrane,Polymorphism,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:NKG2-D type II integral membrane protein,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000117245	kinesin family member 17(KIF17)	Homo sapiens				GO:0007018~microtubule-based movement,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0022008~neurogenesis,GO:0030030~cell projection organization,GO:0031503~protein complex localization,	GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0030992~intraciliary transport particle B,GO:0032391~photoreceptor connecting cilium,GO:0036064~ciliary basal body,GO:0072372~primary cilium,GO:1990075~periciliary membrane compartment,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	Alternative splicing,ATP-binding,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Kinesin-like protein KIF17,domain:Kinesin-motor,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ENSG00000131650	kringle containing transmembrane protein 2(KREMEN2)	Homo sapiens		h_wnt-Lrp6Pathway:Wnt/LRP6 Signalling,		GO:0007154~cell communication,GO:0016055~Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,		IPR000001:Kringle,IPR000859:CUB domain,IPR002889:Carbohydrate-binding WSC,IPR013806:Kringle-like fold,IPR017076:Kremen,IPR018056:Kringle, conserved site,			PIRSF036961:kremen protein,	SM00042:CUB,SM00130:KR,SM00321:WSC,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Kringle,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Kremen protein 2,disulfide bond,domain:CUB,domain:Kringle,domain:WSC,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000160789	lamin A/C(LMNA)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0007077~mitotic nuclear envelope disassembly,GO:0007084~mitotic nuclear envelope reassembly,GO:0007517~muscle organ development,GO:0030334~regulation of cell migration,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0034504~protein localization to nucleus,GO:0035105~sterol regulatory element binding protein import into nucleus,GO:0036498~IRE1-mediated unfolded protein response,GO:0055015~ventricular cardiac muscle cell development,GO:0071456~cellular response to hypoxia,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0090343~positive regulation of cell aging,GO:1900180~regulation of protein localization to nucleus,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005638~lamin filament,GO:0005652~nuclear lamina,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0016607~nuclear speck,GO:0031012~extracellular matrix,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001322:Lamin Tail Domain,IPR001664:Intermediate filament protein,IPR018039:Intermediate filament protein, conserved site,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	115200~Cardiomyopathy, dilated, 1A,151660~Lipodystrophy, familial partial, 2,159001~Muscular dystrophy, limb-girdle, type 1B,176670~Hutchinson-Gilford progeria,181350~Emery-Dreifuss muscular dystrophy 2, AD,212112~Malouf syndrome,248370~Mandibuloacral dysplasia,275210~Restrictive dermopathy, lethal,605588~Charcot-Marie-Tooth disease, type 2B1,610140~Heart-hand syndrome, Slovenian type,613205~Muscular dystrophy, congenital,616516~Emery-Dreifuss muscular dystrophy 3, AR,		SM01391:SM01391,	3D-structure,Acetylation,Alternative splicing,Cardiomyopathy,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Congenital muscular dystrophy,Direct protein sequencing,Disease mutation,Emery-Dreifuss muscular dystrophy,Intermediate filament,Isopeptide bond,Limb-girdle muscular dystrophy,Lipoprotein,Methylation,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Lamin-A/C,helix,lipid moiety-binding region:S-farnesyl cysteine,modified residue,mutagenesis site,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,sequence variant,short sequence motif:Nuclear localization signal,site:Heptad change of phase,site:Stutter,splice variant,strand,turn,
ENSG00000204381	layilin(LAYN)	Homo sapiens					GO:0001726~ruffle,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0005540~hyaluronic acid binding,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Layilin,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:2 X 4 AA repeats of N-X-I-Y,region of interest:3 X 5 AA repeats of E-S-G-X-V,region of interest:Interaction with NF2,region of interest:Interaction with TLN1,repeat:1-1,repeat:1-2,repeat:1-3,repeat:2-1,repeat:2-2,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000162620	leucine rich repeats and IQ motif containing 3(LRRIQ3)	Homo sapiens						GO:0005515~protein binding,	IPR000048:IQ motif, EF-hand binding site,IPR001611:Leucine-rich repeat,IPR025875:Leucine rich repeat 4,					Alternative splicing,Coiled coil,Complete proteome,Leucine-rich repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-rich repeat and IQ domain- containing protein 3,domain:IQ,repeat:LRR 1,repeat:LRR 2,sequence conflict,sequence variant,splice variant,
ENSG00000239961	leukocyte immunoglobulin like receptor A4(LILRA4)	Homo sapiens				GO:0002250~adaptive immune response,	GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR016332:Alpha-1B-glycoprotein/leukocyte immunoglobulin-like receptor,	hsa04380:Osteoclast differentiation,		PIRSF001979:alpha-1B-glycoprotein,	SM00408:IGc2,SM00409:IG,	Adaptive immunity,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Nitration,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leukocyte immunoglobulin-like receptor subfamily A member 4,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000105609	leukocyte immunoglobulin like receptor B5(LILRB5)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006952~defense response,GO:0007166~cell surface receptor signaling pathway,	GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,	hsa04380:Osteoclast differentiation,			SM00408:IGc2,SM00409:IG,	Adaptive immunity,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Leukocyte immunoglobulin-like receptor subfamily B member 5,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000062524	leukocyte receptor tyrosine kinase(LTK)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008283~cell proliferation,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0010976~positive regulation of neuron projection development,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0043066~negative regulation of apoptotic process,GO:0071300~cellular response to retinoic acid,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR026984:Leukocyte tyrosine kinase receptor,				SM00219:TyrKc,	Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Systemic lupus erythematosus,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Leukocyte tyrosine kinase receptor,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000132793	lipin 3(LPIN3)	Homo sapiens				GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0009062~fatty acid catabolic process,GO:0016311~dephosphorylation,GO:0019432~triglyceride biosynthetic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,	GO:0003713~transcription coactivator activity,GO:0008195~phosphatidate phosphatase activity,	IPR007651:Lipin, N-terminal,IPR013209:LNS2, Lipin/Ned1/Smp2,IPR023214:HAD-like domain,	hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa01100:Metabolic pathways,			SM00775:LNS2,	Alternative splicing,Complete proteome,Fatty acid metabolism,Hydrolase,Lipid metabolism,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Phosphatidate phosphatase LPIN3,modified residue,region of interest:C-LIP,region of interest:N-LIP,sequence variant,short sequence motif:DXDXT motif,short sequence motif:LXXIL motif,short sequence motif:Nuclear localization signal,splice variant,
ENSG00000231028	long intergenic non-protein coding RNA 271(LINC00271)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C6orf217,sequence variant,
ENSG00000255874	long intergenic non-protein coding RNA 346(LINC00346)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C13orf29,sequence variant,
ENSG00000187942	low density lipoprotein receptor class A domain containing 2(LDLRAD2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR000859:CUB domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,				SM00192:LDLa,	Complete proteome,Disulfide bond,Glycoprotein,Lipoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor class A domain-containing protein 2,disulfide bond,domain:LDL-receptor class A,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000078081	lysosomal associated membrane protein 3(LAMP3)	Homo sapiens				GO:0002250~adaptive immune response,GO:0010506~regulation of autophagy,GO:0010628~positive regulation of gene expression,GO:0035455~response to interferon-alpha,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0046718~viral entry into host cell,GO:1901799~negative regulation of proteasomal protein catabolic process,GO:1903900~regulation of viral life cycle,	GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031982~vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0097233~alveolar lamellar body membrane,		IPR002000:Lysosome-associated membrane glycoprotein,	hsa04142:Lysosome,				3D-structure,Adaptive immunity,Complete proteome,Cytoplasmic vesicle,Disulfide bond,Glycoprotein,Immunity,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Lysosome-associated membrane glycoprotein 3,compositionally biased region:Thr-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000125869	lysosomal associated membrane protein family member 5(LAMP5)	Homo sapiens					GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0030659~cytoplasmic vesicle membrane,GO:0031901~early endosome membrane,GO:0032584~growth cone membrane,GO:0032590~dendrite membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0055038~recycling endosome membrane,		IPR002000:Lysosome-associated membrane glycoprotein,					Alternative splicing,Cell membrane,Cell projection,Complete proteome,Cytoplasmic vesicle,Endosome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:LAMP family protein C20orf103,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000240972	macrophage migration inhibitory factor (glycosylation-inhibiting factor)(MIF)	Homo sapiens				GO:0001516~prostaglandin biosynthetic process,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0010629~negative regulation of gene expression,GO:0010739~positive regulation of protein kinase A signaling,GO:0019752~carboxylic acid metabolic process,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030890~positive regulation of B cell proliferation,GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0032269~negative regulation of cellular protein metabolic process,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043030~regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045087~innate immune response,GO:0048146~positive regulation of fibroblast proliferation,GO:0050715~positive regulation of cytokine secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050900~leukocyte migration,GO:0050918~positive chemotaxis,GO:0061078~positive regulation of prostaglandin secretion involved in immune response,GO:0061081~positive regulation of myeloid leukocyte cytokine production involved in immune response,GO:0070207~protein homotrimerization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071157~negative regulation of cell cycle arrest,GO:0090238~positive regulation of arachidonic acid secretion,GO:0090344~negative regulation of cell aging,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:2000343~positive regulation of chemokine (C-X-C motif) ligand 2 production,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004167~dopachrome isomerase activity,GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0005515~protein binding,GO:0042056~chemoattractant activity,GO:0050178~phenylpyruvate tautomerase activity,	IPR001398:Macrophage migration inhibitory factor,IPR014347:Tautomerase/MIF superfamily,IPR019829:Macrophage migration inhibitory factor, conserved site,	hsa00350:Tyrosine metabolism,hsa00360:Phenylalanine metabolism,	604302~Rheumatoid arthritis, systemic juvenile, susceptibility to,			3D-structure,Acetylation,Complete proteome,Cytokine,Cytoplasm,Direct protein sequencing,Immunity,Inflammatory response,Innate immunity,Isomerase,Reference proteome,Secreted,	active site:Proton acceptor; via imino nitrogen,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Macrophage migration inhibitory factor,helix,modified residue,sequence conflict,strand,
ENSG00000213920	magnesium dependent phosphatase 1(MDP1)	Homo sapiens				GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0046872~metal ion binding,	IPR010033:HAD-superfamily phosphatase, subfamily IIIC,IPR010036:Magnesium-dependent phosphatase-1, eukaryotic/arcaheal type,IPR023214:HAD-like domain,IPR024734:Magnesium-dependent phosphatase-1, eukaryotic type,					3D-structure,Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Protein phosphatase,Reference proteome,	active site:Nucleophile,active site:Proton donor,binding site:Phosphate,binding site:Phosphate; via amide nitrogen,binding site:Substrate,chain:Magnesium-dependent phosphatase 1,helix,metal ion-binding site:Magnesium,modified residue,splice variant,strand,turn,
ENSG00000205639	major facilitator superfamily domain containing 2B(MFSD2B)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0006810~transport,	GO:0016021~integral component of membrane,		IPR020846:Major facilitator superfamily domain,					Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,
ENSG00000204632	major histocompatibility complex, class I, G(HLA-G)	Homo sapiens				GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,GO:0002645~positive regulation of tolerance induction,GO:0002666~positive regulation of T cell tolerance induction,GO:0002767~immune response-inhibiting cell surface receptor signaling pathway,GO:0006968~cellular defense response,GO:0019882~antigen processing and presentation,GO:0032735~positive regulation of interleukin-12 production,GO:0042130~negative regulation of T cell proliferation,GO:0045591~positive regulation of regulatory T cell differentiation,GO:0050776~regulation of immune response,GO:0050777~negative regulation of immune response,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:2001199~negative regulation of dendritic cell differentiation,	GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0031901~early endosome membrane,GO:0042612~MHC class I protein complex,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0003823~antigen binding,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,	IPR001039:MHC class I, alpha chain, alpha1/alpha2,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,	hsa04144:Endocytosis,hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04940:Type I diabetes mellitus,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,	600807~Asthma, susceptibility to,		SM00407:IGc1,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Membrane,MHC I,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:HLA class I histocompatibility antigen, alpha chain G,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Alpha-3,region of interest:Connecting peptide,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000241106	major histocompatibility complex, class II, DO beta(HLA-DOB)	Homo sapiens				GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0002587~negative regulation of antigen processing and presentation of peptide antigen via MHC class II,GO:0006955~immune response,GO:0007165~signal transduction,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,	GO:0005622~intracellular,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0042613~MHC class II protein complex,	GO:0023026~MHC class II protein complex binding,GO:0032395~MHC class II receptor activity,	IPR000353:MHC class II, beta chain, N-terminal,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05321:Inflammatory bowel disease (IBD),hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,			SM00407:IGc1,SM00921:SM00921,	3D-structure,Complete proteome,Disulfide bond,Endosome,Glycoprotein,Immunity,Lysosome,Membrane,MHC II,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:HLA class II histocompatibility antigen, DO beta chain,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),region of interest:Beta-1,region of interest:Beta-2,region of interest:Connecting peptide,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000237541	major histocompatibility complex, class II, DQ alpha 2(HLA-DQA2)	Homo sapiens				GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0006955~immune response,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0031295~T cell costimulation,GO:0050852~T cell receptor signaling pathway,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0000139~Golgi membrane,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0042613~MHC class II protein complex,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0032395~MHC class II receptor activity,	IPR001003:MHC class II, alpha chain, N-terminal,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05321:Inflammatory bowel disease (IBD),hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,			SM00407:IGc1,SM00920:SM00920,	Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Immunity,Lysosome,Membrane,MHC II,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:HLA class II histocompatibility antigen, DQ alpha 2 chain,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Connecting peptide,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000232629	major histocompatibility complex, class II, DQ beta 2(HLA-DQB2)	Homo sapiens				GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0006955~immune response,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0031295~T cell costimulation,GO:0050852~T cell receptor signaling pathway,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0000139~Golgi membrane,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0042613~MHC class II protein complex,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0032395~MHC class II receptor activity,	IPR000353:MHC class II, beta chain, N-terminal,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,				SM00407:IGc1,SM00921:SM00921,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Immunity,Lysosome,Membrane,MHC II,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,
ENSG00000011028	mannose receptor C type 2(MRC2)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0030574~collagen catabolic process,	GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0030246~carbohydrate binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000772:Ricin B lectin domain,IPR001304:C-type lectin,IPR013806:Kringle-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04145:Phagosome,hsa05152:Tuberculosis,			SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	3D-structure,Calcium,Complete proteome,Direct protein sequencing,Disulfide bond,Endocytosis,Glycoprotein,Isopeptide bond,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:C-type mannose receptor 2,disulfide bond,domain:C-type lectin 1,domain:C-type lectin 2,domain:C-type lectin 3,domain:C-type lectin 4,domain:C-type lectin 5,domain:C-type lectin 6,domain:C-type lectin 7,domain:C-type lectin 8,domain:Fibronectin type-II,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000168282	mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase(MGAT2)	Homo sapiens				GO:0006487~protein N-linked glycosylation,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0018279~protein N-linked glycosylation via asparagine,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008455~alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,GO:0030246~carbohydrate binding,	IPR007754:N-acetylglucosaminyltransferase II,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	212066~Congenital disorder of glycosylation, type IIa,			Complete proteome,Congenital disorder of glycosylation,Direct protein sequencing,Disease mutation,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-1,6-mannosyl-glycoprotein 2-beta-N- acetylglucosaminyltransferase,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000170476	marginal zone B and B1 cell specific protein(MZB1)	Homo sapiens				GO:0002642~positive regulation of immunoglobulin biosynthetic process,GO:0006915~apoptotic process,GO:0008284~positive regulation of cell proliferation,GO:0030888~regulation of B cell proliferation,GO:0033622~integrin activation,GO:0042127~regulation of cell proliferation,GO:2001274~negative regulation of glucose import in response to insulin stimulus,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0034663~endoplasmic reticulum chaperone complex,		IPR021852:Domain of unknown function DUF3456,					Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Disulfide bond,Endoplasmic reticulum,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Proapoptotic caspase adapter protein,signal peptide,splice variant,
ENSG00000162510	matrilin 1, cartilage matrix protein(MATN1)	Homo sapiens				GO:0003429~growth plate cartilage chondrocyte morphogenesis,GO:0006461~protein complex assembly,GO:0030198~extracellular matrix organization,GO:0030500~regulation of bone mineralization,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002035:von Willebrand factor, type A,IPR013032:EGF-like, conserved site,IPR019466:Matrilin, coiled-coil trimerisation domain,				SM00179:EGF_CA,SM00181:EGF,SM00327:VWA,SM01279:SM01279,	Coiled coil,Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Reference proteome,Repeat,Secreted,Signal,	chain:Cartilage matrix protein,disulfide bond,domain:EGF-like,domain:VWFA 1,domain:VWFA 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
ENSG00000100985	matrix metallopeptidase 9(MMP9)	Homo sapiens		h_reckPathway:Inhibition of Matrix Metalloproteinases,		GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001934~positive regulation of protein phosphorylation,GO:0006508~proteolysis,GO:0007566~embryo implantation,GO:0022617~extracellular matrix disassembly,GO:0030225~macrophage differentiation,GO:0030574~collagen catabolic process,GO:0035987~endodermal cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0043388~positive regulation of DNA binding,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051549~positive regulation of keratinocyte migration,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:1900122~positive regulation of receptor binding,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001258~negative regulation of cation channel activity,GO:2001268~negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000585:Hemopexin-like domain,IPR001818:Peptidase M10, metallopeptidase,IPR002477:Peptidoglycan binding-like,IPR006026:Peptidase, metallopeptidase,IPR013806:Kringle-like fold,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR021158:Peptidase M10A, cysteine switch, zinc binding site,IPR021190:Peptidase M10A,IPR024079:Metallopeptidase, catalytic domain,	hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04915:Estrogen signaling pathway,hsa05161:Hepatitis B,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05219:Bladder cancer,	613073~Metaphyseal anadysplasia 2,		SM00059:FN2,SM00120:HX,SM00235:ZnMc,	3D-structure,Calcium,Collagen degradation,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:67 kDa matrix metalloproteinase-9,chain:82 kDa matrix metalloproteinase-9,disulfide bond,domain:Fibronectin type-II 1,domain:Fibronectin type-II 2,domain:Fibronectin type-II 3,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:Hemopexin-like 3,domain:Hemopexin-like 4,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,metal ion-binding site:Zinc 1; structural,metal ion-binding site:Zinc 2; catalytic,metal ion-binding site:Zinc 2; in inhibited form,mutagenesis site,propeptide:Activation peptide,propeptide:Removed in 64 kDa matrix metalloproteinase-9 and 67 kDa matrix metalloproteinase-9,sequence conflict,sequence variant,short sequence motif:Cysteine switch,signal peptide,site:Cleavage; by MMP3,strand,turn,
ENSG00000007264	megakaryocyte-associated tyrosine kinase(MATK)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007498~mesoderm development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038128~ERBB2 signaling pathway,GO:0045087~innate immune response,	GO:0005829~cytosol,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04722:Neurotrophin signaling pathway,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Megakaryocyte-associated tyrosine-protein kinase,domain:Protein kinase,domain:SH2,domain:SH3,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
ENSG00000138587	meiosis specific nuclear structural 1(MNS1)	Homo sapiens				GO:0007283~spermatogenesis,GO:0044782~cilium organization,GO:0045724~positive regulation of cilium assembly,GO:0051321~meiotic cell cycle,GO:0070986~left/right axis specification,	GO:0005635~nuclear envelope,GO:0005882~intermediate filament,GO:0005930~axoneme,GO:0031514~motile cilium,GO:0036126~sperm flagellum,	GO:0042802~identical protein binding,	IPR026504:Meiosis-specific nuclear structural protein 1,					Coiled coil,Complete proteome,Meiosis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Meiosis-specific nuclear structural protein 1,compositionally biased region:Glu-rich,modified residue,sequence variant,
ENSG00000163975	melanotransferrin(MELTF)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0010756~positive regulation of plasminogen activation,GO:0042127~regulation of cell proliferation,GO:0055072~iron ion homeostasis,GO:0090091~positive regulation of extracellular matrix disassembly,GO:0097286~iron ion import,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0005506~iron ion binding,GO:0005515~protein binding,	IPR001156:Transferrin family,IPR016357:Transferrin,IPR018195:Transferrin family, iron binding site,			PIRSF002549:transferrin,	SM00094:TR_FER,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Ion transport,Iron,Iron transport,Lipoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transport,Zinc,	binding site:Carbonate 1,binding site:Carbonate 1; via amide nitrogen,chain:Melanotransferrin,disulfide bond,domain:Transferrin-like 1,domain:Transferrin-like 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated cysteine,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,propeptide:Removed in mature form,region of interest:Antigenic epitope,sequence variant,signal peptide,splice variant,
ENSG00000142606	membrane metalloendopeptidase like 1(MMEL1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR000718:Peptidase M13,IPR008753:Peptidase M13, N-terminal domain,IPR018497:Peptidase M13, C-terminal domain,IPR024079:Metallopeptidase, catalytic domain,					Alternative splicing,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,binding site:Substrate carboxyl,chain:Membrane metallo-endopeptidase-like 1,chain:Membrane metallo-endopeptidase-like 1, soluble form,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence conflict,sequence variant,site:Cleavage,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000156738	membrane spanning 4-domains A1(MS4A1)	Homo sapiens				GO:0006959~humoral immune response,GO:0042100~B cell proliferation,	GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0070062~extracellular exosome,	GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0023026~MHC class II protein complex binding,	IPR007237:CD20-like,	hsa04640:Hematopoietic cell lineage,	613495~Immunodeficiency, common variable, 5,			3D-structure,Alternative splicing,B-cell activation,Cell membrane,Complete proteome,Disulfide bond,Lipoprotein,Membrane,Palmitate,Pharmaceutical,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:B-lymphocyte antigen CD20,disulfide bond,helix,modified residue,mutagenesis site,region of interest:Epitope 1,region of interest:Epitope 2,region of interest:Epitope 3 (recognized by antibodies, including Rituximab),sequence conflict,topological domain:Cytoplasmic,transmembrane region,
ENSG00000102854	mesothelin(MSLN)	Homo sapiens				GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0031016~pancreas development,	GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031225~anchored component of membrane,	GO:0005515~protein binding,	IPR010335:Mesothelin,IPR026664:Stereocilin related,					3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Golgi apparatus,GPI-anchor,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Megakaryocyte-potentiating factor,chain:Mesothelin,chain:Mesothelin, cleaved form,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,region of interest:Required for megakaryocyte-potentiating factor activity,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000169715	metallothionein 1E(MT1E)	Homo sapiens				GO:0045926~negative regulation of growth,GO:0071276~cellular response to cadmium ion,GO:0071294~cellular response to zinc ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000006:Metallothionein, vertebrate,IPR003019:Metallothionein superfamily, eukaryotic,IPR017854:Metallothionein domain,IPR018064:Metallothionein, vertebrate, metal binding site,IPR023587:Metallothionein domain, vertebrate,	hsa04978:Mineral absorption,				Acetylation,Alternative splicing,Cadmium,Complete proteome,Copper,Direct protein sequencing,Metal-binding,Metal-thiolate cluster,Reference proteome,Zinc,	chain:Metallothionein-1E,metal ion-binding site:Divalent metal cation; cluster A,metal ion-binding site:Divalent metal cation; cluster B,modified residue,region of interest:Alpha,region of interest:Beta,
ENSG00000141854	microRNA 1199(MIR1199)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000164114	microtubule associated protein 9(MAP9)	Homo sapiens				GO:0000910~cytokinesis,GO:0007088~regulation of mitotic nuclear division,GO:0051225~spindle assembly,GO:0090307~mitotic spindle assembly,	GO:0000235~astral microtubule,GO:1990023~mitotic spindle midzone,		IPR026106:Microtubule-associated protein 9,					Acetylation,Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Microtubule-associated protein 9,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000140545	milk fat globule-EGF factor 8 protein(MFGE8)	Homo sapiens				GO:0001525~angiogenesis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0007155~cell adhesion,GO:0007338~single fertilization,GO:0016032~viral process,GO:0044267~cellular protein metabolic process,GO:2000427~positive regulation of apoptotic cell clearance,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0019897~extrinsic component of plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0001786~phosphatidylserine binding,GO:0005178~integrin binding,GO:0008429~phosphatidylethanolamine binding,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR000742:Epidermal growth factor-like domain,IPR008979:Galactose-binding domain-like,IPR013032:EGF-like, conserved site,IPR027060:Lactadherin,				SM00181:EGF,SM00231:FA58C,	Alternative splicing,Amyloid,Angiogenesis,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Fertilization,Glycoprotein,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Lactadherin,chain:Lactadherin short form,chain:Medin,disulfide bond,domain:EGF-like,domain:F5/8 type C 1,domain:F5/8 type C 2,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Cell attachment site,signal peptide,
ENSG00000242114	mitochondrial fission process 1(MTFP1)	Homo sapiens				GO:0000266~mitochondrial fission,GO:0006915~apoptotic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,		IPR019560:Mitochondrial 18kDa protein,					Alternative splicing,Apoptosis,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Mitochondrial 18 kDa protein,sequence conflict,
ENSG00000262814	mitochondrial ribosomal protein L12(MRPL12)	Homo sapiens				GO:0006390~transcription from mitochondrial promoter,GO:0045893~positive regulation of transcription, DNA-templated,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005762~mitochondrial large ribosomal subunit,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,	IPR000206:Ribosomal protein L7/L12,IPR008932:Ribosomal protein L7/L12, oligomerisation,IPR013823:Ribosomal protein L7/L12, C-terminal,IPR014719:Ribosomal protein L7/L12, C-terminal/adaptor protein ClpS-like,	hsa03010:Ribosome,				Acetylation,Complete proteome,Mitochondrion,Polymorphism,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L12, mitochondrial,sequence conflict,sequence variant,transit peptide:Mitochondrion,
ENSG00000075643	molybdenum cofactor sulfurase(MOCOS)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006777~Mo-molybdopterin cofactor biosynthetic process,GO:0032324~molybdopterin cofactor biosynthetic process,GO:0043545~molybdopterin cofactor metabolic process,	GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008265~Mo-molybdopterin cofactor sulfurase activity,GO:0016740~transferase activity,GO:0016829~lyase activity,GO:0030151~molybdenum ion binding,GO:0030170~pyridoxal phosphate binding,	IPR000192:Aminotransferase, class V/Cysteine desulfurase,IPR005302:Molybdenum cofactor sulfurase, C-terminal,IPR005303:MOSC, N-terminal beta barrel,IPR011037:Pyruvate kinase-like, insert domain,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,					Complete proteome,Disease mutation,Molybdenum cofactor biosynthesis,Phosphoprotein,Polymorphism,Pyridoxal phosphate,Reference proteome,Transferase,	chain:Molybdenum cofactor sulfurase,domain:MOSC,modified residue,sequence conflict,sequence variant,
ENSG00000205277	mucin 12, cell surface associated(MUC12)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0016266~O-glycan processing,	GO:0005796~Golgi lumen,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,		IPR000082:SEA domain,IPR013032:EGF-like, conserved site,					Alternative splicing,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Mucin-12,compositionally biased region:Ser-rich,disulfide bond,domain:EGF-like,domain:SEA,glycosylation site:N-linked (GlcNAc...),region of interest:28 X 19 AA approximate tandem repeats of E-E-S-X-X-X-H-X-X-P-X-X-T-X-T-X-X-X-P,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,short sequence motif:Cleavage motif,signal peptide,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000176945	mucin 20, cell surface associated(MUC20)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0016266~O-glycan processing,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0051260~protein homooligomerization,	GO:0005576~extracellular region,GO:0005796~Golgi lumen,GO:0009925~basal plasma membrane,GO:0016324~apical plasma membrane,GO:0031528~microvillus membrane,							Alternative splicing,Cell membrane,Cell projection,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Mucin-20,compositionally biased region:Ser-rich,compositionally biased region:Thr-rich,glycosylation site:N-linked (GlcNAc...),region of interest:12 X 20 AA approximate tandem repeats of S-S-E-S-S-A-S-S-D-S-P-H-P-V-I-T-P-S-R-A,region of interest:Interaction with MET,region of interest:Involved in oligomerization,repeat:1,repeat:10,repeat:11,repeat:12; approximate,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000178860	musculin(MSC)	Homo sapiens	79.B_cell_Activation,			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0014707~branchiomeric skeletal muscle development,GO:0060021~palate development,GO:0060539~diaphragm development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001206~transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Complete proteome,DNA-binding,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Musculin,compositionally biased region:Glu-rich (acidic),compositionally biased region:Gly-rich,compositionally biased region:Poly-Gly,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,sequence conflict,short sequence motif:Nuclear localization signal,
ENSG00000172927	myeloma overexpressed(MYEOV)	Homo sapiens												Complete proteome,Polymorphism,Proto-oncogene,Reference proteome,	chain:Myeloma-overexpressed gene protein,sequence conflict,sequence variant,
ENSG00000176658	myosin ID(MYO1D)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,GO:0051641~cellular localization,GO:0061502~early endosome to recycling endosome transport,	GO:0005768~endosome,GO:0005790~smooth endoplasmic reticulum,GO:0005829~cytosol,GO:0005903~brush border,GO:0016323~basolateral plasma membrane,GO:0016459~myosin complex,GO:0030424~axon,GO:0030673~axolemma,GO:0031410~cytoplasmic vesicle,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0044853~plasma membrane raft,GO:0070062~extracellular exosome,GO:0097440~apical dendrite,	GO:0000146~microfilament motor activity,GO:0003774~motor activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0019904~protein domain specific binding,GO:0030898~actin-dependent ATPase activity,GO:0048306~calcium-dependent protein binding,GO:0051015~actin filament binding,	IPR000048:IQ motif, EF-hand binding site,IPR001609:Myosin head, motor domain,IPR010926:Myosin tail 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,SM00242:MYSc,	Acetylation,Actin-binding,ATP-binding,Calmodulin-binding,Complete proteome,Direct protein sequencing,Motor protein,Myosin,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Myosin-Id,domain:IQ 1,domain:IQ 2,domain:Myosin head-like,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
ENSG00000196586	myosin VI(MYO6)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0007605~sensory perception of sound,GO:0030048~actin filament-based movement,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0042493~response to drug,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051046~regulation of secretion,GO:0098609~cell-cell adhesion,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005905~clathrin-coated pit,GO:0005913~cell-cell adherens junction,GO:0005938~cell cortex,GO:0016020~membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016459~myosin complex,GO:0016461~unconventional myosin complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0030139~endocytic vesicle,GO:0030665~clathrin-coated vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031941~filamentous actin,GO:0031965~nuclear membrane,GO:0032587~ruffle membrane,GO:0045177~apical part of cell,GO:0045334~clathrin-coated endocytic vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003774~motor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0043531~ADP binding,GO:0051015~actin filament binding,GO:0060001~minus-end directed microfilament motor activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001609:Myosin head, motor domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		606346~Deafness, autosomal dominant 22,606346~Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy,607821~Deafness, autosomal recessive 37,		SM00242:MYSc,	3D-structure,Actin-binding,Alternative splicing,ATP-binding,Calmodulin-binding,Cardiomyopathy,Cell membrane,Cell projection,Coated pit,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Deafness,Disease mutation,Endocytosis,Golgi apparatus,Hearing,Membrane,Motor protein,Myosin,Non-syndromic deafness,Nucleotide-binding,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Myosin-VI,compositionally biased region:Glu-rich,domain:IQ,domain:Myosin head-like,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Actin-binding,region of interest:Required for binding calmodulin,region of interest:Responsible for slow ATPase activity,sequence conflict,sequence variant,splice variant,
ENSG00000101335	myosin light chain 9(MYL9)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0006936~muscle contraction,GO:0006937~regulation of muscle contraction,GO:0070527~platelet aggregation,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005859~muscle myosin complex,GO:0030018~Z disc,	GO:0005509~calcium ion binding,GO:0008307~structural constituent of muscle,GO:0032036~myosin heavy chain binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04510:Focal adhesion,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa04921:Oxytocin signaling pathway,			SM00054:EFh,	Acetylation,Alternative splicing,Calcium,Complete proteome,Metal-binding,Motor protein,Muscle protein,Myosin,Phosphoprotein,Reference proteome,Repeat,	chain:Myosin regulatory light polypeptide 9,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,modified residue,sequence conflict,
ENSG00000182636	necdin, MAGE family member(NDN)	Homo sapiens				GO:0001764~neuron migration,GO:0003016~respiratory system process,GO:0006366~transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0007413~axonal fasciculation,GO:0007417~central nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0008347~glial cell migration,GO:0009791~post-embryonic development,GO:0019233~sensory perception of pain,GO:0040008~regulation of growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048666~neuron development,GO:0048675~axon extension,GO:0048871~multicellular organismal homeostasis,GO:0071514~genetic imprinting,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005829~cytosol,GO:0042995~cell projection,GO:0043204~perikaryon,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0043015~gamma-tubulin binding,	IPR002190:MAGE protein,		176270~Prader-Willi syndrome,		SM01373:SM01373,	Complete proteome,DNA-binding,Growth regulation,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Necdin,domain:MAGE,
ENSG00000204099	neuraminidase 4(NEU4)	Homo sapiens				GO:0006516~glycoprotein catabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0006689~ganglioside catabolic process,GO:0009313~oligosaccharide catabolic process,	GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0019866~organelle inner membrane,GO:0043202~lysosomal lumen,	GO:0004308~exo-alpha-sialidase activity,GO:0005515~protein binding,GO:0052794~exo-alpha-(2->3)-sialidase activity,GO:0052795~exo-alpha-(2->6)-sialidase activity,GO:0052796~exo-alpha-(2->8)-sialidase activity,	IPR011040:Sialidases,IPR026856:Sialidase family,IPR026946:Sialidase-4,	hsa00511:Other glycan degradation,hsa00600:Sphingolipid metabolism,				Alternative splicing,Carbohydrate metabolism,Complete proteome,Glycosidase,Hydrolase,Lipid degradation,Lipid metabolism,Lysosome,Membrane,Polymorphism,Reference proteome,Repeat,	active site:Nucleophile,active site:Proton acceptor,binding site:Substrate,chain:Sialidase-4,compositionally biased region:Pro-rich,repeat:BNR 1,repeat:BNR 2,repeat:BNR 3,sequence conflict,short sequence motif:FRIP motif,splice variant,
ENSG00000158747	neuroblastoma 1, DAN family BMP antagonist(NBL1)	Homo sapiens				GO:0007399~nervous system development,GO:0030514~negative regulation of BMP signaling pathway,GO:0035582~sequestering of BMP in extracellular matrix,GO:0038098~sequestering of BMP from receptor via BMP binding,GO:0045666~positive regulation of neuron differentiation,GO:0048263~determination of dorsal identity,GO:0048812~neuron projection morphogenesis,GO:0090027~negative regulation of monocyte chemotaxis,	GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0016015~morphogen activity,GO:0036122~BMP binding,GO:0042803~protein homodimerization activity,	IPR004133:DAN,IPR006207:Cystine knot, C-terminal,IPR016728:Neuroblastoma suppressor of tumorigenicity 1,	hsa04350:TGF-beta signaling pathway,		PIRSF018557:DAN protein,	SM00041:CT,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Proteomics identification,Reference proteome,Secreted,Signal,Tumor suppressor,	chain:Neuroblastoma suppressor of tumorigenicity 1,compositionally biased region:Pro-rich,disulfide bond,domain:CTCK,signal peptide,splice variant,
ENSG00000162825	neuroblastoma breakpoint family member 20(NBPF20)	Homo sapiens					GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Coiled coil,Complete proteome,Reference proteome,
ENSG00000142794	neuroblastoma breakpoint family member 3(NBPF3)	Homo sapiens				GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005737~cytoplasm,		IPR010630:Neuroblastoma breakpoint family (NBPF) domain,				SM01148:SM01148,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Repeat,	chain:Neuroblastoma breakpoint family member 3,compositionally biased region:Poly-Glu,domain:NBPF 1,domain:NBPF 2,domain:NBPF 3,domain:NBPF 4,domain:NBPF 5,sequence conflict,sequence variant,splice variant,
ENSG00000104490	neurocalcin delta(NCALD)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0003073~regulation of systemic arterial blood pressure,GO:0016192~vesicle-mediated transport,GO:0019722~calcium-mediated signaling,GO:0034220~ion transmembrane transport,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0030130~clathrin coat of trans-Golgi network vesicle,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0015276~ligand-gated ion channel activity,GO:0015631~tubulin binding,GO:0030276~clathrin binding,GO:0043014~alpha-tubulin binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Calcium,Complete proteome,Lipoprotein,Metal-binding,Myristate,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,calcium-binding region:3,chain:Neurocalcin-delta,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,domain:EF-hand 4,lipid moiety-binding region:N-myristoyl glycine,sequence conflict,
ENSG00000101188	neurotensin receptor 1(NTSR1)	Homo sapiens				GO:0001659~temperature homeostasis,GO:0003085~negative regulation of systemic arterial blood pressure,GO:0003254~regulation of membrane depolarization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007612~learning,GO:0008344~adult locomotory behavior,GO:0014049~positive regulation of glutamate secretion,GO:0014054~positive regulation of gamma-aminobutyric acid secretion,GO:0033993~response to lipid,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043576~regulation of respiratory gaseous exchange,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,GO:0051280~negative regulation of release of sequestered calcium ion into cytosol,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051930~regulation of sensory perception of pain,GO:0060732~positive regulation of inositol phosphate biosynthetic process,GO:0070779~D-aspartate import,GO:0071545~inositol phosphate catabolic process,GO:0090238~positive regulation of arachidonic acid secretion,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:0098900~regulation of action potential,GO:1990123~L-glutamate import into cell,GO:2001259~positive regulation of cation channel activity,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0009986~cell surface,GO:0032280~symmetric synapse,GO:0043195~terminal bouton,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0043204~perikaryon,GO:0045121~membrane raft,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0016492~G-protein coupled neurotensin receptor activity,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR003984:Neurotensin receptor,IPR003985:Neurotensin type 1 receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,				3D-structure,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Neurotensin receptor type 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000189233	nuclear GTPase, germinal center associated(NUGGC)	Homo sapiens					GO:0016607~nuclear speck,	GO:0005525~GTP binding,GO:0016787~hydrolase activity,	IPR022812:Dynamin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Coiled coil,Complete proteome,GTP-binding,Hydrolase,Nucleotide-binding,Nucleus,Polymorphism,Reference proteome,	chain:GTPase SLIP-GC,compositionally biased region:Poly-Lys,modified residue,nucleotide phosphate-binding region:GTP,sequence variant,splice variant,
ENSG00000183793	nuclear pore complex interacting protein family member A5(NPIPA5)	Homo sapiens							IPR009443:Nuclear pore complex interacting,					Alternative splicing,Complete proteome,Reference proteome,
ENSG00000255524	nuclear pore complex interacting protein family member B8(NPIPB8)	Homo sapiens							IPR009443:Nuclear pore complex interacting,					Complete proteome,Reference proteome,
ENSG00000198064	nuclear pore complex interacting protein family, member B13(NPIPB13)	Homo sapiens					GO:0016021~integral component of membrane,		IPR009443:Nuclear pore complex interacting,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
ENSG00000186462	nucleosome assembly protein 1 like 2(NAP1L2)	Homo sapiens				GO:0006334~nucleosome assembly,GO:0045666~positive regulation of neuron differentiation,GO:0071442~positive regulation of histone H3-K14 acetylation,GO:2000035~regulation of stem cell division,GO:2000617~positive regulation of histone H3-K9 acetylation,	GO:0005634~nucleus,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0042393~histone binding,	IPR002164:Nucleosome assembly protein (NAP),					Alternative splicing,Complete proteome,Nucleus,Reference proteome,	chain:Nucleosome assembly protein 1-like 2,compositionally biased region:Glu-rich (acidic),sequence conflict,short sequence motif:Nuclear localization signal,
ENSG00000167799	nudix hydrolase 8(NUDT8)	Homo sapiens					GO:0005739~mitochondrion,	GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000086:NUDIX hydrolase domain,IPR015797:NUDIX hydrolase domain-like,					Alternative splicing,Complete proteome,Hydrolase,Magnesium,Manganese,Metal-binding,Reference proteome,	chain:Nucleoside diphosphate-linked moiety X motif 8, mitochondrial,domain:Nudix hydrolase,metal ion-binding site:Magnesium or manganese,short sequence motif:Nudix box,splice variant,transit peptide:Mitochondrion,
ENSG00000124006	obscurin like 1(OBSL1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0007010~cytoskeleton organization,GO:0007030~Golgi organization,GO:0007088~regulation of mitotic nuclear division,GO:0034067~protein localization to Golgi apparatus,GO:0050775~positive regulation of dendrite morphogenesis,GO:0055003~cardiac myofibril assembly,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0014704~intercalated disc,GO:0030018~Z disc,GO:0031430~M band,GO:0048471~perinuclear region of cytoplasm,GO:1990393~3M complex,	GO:0005515~protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0016301~kinase activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,		612921~3-M syndrome 2,		SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Disulfide bond,Dwarfism,Golgi apparatus,Immunoglobulin domain,Kinase,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transferase,
ENSG00000164920	odd-skipped related transciption factor 2(OSR2)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001656~metanephros development,GO:0001823~mesonephros development,GO:0002062~chondrocyte differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0009790~embryo development,GO:0010628~positive regulation of gene expression,GO:0030154~cell differentiation,GO:0030501~positive regulation of bone mineralization,GO:0033687~osteoblast proliferation,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0036023~embryonic skeletal limb joint morphogenesis,GO:0042474~middle ear morphogenesis,GO:0042476~odontogenesis,GO:0042733~embryonic digit morphogenesis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048704~embryonic skeletal system morphogenesis,GO:0048793~pronephros development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0060021~palate development,GO:0060272~embryonic skeletal joint morphogenesis,GO:0060322~head development,GO:0060349~bone morphogenesis,GO:0061029~eyelid development in camera-type eye,GO:0072498~embryonic skeletal joint development,GO:2000543~positive regulation of gastrulation,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Signal,Zinc,Zinc-finger,	chain:Protein odd-skipped-related 2,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5; degenerate,
ENSG00000130558	olfactomedin 1(OLFM1)	Homo sapiens				GO:0003190~atrioventricular valve formation,GO:0007399~nervous system development,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0023041~neuronal signal transduction,GO:0030516~regulation of axon extension,GO:0060317~cardiac epithelial to mesenchymal transition,	GO:0005615~extracellular space,GO:0005623~cell,GO:0005783~endoplasmic reticulum,GO:0030054~cell junction,GO:0030424~axon,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0044295~axonal growth cone,GO:0045202~synapse,	GO:0005515~protein binding,	IPR003112:Olfactomedin-like,IPR011044:Quinoprotein amine dehydrogenase, beta chain-like,IPR022082:Neurogenesis glycoprotein,				SM00284:OLF,	3D-structure,Alternative splicing,Cell junction,Cell projection,Coiled coil,Complete proteome,Developmental protein,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Synapse,	chain:Noelin,disulfide bond,domain:Olfactomedin-like,glycosylation site:N-linked (GlcNAc...),short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
ENSG00000143450	ornithine decarboxylase antizyme 3(OAZ3)	Homo sapiens				GO:0006521~regulation of cellular amino acid metabolic process,GO:0006595~polyamine metabolic process,GO:0006596~polyamine biosynthetic process,GO:0007283~spermatogenesis,GO:0015847~putrescine transport,GO:0043086~negative regulation of catalytic activity,GO:0045732~positive regulation of protein catabolic process,GO:1902268~negative regulation of polyamine transmembrane transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0008073~ornithine decarboxylase inhibitor activity,GO:0015489~putrescine transmembrane transporter activity,	IPR002993:Ornithine decarboxylase antizyme,IPR016181:Acyl-CoA N-acyltransferase,					Alternative splicing,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polyamine biosynthesis,Proteomics identification,Reference proteome,Ribosomal frameshifting,	chain:Ornithine decarboxylase antizyme 3,
ENSG00000155719	otoancorin(OTOA)	Homo sapiens				GO:0007160~cell-matrix adhesion,GO:0007605~sensory perception of sound,GO:0019226~transmission of nerve impulse,	GO:0005578~proteinaceous extracellular matrix,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0031225~anchored component of membrane,		IPR026663:Otoancorin,IPR026664:Stereocilin related,		607039~Deafness, autosomal recessive 22,			Alternative splicing,Cell membrane,Complete proteome,Deafness,Extracellular matrix,Glycoprotein,GPI-anchor,Hearing,Lipoprotein,Membrane,Non-syndromic deafness,Reference proteome,Secreted,Signal,	chain:Otoancorin,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated alanine,modified residue,propeptide:Removed in mature form,signal peptide,splice variant,
ENSG00000125618	paired box 8(PAX8)	Homo sapiens				GO:0001655~urogenital system development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006790~sulfur compound metabolic process,GO:0007275~multicellular organism development,GO:0007417~central nervous system development,GO:0009653~anatomical structure morphogenesis,GO:0030154~cell differentiation,GO:0030878~thyroid gland development,GO:0038194~thyroid-stimulating hormone signaling pathway,GO:0039003~pronephric field specification,GO:0042472~inner ear morphogenesis,GO:0042981~regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048793~pronephros development,GO:0071371~cellular response to gonadotropin stimulus,GO:0071599~otic vesicle development,GO:0072050~S-shaped body morphogenesis,GO:0072108~positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0072164~mesonephric tubule development,GO:0072207~metanephric epithelium development,GO:0072221~metanephric distal convoluted tubule development,GO:0072278~metanephric comma-shaped body morphogenesis,GO:0072284~metanephric S-shaped body morphogenesis,GO:0072289~metanephric nephron tubule formation,GO:0072305~negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,GO:0072307~regulation of metanephric nephron tubule epithelial cell differentiation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:1900212~negative regulation of mesenchymal cell apoptotic process involved in metanephros development,GO:1900215~negative regulation of apoptotic process involved in metanephric collecting duct development,GO:1900218~negative regulation of apoptotic process involved in metanephric nephron tubule development,GO:2000594~positive regulation of metanephric DCT cell differentiation,GO:2000611~positive regulation of thyroid hormone generation,GO:2000612~regulation of thyroid-stimulating hormone secretion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004996~thyroid-stimulating hormone receptor activity,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,	IPR001523:Paired domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR022130:Paired-box protein 2 C-terminal,	hsa04918:Thyroid hormone synthesis,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05216:Thyroid cancer,	218700~Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia,		SM00351:PAX,	3D-structure,Alternative splicing,Complete proteome,Congenital hypothyroidism,Developmental protein,Differentiation,Disease mutation,DNA-binding,Nucleus,Paired box,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Paired box protein Pax-8,compositionally biased region:Ser-rich,domain:Paired,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000198883	paraneoplastic Ma antigen family member 5(PNMA5)	Homo sapiens				GO:0043065~positive regulation of apoptotic process,		GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR026523:Paraneoplastic antigen Ma,IPR026527:Paraneoplastic antigen-like protein 5,					Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Paraneoplastic antigen-like protein 5,sequence conflict,sequence variant,
ENSG00000141744	phenylethanolamine N-methyltransferase(PNMT)	Homo sapiens				GO:0032259~methylation,GO:0042418~epinephrine biosynthetic process,GO:0042423~catecholamine biosynthetic process,	GO:0005829~cytosol,	GO:0004603~phenylethanolamine N-methyltransferase activity,GO:0008168~methyltransferase activity,	IPR000940:Methyltransferase, NNMT/PNMT/TEMT,IPR025820:Methyltransferase NNMT/PNMT/TEMT, conserved site,	hsa00350:Tyrosine metabolism,hsa01100:Metabolic pathways,		PIRSF000384:phenylethanolamine N-methyltransferase,		3D-structure,Catecholamine biosynthesis,Complete proteome,Methyltransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transferase,	binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via carbonyl oxygen,binding site:Substrate,chain:Phenylethanolamine N-methyltransferase,helix,mutagenesis site,region of interest:S-adenosyl-L-methionine binding,sequence conflict,sequence variant,strand,turn,
ENSG00000087495	phosphatase and actin regulator 3(PHACTR3)	Homo sapiens				GO:0043086~negative regulation of catalytic activity,	GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,	GO:0003779~actin binding,GO:0004864~protein phosphatase inhibitor activity,GO:0008157~protein phosphatase 1 binding,GO:0008599~protein phosphatase type 1 regulator activity,	IPR004018:RPEL repeat,				SM00707:RPEL,	Actin-binding,Alternative splicing,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase inhibitor,Reference proteome,Repeat,	chain:Phosphatase and actin regulator 3,compositionally biased region:Pro-rich,modified residue,region of interest:Required for PP1CA binding and inhibition of PP1 activity,repeat:RPEL 1,repeat:RPEL 2,repeat:RPEL 3,repeat:RPEL 4,sequence conflict,sequence variant,splice variant,
ENSG00000102174	phosphate regulating endopeptidase homolog, X-linked(PHEX)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0001501~skeletal system development,GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0007267~cell-cell signaling,GO:0019637~organophosphate metabolic process,GO:0030282~bone mineralization,	GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004177~aminopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008270~zinc ion binding,	IPR000718:Peptidase M13,IPR008753:Peptidase M13, N-terminal domain,IPR018497:Peptidase M13, C-terminal domain,IPR024079:Metallopeptidase, catalytic domain,		307800~Hypophosphatemic rickets, X-linked dominant,			Aminopeptidase,Biomineralization,Complete proteome,Disease mutation,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Protease,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,chain:Phosphate-regulating neutral endopeptidase,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000105650	phosphodiesterase 4C(PDE4C)	Homo sapiens				GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,	GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005929~cilium,GO:0072372~primary cilium,	GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0046872~metal ion binding,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa04024:cAMP signaling pathway,hsa05032:Morphine addiction,			SM00471:HDc,	3D-structure,Alternative splicing,cAMP,Cell projection,Cilium,Coiled coil,Complete proteome,Hydrolase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton donor,binding site:cAMP,chain:cAMP-specific 3',5'-cyclic phosphodiesterase 4C,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,nucleotide phosphate-binding region:cAMP,sequence conflict,sequence variant,site:Binds AMP, but not cAMP,splice variant,strand,turn,
ENSG00000160191	phosphodiesterase 9A(PDE9A)	Homo sapiens				GO:0007165~signal transduction,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0019934~cGMP-mediated signaling,GO:0046068~cGMP metabolic process,GO:0046069~cGMP catabolic process,	GO:0005622~intracellular,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0032587~ruffle membrane,GO:0042383~sarcolemma,GO:0043204~perikaryon,GO:0048471~perinuclear region of cytoplasm,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,			SM00471:HDc,	3D-structure,Alternative splicing,Cell membrane,Cell projection,cGMP,Complete proteome,Cytoplasm,Endoplasmic reticulum,Golgi apparatus,Hydrolase,Magnesium,Membrane,Metal-binding,Phosphoprotein,Reference proteome,Zinc,	active site:Proton donor,binding site:cGMP,chain:High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,mutagenesis site,nucleotide phosphate-binding region:cGMP,region of interest:Catalytic,sequence conflict,splice variant,strand,turn,
ENSG00000154330	phosphoglucomutase 5(PGM5)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0005978~glycogen biosynthetic process,GO:0006006~glucose metabolic process,GO:0007155~cell adhesion,GO:0019388~galactose catabolic process,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0005914~spot adherens junction,GO:0005925~focal adhesion,GO:0009898~cytoplasmic side of plasma membrane,GO:0014704~intercalated disc,GO:0016010~dystrophin-associated glycoprotein complex,GO:0030018~Z disc,GO:0042383~sarcolemma,GO:0043034~costamere,	GO:0000287~magnesium ion binding,GO:0004614~phosphoglucomutase activity,GO:0005198~structural molecule activity,GO:0016868~intramolecular transferase activity, phosphotransferases,	IPR005841:Alpha-D-phosphohexomutase superfamily,IPR005843:Alpha-D-phosphohexomutase, C-terminal,IPR005844:Alpha-D-phosphohexomutase, alpha/beta/alpha domain I,IPR005845:Alpha-D-phosphohexomutase, alpha/beta/alpha domain II,IPR005846:Alpha-D-phosphohexomutase, alpha/beta/alpha domain III,IPR016055:Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III,IPR016066:Alpha-D-phosphohexomutase, conserved site,					Alternative splicing,Carbohydrate metabolism,Cell adhesion,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Glucose metabolism,Magnesium,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Phosphoglucomutase-like protein 5,compositionally biased region:Poly-Ser,metal ion-binding site:Magnesium,modified residue,sequence conflict,splice variant,
ENSG00000092621	phosphoglycerate dehydrogenase(PHGDH)	Homo sapiens				GO:0006541~glutamine metabolic process,GO:0006544~glycine metabolic process,GO:0006564~L-serine biosynthetic process,GO:0006566~threonine metabolic process,GO:0007420~brain development,GO:0009070~serine family amino acid biosynthetic process,GO:0009448~gamma-aminobutyric acid metabolic process,GO:0010468~regulation of gene expression,GO:0019530~taurine metabolic process,GO:0021510~spinal cord development,GO:0021782~glial cell development,GO:0021915~neural tube development,GO:0031175~neuron projection development,GO:0055114~oxidation-reduction process,GO:0070314~G1 to G0 transition,	GO:0005829~cytosol,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004617~phosphoglycerate dehydrogenase activity,GO:0009055~electron carrier activity,GO:0051287~NAD binding,	IPR006139:D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain,IPR006140:D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding,IPR006236:D-3-phosphoglycerate dehydrogenase,IPR016040:NAD(P)-binding domain,	hsa00260:Glycine, serine and threonine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa01230:Biosynthesis of amino acids,	256520~Neu-Laxova syndrome 1,601815~Phosphoglycerate dehydrogenase deficiency,			3D-structure,Acetylation,Amino-acid biosynthesis,Complete proteome,Direct protein sequencing,Disease mutation,Isopeptide bond,NAD,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Serine biosynthesis,Signal,Ubl conjugation,	active site:Proton donor,binding site:NAD,binding site:NAD; via carbonyl oxygen,chain:D-3-phosphoglycerate dehydrogenase,helix,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,strand,turn,
ENSG00000187980	phospholipase A2 group IIC(PLA2G2C)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0016042~lipid catabolic process,GO:0050482~arachidonic acid secretion,	GO:0005576~extracellular region,	GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,	IPR001211:Phospholipase A2,IPR016090:Phospholipase A2 domain,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04972:Pancreatic secretion,hsa04975:Fat digestion and absorption,			SM00085:PA2c,	Calcium,Complete proteome,Disulfide bond,Hydrolase,Lipid metabolism,Metal-binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Putative inactive group IIC secretory phospholipase A2,disulfide bond,metal ion-binding site:Calcium; via carbonyl oxygen,sequence conflict,sequence variant,signal peptide,
ENSG00000105499	phospholipase A2 group IVC(PLA2G4C)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0006954~inflammatory response,GO:0007567~parturition,GO:0008152~metabolic process,GO:0009395~phospholipid catabolic process,GO:0019369~arachidonic acid metabolic process,GO:0035556~intracellular signal transduction,GO:0036149~phosphatidylinositol acyl-chain remodeling,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0046475~glycerophospholipid catabolic process,	GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005938~cell cortex,GO:0016020~membrane,	GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0005543~phospholipid binding,GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0047499~calcium-independent phospholipase A2 activity,	IPR002642:Lysophospholipase, catalytic domain,IPR016035:Acyl transferase/acyl hydrolase/lysophospholipase,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04370:VEGF signaling pathway,hsa04611:Platelet activation,hsa04664:Fc epsilon RI signaling pathway,hsa04724:Glutamatergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04921:Oxytocin signaling pathway,hsa05231:Choline metabolism in cancer,			SM00022:PLAc,	Alternative splicing,Complete proteome,Hydrolase,Lipid degradation,Lipid metabolism,Lipoprotein,Membrane,Methylation,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,	chain:Cytosolic phospholipase A2 gamma,domain:PLA2c,lipid moiety-binding region:S-farnesyl cysteine,modified residue,mutagenesis site,propeptide:Removed in mature form,sequence conflict,sequence variant,
ENSG00000176485	phospholipase A2 group XVI(PLA2G16)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0008654~phospholipid biosynthetic process,GO:0016042~lipid catabolic process,GO:0036149~phosphatidylinositol acyl-chain remodeling,GO:0036150~phosphatidylserine acyl-chain remodeling,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0045786~negative regulation of cell cycle,	GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004623~phospholipase A2 activity,GO:0005515~protein binding,GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0052739~phosphatidylserine 1-acylhydrolase activity,GO:0052740~1-acyl-2-lysophosphatidylserine acylhydrolase activity,	IPR007053:LRAT-like domain,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,				3D-structure,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Group XVI phospholipase A2,sequence conflict,transmembrane region,
ENSG00000187838	phospholipid scramblase 3(PLSCR3)	Homo sapiens				GO:0006915~apoptotic process,GO:0017121~phospholipid scrambling,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0071222~cellular response to lipopolysaccharide,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0017128~phospholipid scramblase activity,GO:0048306~calcium-dependent protein binding,	IPR005552:Scramblase,					Apoptosis,Calcium,Complete proteome,Lipoprotein,Membrane,Mitochondrion,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3-binding,Transmembrane,Transmembrane helix,	chain:Phospholipid scramblase 3,compositionally biased region:Cys-rich,compositionally biased region:Poly-Pro,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,sequence conflict,sequence variant,short sequence motif:SH3-binding 1,short sequence motif:SH3-binding 2,short sequence motif:SH3-binding 3,short sequence motif:WW-binding,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000183281	plasminogen-like B1(PLGLB1)	Homo sapiens					GO:0005576~extracellular region,		IPR003609:Apple-like,IPR016351:Plasminogen-related,			PIRSF002483:plasminogen-related protein,	SM00473:PAN_AP,	Complete proteome,Disulfide bond,Reference proteome,Secreted,Signal,	chain:Plasminogen-related protein B,disulfide bond,domain:PAN,signal peptide,
ENSG00000102024	plastin 3(PLS3)	Homo sapiens			Cytoskeleton,	GO:0051017~actin filament bundle assembly,GO:0051639~actin filament network formation,GO:0051764~actin crosslink formation,GO:0060348~bone development,	GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0032432~actin filament bundle,	GO:0005509~calcium ion binding,GO:0051015~actin filament binding,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,		300910~Bone mineral density QTL18, osteoporosis,		SM00033:CH,SM00054:EFh,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Calcium,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Isopeptide bond,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:Plastin-3,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Actin-binding 1,domain:Actin-binding 2,domain:CH 1,domain:CH 2,domain:CH 3,domain:CH 4,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,sequence variant,strand,turn,
ENSG00000105559	pleckstrin homology domain containing A4(PLEKHA4)	Homo sapiens					GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005545~1-phosphatidylinositol binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Pleckstrin homology domain-containing family A member 4,compositionally biased region:Pro-rich,domain:PH,helix,sequence conflict,sequence variant,splice variant,strand,
ENSG00000139289	pleckstrin homology like domain family A member 1(PHLDA1)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006915~apoptotic process,GO:0045210~FasL biosynthetic process,	GO:0005730~nucleolus,GO:0005829~cytosol,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Apoptosis,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Nucleus,Proteomics identification,Reference proteome,Repeat,Signal,	chain:Pleckstrin homology-like domain family A member 1,compositionally biased region:Poly-Gln,domain:PH,region of interest:14 X 2 AA repeats of P-H,region of interest:15 X 2 AA repeats of P-Q,sequence conflict,
ENSG00000181649	pleckstrin homology like domain family A member 2(PHLDA2)	Homo sapiens				GO:0001890~placenta development,GO:0006915~apoptotic process,GO:0009887~organ morphogenesis,GO:0010468~regulation of gene expression,GO:0030334~regulation of cell migration,GO:0045995~regulation of embryonic development,GO:0070873~regulation of glycogen metabolic process,	GO:0005737~cytoplasm,GO:0016020~membrane,		IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Reference proteome,	chain:Pleckstrin homology-like domain family A member 2,compositionally biased region:Poly-Ala,domain:PH,modified residue,sequence conflict,
ENSG00000174307	pleckstrin homology like domain family A member 3(PHLDA3)	Homo sapiens				GO:0009653~anatomical structure morphogenesis,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043065~positive regulation of apoptotic process,GO:0051898~negative regulation of protein kinase B signaling,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Apoptosis,Complete proteome,Cytoplasm,Membrane,Polymorphism,Reference proteome,Tumor suppressor,	chain:Pleckstrin homology-like domain family A member 3,domain:PH,sequence conflict,sequence variant,
ENSG00000151846	poly(A) binding protein cytoplasmic 3(PABPC3)	Homo sapiens				GO:0016071~mRNA metabolic process,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008143~poly(A) binding,	IPR000504:RNA recognition motif domain,IPR002004:Polyadenylate-binding protein/Hyperplastic disc protein,IPR003954:RNA recognition motif domain, eukaryote,IPR006515:Polyadenylate binding protein, human types 1, 2, 3, 4,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa03018:RNA degradation,			SM00360:RRM,SM00361:RRM_1,SM00517:PolyA,	3D-structure,Complete proteome,Cytoplasm,Reference proteome,Repeat,RNA-binding,	chain:Polyadenylate-binding protein 3,domain:PABC,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,helix,modified residue,sequence conflict,strand,turn,
ENSG00000205038	polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1(PKHD1L1)	Homo sapiens				GO:0006955~immune response,	GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005929~cilium,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,	IPR002909:Cell surface receptor IPT/TIG,IPR006626:Parallel beta-helix repeat,IPR008972:Cupredoxin,IPR011050:Pectin lyase fold/virulence factor,IPR011658:PA14,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR019316:G8 domain,				SM00429:IPT,SM00710:PbH1,SM00758:PA14,SM01225:SM01225,	Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fibrocystin-L,compositionally biased region:Poly-Ser,domain:IPT/TIG 1,domain:IPT/TIG 10,domain:IPT/TIG 11,domain:IPT/TIG 12,domain:IPT/TIG 13,domain:IPT/TIG 14,domain:IPT/TIG 2,domain:IPT/TIG 3,domain:IPT/TIG 4,domain:IPT/TIG 5,domain:IPT/TIG 6,domain:IPT/TIG 7,domain:IPT/TIG 8,domain:IPT/TIG 9,glycosylation site:O-linked (GalNAc...),repeat:PbH1 1,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,repeat:PbH1 5,repeat:PbH1 6,repeat:PbH1 7,repeat:PbH1 8,repeat:PbH1 9,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000107593	polycystin 2 like 1, transient receptor potential cation channel(PKD2L1)	Homo sapiens				GO:0001581~detection of chemical stimulus involved in sensory perception of sour taste,GO:0006812~cation transport,GO:0007224~smoothened signaling pathway,GO:0035725~sodium ion transmembrane transport,GO:0050915~sensory perception of sour taste,GO:0050982~detection of mechanical stimulus,GO:0070207~protein homotrimerization,GO:0070588~calcium ion transmembrane transport,GO:0071468~cellular response to acidic pH,GO:0071805~potassium ion transmembrane transport,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031513~nonmotile primary cilium,GO:0034704~calcium channel complex,GO:0043231~intracellular membrane-bounded organelle,GO:0043235~receptor complex,GO:0060170~ciliary membrane,	GO:0005227~calcium activated cation channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005272~sodium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008092~cytoskeletal protein binding,GO:0008324~cation transmembrane transporter activity,GO:0015269~calcium-activated potassium channel activity,GO:0033040~sour taste receptor activity,GO:0042802~identical protein binding,GO:0051371~muscle alpha-actinin binding,GO:0051393~alpha-actinin binding,	IPR003915:Polycystic kidney disease type 2 protein,IPR011992:EF-hand-like domain,IPR013122:Polycystin cation channel, PKD1/PKD2,					3D-structure,Alternative splicing,Calcium,Calcium channel,Calcium transport,Cell membrane,Cell projection,Cilium,Coiled coil,Complete proteome,Endoplasmic reticulum,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Polycystic kidney disease 2-like 1 protein,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Polycystin motif,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000156113	potassium calcium-activated channel subfamily M alpha 1(KCNMA1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006813~potassium ion transport,GO:0006970~response to osmotic stress,GO:0030007~cellular potassium ion homeostasis,GO:0034465~response to carbon monoxide,GO:0034765~regulation of ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0043065~positive regulation of apoptotic process,GO:0045794~negative regulation of cell volume,GO:0051592~response to calcium ion,GO:0060073~micturition,GO:0060083~smooth muscle contraction involved in micturition,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005901~caveola,GO:0008076~voltage-gated potassium channel complex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005249~voltage-gated potassium channel activity,GO:0005515~protein binding,GO:0015269~calcium-activated potassium channel activity,GO:0046872~metal ion binding,GO:0060072~large conductance calcium-activated potassium channel activity,	IPR003148:Regulator of K+ conductance, N-terminal,IPR003929:Potassium channel, calcium-activated, BK, alpha subunit,IPR005821:Ion transport domain,IPR013099:Ion transport 2,IPR016040:NAD(P)-binding domain,	hsa04022:cGMP-PKG signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04911:Insulin secretion,hsa04924:Renin secretion,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,	609446~Generalized epilepsy and paroxysmal dyskinesia,			3D-structure,Alternative splicing,Calcium,Cell membrane,Complete proteome,Disease mutation,Epilepsy,Ion channel,Ion transport,Lipoprotein,Magnesium,Membrane,Metal-binding,Palmitate,Phosphoprotein,Potassium,Potassium channel,Potassium transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Calcium-activated potassium channel subunit alpha-1,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ser,domain:RCK N-terminal,helix,metal ion-binding site:Magnesium,modified residue,mutagenesis site,region of interest:Heme-binding motif,region of interest:Pore-forming, in membrane,region of interest:Segment S10,region of interest:Segment S7,region of interest:Segment S8,region of interest:Segment S9,sequence conflict,sequence variant,short sequence motif:Calcium bowl,short sequence motif:Selectivity for potassium,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000164626	potassium two pore domain channel subfamily K member 5(KCNK5)	Homo sapiens				GO:0006813~potassium ion transport,GO:0007588~excretion,GO:0030322~stabilization of membrane potential,GO:0034765~regulation of ion transmembrane transport,GO:0071805~potassium ion transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005249~voltage-gated potassium channel activity,GO:0005267~potassium channel activity,GO:0022841~potassium ion leak channel activity,	IPR003092:Two pore domain potassium channel, TASK family,IPR003280:Two pore domain potassium channel,IPR013099:Ion transport 2,	hsa04974:Protein digestion and absorption,				Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium channel subfamily K member 5,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Pore-forming 1,region of interest:Pore-forming 2,sequence variant,topological domain:Cytoplasmic,transmembrane region,
ENSG00000089558	potassium voltage-gated channel subfamily H member 4(KCNH4)	Homo sapiens				GO:0000160~phosphorelay signal transduction system,GO:0006813~potassium ion transport,GO:0023014~signal transduction by protein phosphorylation,GO:0034765~regulation of ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0071805~potassium ion transmembrane transport,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,	GO:0000155~phosphorelay sensor kinase activity,GO:0005249~voltage-gated potassium channel activity,	IPR000014:PAS domain,IPR000595:Cyclic nucleotide-binding domain,IPR000700:PAS-associated, C-terminal,IPR001610:PAC motif,IPR003938:Potassium channel, voltage-dependent, EAG/ELK/ERG,IPR003950:Potassium channel, voltage-dependent, ELK,IPR005821:Ion transport domain,IPR014710:RmlC-like jelly roll fold,IPR018490:Cyclic nucleotide-binding-like,				SM00086:PAC,SM00100:cNMP,	Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily H member 4,domain:PAC,domain:PAS,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:cNMP,region of interest:Segment H5 (pore-forming),sequence variant,short sequence motif:Selectivity filter,topological domain:Cytoplasmic,transmembrane region,
ENSG00000171611	pre T-cell antigen receptor alpha(PTCRA)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04330:Notch signaling pathway,hsa05202:Transcriptional misregulation in cancer,				3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Pre T-cell antigen receptor alpha,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000177425	pro-apoptotic WT1 regulator(PAWR)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0010628~positive regulation of gene expression,GO:0030889~negative regulation of B cell proliferation,GO:0042094~interleukin-2 biosynthetic process,GO:0042130~negative regulation of T cell proliferation,GO:0042986~positive regulation of amyloid precursor protein biosynthetic process,GO:0043065~positive regulation of apoptotic process,GO:0048147~negative regulation of fibroblast proliferation,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0051017~actin filament bundle assembly,GO:0097190~apoptotic signaling pathway,GO:1901300~positive regulation of hydrogen peroxide-mediated programmed cell death,GO:2000774~positive regulation of cellular senescence,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,	GO:0003714~transcription corepressor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0043522~leucine zipper domain binding,	IPR026117:Prostate apoptosis response 4,					3D-structure,Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:PRKC apoptosis WT1 regulator protein,compositionally biased region:Ala-rich,domain:Leucine-zipper,modified residue,region of interest:Selective for apoptosis induction in cancer cells (SAC),sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
ENSG00000100033	proline dehydrogenase 1(PRODH)	Homo sapiens		h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline,		GO:0006560~proline metabolic process,GO:0006562~proline catabolic process,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0010133~proline catabolic process to glutamate,GO:0010942~positive regulation of cell death,GO:0019470~4-hydroxyproline catabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,	GO:0004657~proline dehydrogenase activity,GO:0071949~FAD binding,	IPR002872:Proline dehydrogenase,IPR015659:Proline oxidase,	hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,	239500~Hyperprolinemia, type I,600850~Schizophrenia, susceptibility to, 4,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,FAD,Flavoprotein,Mitochondrion,Oxidoreductase,Polymorphism,Proline metabolism,Proteomics identification,Reference proteome,Schizophrenia,Transit peptide,	chain:Proline dehydrogenase, mitochondrial,sequence conflict,sequence variant,splice variant,transit peptide:Mitochondrion,
ENSG00000188368	proline rich 19(PRR19)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Proline-rich protein 19,compositionally biased region:Pro-rich,sequence conflict,splice variant,
ENSG00000186654	proline rich 5(PRR5)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0007049~cell cycle,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0031295~T cell costimulation,GO:0038203~TORC2 signaling,GO:0048015~phosphatidylinositol-mediated signaling,	GO:0005829~cytosol,GO:0031932~TORC2 complex,		IPR013745:HbrB-like,IPR016159:Cullin repeat-like-containing domain,					Alternative splicing,Cell cycle,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Protor-1,chain:Rho GTPase-activating protein 8,compositionally biased region:Poly-Ala,domain:CRAL-TRIO,domain:Rho-GAP,modified residue,region of interest:Interaction with RICTOR,sequence conflict,sequence variant,splice variant,
ENSG00000126460	proline rich and Gla domain 2(PRRG2)	Homo sapiens					GO:0005576~extracellular region,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000294:Gamma-carboxyglutamic acid-rich (GLA) domain,IPR017857:Coagulation factor, subgroup, Gla domain,				SM00069:GLA,	Complete proteome,Disulfide bond,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane gamma-carboxyglutamic acid protein 2,compositionally biased region:Poly-Pro,disulfide bond,domain:Gla,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000224940	proline rich transmembrane protein 4(PRRT4)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Reference proteome,Signal,Transmembrane,Transmembrane helix,
ENSG00000115138	proopiomelanocortin(POMC)	Homo sapiens	110.CRHandLC-NA,			GO:0006091~generation of precursor metabolites and energy,GO:0007165~signal transduction,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0008217~regulation of blood pressure,GO:0016486~peptide hormone processing,GO:0032098~regulation of appetite,GO:0032720~negative regulation of tumor necrosis factor production,GO:0033059~cellular pigmentation,GO:0042593~glucose homeostasis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070873~regulation of glycogen metabolic process,GO:2000852~regulation of corticosterone secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005782~peroxisomal matrix,GO:0030141~secretory granule,GO:0034774~secretory granule lumen,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0005179~hormone activity,GO:0005184~neuropeptide hormone activity,GO:0031781~type 3 melanocortin receptor binding,GO:0031782~type 4 melanocortin receptor binding,GO:0070996~type 1 melanocortin receptor binding,	IPR001941:Pro-opiomelanocortin/corticotropin, ACTH,IPR013531:Pro-opiomelanocortin/corticotropin, ACTH, central region,IPR013532:Opiodes neuropeptide,IPR013593:Pro-opiomelanocortin N-terminal,	hsa04916:Melanogenesis,hsa04920:Adipocytokine signaling pathway,	601665~Obesity, early-onset, susceptibility to,609734~Obesity, adrenal insufficiency, and red hair due to POMC deficiency,		SM01363:SM01363,SM01364:SM01364,SM01365:SM01365,	3D-structure,Acetylation,Amidation,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Endorphin,Glycoprotein,Hormone,Obesity,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (HexNAc...),modified residue,peptide:Beta-endorphin,peptide:Corticotropin,peptide:Corticotropin-like intermediary peptide,peptide:Lipotropin beta,peptide:Lipotropin gamma,peptide:Melanotropin alpha,peptide:Melanotropin beta,peptide:Melanotropin gamma,peptide:Met-enkephalin,peptide:NPP,peptide:Potential peptide,sequence conflict,sequence variant,signal peptide,
ENSG00000168229	prostaglandin D2 receptor(PTGDR)	Homo sapiens				GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0030238~male sex determination,GO:0030431~sleep,GO:0045909~positive regulation of vasodilation,GO:0046085~adenosine metabolic process,GO:0071799~cellular response to prostaglandin D stimulus,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0001785~prostaglandin J receptor activity,GO:0004956~prostaglandin D receptor activity,GO:0005515~protein binding,GO:0016501~prostacyclin receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000376:Prostaglandin D receptor,IPR008365:Prostanoid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,	607277~Asthma, susceptibility to, 1,			Alternative splicing,Asthma,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Prostaglandin D2 receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000107317	prostaglandin D2 synthase(PTGDS)	Homo sapiens				GO:0001516~prostaglandin biosynthetic process,GO:0006629~lipid metabolic process,GO:0006810~transport,GO:0019371~cyclooxygenase pathway,GO:0045187~regulation of circadian sleep/wake cycle, sleep,GO:0051384~response to glucocorticoid,GO:2000255~negative regulation of male germ cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005789~endoplasmic reticulum membrane,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004667~prostaglandin-D synthase activity,GO:0005215~transporter activity,GO:0005501~retinoid binding,GO:0005504~fatty acid binding,GO:0005515~protein binding,GO:0036094~small molecule binding,	IPR000566:Lipocalin/cytosolic fatty-acid binding protein domain,IPR002345:Lipocalin,IPR002972:Prostaglandin D synthase,IPR011038:Calycin-like,IPR012674:Calycin,IPR022272:Lipocalin conserved site,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,				3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Golgi apparatus,Isomerase,Lipid biosynthesis,Lipid metabolism,Membrane,Nucleus,Polymorphism,Prostaglandin biosynthesis,Prostaglandin metabolism,Proteomics identification,Reference proteome,Secreted,Signal,Transport,	active site:Nucleophile,chain:Hematopoietic prostaglandin D synthase,chain:Prostaglandin-H2 D-isomerase,disulfide bond,domain:GST C-terminal,domain:GST N-terminal,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000050628	prostaglandin E receptor 3(PTGER3)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0008219~cell death,GO:0014827~intestine smooth muscle contraction,GO:0031622~positive regulation of fever generation,GO:0060455~negative regulation of gastric acid secretion,	GO:0005635~nuclear envelope,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004957~prostaglandin E receptor activity,	IPR000265:Prostanoid EP3 receptor,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001244:Prostaglandin DP receptor,IPR001481:Prostanoid EP3 receptor, type 2,IPR008365:Prostanoid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04923:Regulation of lipolysis in adipocytes,hsa05200:Pathways in cancer,				Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Prostaglandin E2 receptor EP3 subtype,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000148344	prostaglandin E synthase(PTGES)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0001516~prostaglandin biosynthetic process,GO:0002526~acute inflammatory response,GO:0002544~chronic inflammatory response,GO:0006693~prostaglandin metabolic process,GO:0007165~signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0014070~response to organic cyclic compound,GO:0019371~cyclooxygenase pathway,GO:0032496~response to lipopolysaccharide,GO:0032526~response to retinoic acid,GO:0034097~response to cytokine,GO:0051592~response to calcium ion,	GO:0005641~nuclear envelope lumen,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0043295~glutathione binding,GO:0050220~prostaglandin-E synthase activity,	IPR001129:Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein,IPR023352:Membrane associated eicosanoid/glutathione metabolism-like domain,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,				3D-structure,Complete proteome,Fatty acid biosynthesis,Fatty acid metabolism,Isomerase,Lipid biosynthesis,Lipid metabolism,Membrane,Prostaglandin biosynthesis,Prostaglandin metabolism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Prostaglandin E synthase,sequence conflict,transmembrane region,
ENSG00000124225	prostate transmembrane protein, androgen induced 1(PMEPA1)	Homo sapiens				GO:0010991~negative regulation of SMAD protein complex assembly,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0060394~negative regulation of pathway-restricted SMAD protein phosphorylation,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0050699~WW domain binding,GO:0070412~R-SMAD binding,						Alternative splicing,Complete proteome,Endosome,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal transduction inhibitor,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	chain:Transmembrane prostate androgen-induced protein,mutagenesis site,sequence variant,short sequence motif:WW-binding 1,short sequence motif:WW-binding 2,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000007038	protease, serine 21(PRSS21)	Homo sapiens				GO:0006508~proteolysis,GO:0007283~spermatogenesis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031225~anchored component of membrane,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Testisin,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,splice variant,
ENSG00000150687	protease, serine 23(PRSS23)	Homo sapiens				GO:0006508~proteolysis,	GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,					Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,	active site:Charge relay system,chain:Serine protease 23,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,
ENSG00000185198	protease, serine 57(PRSS57)	Homo sapiens				GO:0006508~proteolysis,	GO:0005615~extracellular space,GO:0035578~azurophil granule lumen,	GO:0004252~serine-type endopeptidase activity,GO:0008201~heparin binding,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Heparin-binding,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,	active site:Charge relay system,chain:Serine protease 1-like protein 1,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
ENSG00000135549	protein kinase (cAMP-dependent, catalytic) inhibitor beta(PKIB)	Homo sapiens				GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0051973~positive regulation of telomerase activity,GO:1904355~positive regulation of telomere capping,GO:2000480~negative regulation of cAMP-dependent protein kinase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004862~cAMP-dependent protein kinase inhibitor activity,	IPR004171:cAMP-dependent protein kinase inhibitor,			PIRSF001667:cAMP-dependent protein kinase inhibitor,		Alternative splicing,Complete proteome,Protein kinase inhibitor,Proteomics identification,Reference proteome,	chain:cAMP-dependent protein kinase inhibitor beta,site:Important for inhibition,
ENSG00000124507	protein kinase C and casein kinase substrate in neurons 1(PACSIN1)	Homo sapiens				GO:0007015~actin filament organization,GO:0030100~regulation of endocytosis,GO:0045806~negative regulation of endocytosis,GO:0048488~synaptic vesicle endocytosis,GO:0048666~neuron development,GO:0048812~neuron projection morphogenesis,GO:0072657~protein localization to membrane,GO:0090002~establishment of protein localization to plasma membrane,GO:0097320~membrane tubulation,GO:1900006~positive regulation of dendrite development,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0030137~COPI-coated vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0032587~ruffle membrane,GO:0043209~myelin sheath,GO:0043679~axon terminus,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008092~cytoskeletal protein binding,GO:0016301~kinase activity,	IPR001060:FCH domain,IPR001452:Src homology-3 domain,				SM00055:FCH,SM00326:SH3,	3D-structure,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Endocytosis,Kinase,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,Synapse,Synaptosome,Transferase,	chain:Protein kinase C and casein kinase substrate in neurons protein 1,domain:FCH,domain:SH3,helix,modified residue,sequence variant,turn,
ENSG00000170955	protein kinase C delta binding protein(PRKCDBP)	Homo sapiens				GO:0030866~cortical actin cytoskeleton organization,GO:0032922~circadian regulation of gene expression,GO:0051898~negative regulation of protein kinase B signaling,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1901003~negative regulation of fermentation,	GO:0005737~cytoplasm,GO:0005901~caveola,GO:0043234~protein complex,	GO:0005080~protein kinase C binding,GO:0005515~protein binding,	IPR026752:Cavin family,					Biological rhythms,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Protein kinase C delta-binding protein,modified residue,sequence variant,
ENSG00000155367	protein phosphatase, Mg2+/Mn2+ dependent 1J(PPM1J)	Homo sapiens				GO:0006470~protein dephosphorylation,		GO:0004722~protein serine/threonine phosphatase activity,	IPR001932:Protein phosphatase 2C (PP2C)-like,IPR015655:Protein phosphatase 2C,				SM00332:PP2Cc,	Alternative splicing,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	chain:Protein phosphatase 1J,domain:PP2C-like,modified residue,sequence variant,splice variant,
ENSG00000112655	protein tyrosine kinase 7 (inactive)(PTK7)	Homo sapiens				GO:0001736~establishment of planar polarity,GO:0003281~ventricular septum development,GO:0003401~axis elongation,GO:0006468~protein phosphorylation,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0031532~actin cytoskeleton reorganization,GO:0042060~wound healing,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0060026~convergent extension,GO:0060070~canonical Wnt signaling pathway,GO:0060484~lung-associated mesenchyme development,GO:0060976~coronary vasculature development,GO:0071300~cellular response to retinoic acid,GO:0090103~cochlea morphogenesis,GO:0090179~planar cell polarity pathway involved in neural tube closure,	GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,	GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:1904929~coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell junction,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Tyrosine-protein kinase-like 7,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Protein kinase; inactive,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000152894	protein tyrosine phosphatase, receptor type K(PTPRK)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0010839~negative regulation of keratinocyte proliferation,GO:0016477~cell migration,GO:0030336~negative regulation of cell migration,GO:0031175~neuron projection development,GO:0034394~protein localization to cell surface,GO:0034614~cellular response to reactive oxygen species,GO:0034644~cellular response to UV,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048041~focal adhesion assembly,	GO:0001750~photoreceptor outer segment,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031256~leading edge membrane,GO:0043025~neuronal cell body,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0019901~protein kinase binding,GO:0045295~gamma-catenin binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR000998:MAM domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,				SM00060:FN3,SM00137:MAM,SM00194:PTPc,SM00404:PTPc_motif,SM00409:IG,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Immunoglobulin domain,Membrane,Phosphoprotein,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase kappa,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type,domain:MAM,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,signal peptide,site:Cleavage,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000105426	protein tyrosine phosphatase, receptor type S(PTPRS)	Homo sapiens				GO:0007155~cell adhesion,GO:0007268~chemical synaptic transmission,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,				SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Immunoglobulin domain,Membrane,Polymorphism,Protein phosphatase,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase S,compositionally biased region:Poly-Pro,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Cleavage,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000060656	protein tyrosine phosphatase, receptor type U(PTPRU)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0007155~cell adhesion,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0016337~single organismal cell-cell adhesion,GO:0030154~cell differentiation,GO:0030336~negative regulation of cell migration,GO:0031100~organ regeneration,GO:0034109~homotypic cell-cell adhesion,GO:0034394~protein localization to cell surface,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0051384~response to glucocorticoid,GO:0060070~canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,	GO:0004725~protein tyrosine phosphatase activity,GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR000998:MAM domain,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,				SM00060:FN3,SM00137:MAM,SM00194:PTPc,SM00404:PTPc_motif,	Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Differentiation,Disulfide bond,Glycoprotein,Hydrolase,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Protein phosphatase,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase U,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type,domain:MAM,domain:Tyrosine-protein phosphatase 1,domain:Tyrosine-protein phosphatase 2,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Mediates interaction with CTNNB1,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000089169	rabphilin 3A(RPH3A)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0006906~vesicle fusion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0030141~secretory granule,GO:0030672~synaptic vesicle membrane,GO:0043005~neuron projection,GO:0043234~protein complex,GO:0045202~synapse,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0008270~zinc ion binding,GO:0008430~selenium binding,GO:0017137~Rab GTPase binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,GO:0032403~protein complex binding,GO:0042301~phosphate ion binding,GO:0046872~metal ion binding,GO:0070679~inositol 1,4,5 trisphosphate binding,GO:1901981~phosphatidylinositol phosphate binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,IPR010911:Rab-binding domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,				SM00239:C2,	Alternative splicing,Calcium,Cell junction,Coiled coil,Complete proteome,Lipid-binding,Membrane,Metal-binding,Methylation,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Repeat,Synapse,Transport,Zinc,Zinc-finger,	chain:Rabphilin-3A,compositionally biased region:Pro-rich,domain:C2 1,domain:C2 2,domain:RabBD,modified residue,splice variant,zinc finger region:FYVE-type,
ENSG00000205517	ral guanine nucleotide dissociation stimulator like 3(RGL3)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,	GO:0008321~Ral guanyl-nucleotide exchange factor activity,GO:0017016~Ras GTPase binding,	IPR000159:Ras-association,IPR000651:Ras-like guanine nucleotide exchange factor, N-terminal,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR019804:Ras guanine-nucleotide exchange factor, conserved site,IPR023578:Ras guanine nucleotide exchange factor, domain,				SM00147:RasGEF,SM00229:RasGEFN,SM00314:RA,	Alternative splicing,Coiled coil,Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Ral guanine nucleotide dissociation stimulator-like 3,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,domain:N-terminal Ras-GEF,domain:Ras-associating,domain:Ras-GEF,modified residue,region of interest:Interaction with HRAS, MRAS and RIT1,sequence variant,
ENSG00000139725	ras homolog family member F, filopodia associated(RHOF)	Homo sapiens				GO:0007015~actin filament organization,GO:0007264~small GTPase mediated signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Proteomics identification,Reference proteome,	chain:Rho-related GTP-binding protein RhoF,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence conflict,short sequence motif:Effector region,splice variant,
ENSG00000166349	recombination activating 1(RAG1)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002331~pre-B cell allelic exclusion,GO:0006310~DNA recombination,GO:0006955~immune response,GO:0010390~histone monoubiquitination,GO:0030183~B cell differentiation,GO:0033077~T cell differentiation in thymus,GO:0033151~V(D)J recombination,GO:0043029~T cell homeostasis,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045582~positive regulation of T cell differentiation,GO:0048538~thymus development,GO:0051865~protein autoubiquitination,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0004519~endonuclease activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0042393~histone binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR019485:Zinc finger, V(D)J recombination-activating protein 1,IPR023336:RAG nonamer-binding domain,IPR024627:Recombination-activation protein 1,	hsa04068:FoxO signaling pathway,hsa05340:Primary immunodeficiency,	233650~Combined cellular and humoral immune defects with granulomas,601457~Severe combined immunodeficiency, B cell-negative,603554~Omenn syndrome,609889~Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity,		SM00184:RING,	Alternative splicing,Chromatin regulator,Complete proteome,Disease mutation,DNA recombination,DNA-binding,Endonuclease,Hydrolase,Isopeptide bond,Ligase,Metal-binding,Multifunctional enzyme,Nuclease,Nucleus,Polymorphism,Reference proteome,SCID,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:V(D)J recombination-activating protein 1,DNA-binding region:NBD,metal ion-binding site:Divalent metal cation,region of interest:Interaction with importin alpha-1,sequence variant,zinc finger region:RING-type,
ENSG00000090104	regulator of G-protein signaling 1(RGS1)	Homo sapiens				GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0061737~leukotriene signaling pathway,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0001965~G-protein alpha-subunit binding,GO:0005096~GTPase activator activity,GO:0005516~calmodulin binding,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,GTPase activation,Membrane,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 1,domain:RGS,helix,modified residue,sequence conflict,splice variant,strand,turn,
ENSG00000143333	regulator of G-protein signaling 16(RGS16)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007601~visual perception,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0031224~intrinsic component of membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	3D-structure,Complete proteome,GTPase activation,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 16,domain:RGS,helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,sequence conflict,sequence variant,turn,
ENSG00000133818	related RAS viral (r-ras) oncogene homolog 2(RRAS2)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0030335~positive regulation of cell migration,GO:1901214~regulation of neuron death,	GO:0005622~intracellular,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04024:cAMP signaling pathway,hsa04530:Tight junction,hsa04810:Regulation of actin cytoskeleton,hsa05166:HTLV-I infection,hsa05205:Proteoglycans in cancer,	Ovarian carcinoma~Ovarian carcinoma,			3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Palmitate,Phosphoprotein,Prenylation,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Ras-related protein R-Ras2,helix,lipid moiety-binding region:S-farnesyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,sequence variant,short sequence motif:Effector region,strand,turn,
ENSG00000182175	repulsive guidance molecule family member a(RGMA)	Homo sapiens				GO:0001843~neural tube closure,GO:0010976~positive regulation of neuron projection development,GO:0030509~BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048671~negative regulation of collateral sprouting,GO:0048681~negative regulation of axon regeneration,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0031225~anchored component of membrane,GO:0043005~neuron projection,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:1990459~transferrin receptor binding,	IPR009496:Repulsive guidance molecule, C-terminal,IPR010536:Repulsive guidance molecule, N-terminal,					3D-structure,Alternative splicing,Autocatalytic cleavage,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Repulsive guidance molecule A,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated alanine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000128253	ret finger protein like 2(RFPL2)	Homo sapiens						GO:0046872~metal ion binding,	IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR022723:RDM domain, Ret finger protein-like,				SM00449:SPRY,SM00589:PRY,	Alternative splicing,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Ret finger protein-like 2,chain:Ret finger protein-like 3,domain:B30.2/SPRY,sequence variant,splice variant,zinc finger region:RING-type,zinc finger region:RING-type; degenerate,
ENSG00000185924	reticulon 4 receptor like 1(RTN4RL1)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0019221~cytokine-mediated signaling pathway,GO:0031103~axon regeneration,GO:0046426~negative regulation of JAK-STAT cascade,	GO:0005737~cytoplasm,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0045121~membrane raft,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004860~protein kinase inhibitor activity,GO:0004872~receptor activity,GO:0005515~protein binding,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00082:LRRCT,SM00369:LRR_TYP,	Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Leucine-rich repeat,Lipoprotein,Membrane,Receptor,Reference proteome,Repeat,Signal,	chain:Reticulon-4 receptor-like 1,lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,sequence conflict,signal peptide,
ENSG00000186907	reticulon 4 receptor-like 2(RTN4RL2)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0019221~cytokine-mediated signaling pathway,GO:0031103~axon regeneration,GO:0046426~negative regulation of JAK-STAT cascade,	GO:0005737~cytoplasm,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0045121~membrane raft,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004860~protein kinase inhibitor activity,GO:0004872~receptor activity,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00082:LRRCT,SM00369:LRR_TYP,	Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Leucine-rich repeat,Lipoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,	chain:Reticulon-4 receptor-like 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated cysteine,propeptide:Removed in mature form,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,sequence conflict,signal peptide,
ENSG00000102104	retinoschisin 1(RS1)	Homo sapiens				GO:0007155~cell adhesion,GO:0007275~multicellular organism development,GO:0007601~visual perception,GO:0010842~retina layer formation,GO:0016062~adaptation of rhodopsin mediated signaling,	GO:0005615~extracellular space,GO:0019897~extrinsic component of plasma membrane,	GO:0001786~phosphatidylserine binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR000421:Coagulation factor 5/8 C-terminal type domain,IPR008979:Galactose-binding domain-like,		312700~Retinoschisis,		SM00231:FA58C,	3D-structure,Cell adhesion,Complete proteome,Disease mutation,Disulfide bond,Polymorphism,Reference proteome,Secreted,Sensory transduction,Signal,Vision,	chain:Retinoschisin,disulfide bond,domain:F5/8 type C,sequence variant,signal peptide,
ENSG00000158106	rhophilin Rho GTPase binding protein 1(RHPN1)	Homo sapiens				GO:0007165~signal transduction,	GO:0005829~cytosol,	GO:0005515~protein binding,	IPR001478:PDZ domain,IPR004328:BRO1 domain,IPR011072:HR1 rho-binding repeat,				SM00228:PDZ,SM00742:Hr1,SM01041:SM01041,	Alternative splicing,Complete proteome,Phosphoprotein,Reference proteome,	chain:Rhophilin-1,domain:BRO1,domain:PDZ,repeat:REM,splice variant,
ENSG00000135119	ring finger protein, transmembrane 2(RNFT2)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,	Alternative splicing,Complete proteome,Membrane,Metal-binding,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Ring finger and transmembrane domain- containing protein 2,compositionally biased region:His-rich,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,zinc finger region:RING-type,
ENSG00000169855	roundabout guidance receptor 1(ROBO1)	Homo sapiens				GO:0002042~cell migration involved in sprouting angiogenesis,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0007507~heart development,GO:0016199~axon midline choice point recognition,GO:0021836~chemorepulsion involved in postnatal olfactory bulb interneuron migration,GO:0030336~negative regulation of cell migration,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035385~Roundabout signaling pathway,GO:0050772~positive regulation of axonogenesis,GO:0050925~negative regulation of negative chemotaxis,GO:0070100~negative regulation of chemokine-mediated signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0030424~axon,	GO:0005515~protein binding,GO:0008046~axon guidance receptor activity,GO:0030275~LRR domain binding,GO:0042802~identical protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04360:Axon guidance,			SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Chemotaxis,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Roundabout homolog 1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000108823	sarcoglycan alpha(SGCA)	Homo sapiens				GO:0006936~muscle contraction,GO:0007517~muscle organ development,GO:0061024~membrane organization,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005911~cell-cell junction,GO:0016010~dystrophin-associated glycoprotein complex,GO:0016012~sarcoglycan complex,GO:0016021~integral component of membrane,GO:0042383~sarcolemma,GO:0045121~membrane raft,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR006644:Dystroglycan-type cadherin-like,IPR008908:Sarcoglycan alphaepsilon,IPR013783:Immunoglobulin-like fold,IPR015919:Cadherin-like,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,hsa05416:Viral myocarditis,	608099~Muscular dystrophy, limb-girdle, type 2D,		SM00736:CADG,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Glycoprotein,Limb-girdle muscular dystrophy,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Alpha-sarcoglycan,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000179954	scavenger receptor cysteine rich family member with 5 domains(SSC5D)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0007275~multicellular organism development,GO:0042494~detection of bacterial lipoprotein,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:2000483~negative regulation of interleukin-8 secretion,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031012~extracellular matrix,	GO:0001968~fibronectin binding,GO:0005044~scavenger receptor activity,GO:0005515~protein binding,GO:0043236~laminin binding,GO:0050840~extracellular matrix binding,	IPR001190:Speract/scavenger receptor,IPR017448:Speract/scavenger receptor-related,				SM00202:SR,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,
ENSG00000198794	secretory carrier membrane protein 5(SCAMP5)	Homo sapiens				GO:0006887~exocytosis,GO:0015031~protein transport,GO:0034976~response to endoplasmic reticulum stress,GO:0045806~negative regulation of endocytosis,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0050715~positive regulation of cytokine secretion,	GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0031201~SNARE complex,GO:0032588~trans-Golgi network membrane,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,	IPR007273:SCAMP,					Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endosome,Exocytosis,Golgi apparatus,Membrane,Protein transport,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Secretory carrier-associated membrane protein 5,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000010319	semaphorin 3G(SEMA3G)	Homo sapiens				GO:0001755~neural crest cell migration,GO:0030335~positive regulation of cell migration,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR007110:Immunoglobulin-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	hsa04360:Axon guidance,			SM00423:PSI,SM00630:Sema,	Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Semaphorin-3G,disulfide bond,domain:Ig-like C2-type,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,
ENSG00000140623	septin 12(SEPT12)	Homo sapiens				GO:0007049~cell cycle,GO:0051301~cell division,	GO:0001725~stress fiber,GO:0005819~spindle,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0031105~septin complex,GO:0032154~cleavage furrow,GO:0048471~perinuclear region of cytoplasm,GO:0097227~sperm annulus,	GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0035091~phosphatidylinositol binding,GO:0042803~protein homodimerization activity,	IPR016491:Septin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05100:Bacterial invasion of epithelial cells,	614822~Spermatogenic failure 10,	PIRSF006698:septin,		Alternative splicing,Cell cycle,Cell division,Cell projection,Cilium,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Flagellum,GTP-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,	binding site:GTP; via amide nitrogen and carbonyl oxygen,chain:Septin-12,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,splice variant,
ENSG00000106366	serpin family E member 1(SERPINE1)	Homo sapiens		h_fibrinolysisPathway:Fibrinolysis Pathway,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,		GO:0001300~chronological cell aging,GO:0001525~angiogenesis,GO:0002576~platelet degranulation,GO:0007623~circadian rhythm,GO:0010469~regulation of receptor activity,GO:0010757~negative regulation of plasminogen activation,GO:0010951~negative regulation of endopeptidase activity,GO:0014912~negative regulation of smooth muscle cell migration,GO:0030194~positive regulation of blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0030198~extracellular matrix organization,GO:0030336~negative regulation of cell migration,GO:0032757~positive regulation of interleukin-8 production,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0035491~positive regulation of leukotriene production involved in inflammatory response,GO:0042730~fibrinolysis,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050729~positive regulation of inflammatory response,GO:0050829~defense response to Gram-negative bacterium,GO:0051918~negative regulation of fibrinolysis,GO:0061044~negative regulation of vascular wound healing,GO:0061045~negative regulation of wound healing,GO:0071222~cellular response to lipopolysaccharide,GO:0090026~positive regulation of monocyte chemotaxis,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000098~negative regulation of smooth muscle cell-matrix adhesion,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,	IPR000215:Serpin family,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,	hsa04066:HIF-1 signaling pathway,hsa04115:p53 signaling pathway,hsa04390:Hippo signaling pathway,hsa04610:Complement and coagulation cascades,hsa05142:Chagas disease (American trypanosomiasis),	613329~Plasminogen activator inhibitor-1 deficiency,Transcription of plasminogen activator inhibitor, modulator of~Transcription of plasminogen activator inhibitor, modulator of,		SM00093:SERPIN,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Glycoprotein,Polymorphism,Protease inhibitor,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:Plasminogen activator inhibitor 1,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Reactive bond,strand,turn,
ENSG00000254521	sialic acid binding Ig like lectin 12 (gene/pseudogene)(SIGLEC12)	Homo sapiens				GO:0007155~cell adhesion,	GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Lectin,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Sialic acid-binding Ig-like lectin 12,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:ITIM motif,short sequence motif:SLAM-like motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000159307	signal peptide, CUB domain and EGF like domain containing 1(SCUBE1)	Homo sapiens				GO:0006954~inflammatory response,GO:0007512~adult heart development,GO:0007596~blood coagulation,GO:0009791~post-embryonic development,GO:0045446~endothelial cell differentiation,GO:0051260~protein homooligomerization,	GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0019897~extrinsic component of plasma membrane,	GO:0005509~calcium ion binding,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR000859:CUB domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011641:Tyrosine-protein kinase ephrin type A/B receptor-like,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR024731:EGF domain, merozoite surface protein 1-like,IPR026823:Complement Clr-like EGF domain,				SM00042:CUB,SM00179:EGF_CA,SM00181:EGF,SM01411:SM01411,	Calcium,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Signal peptide, CUB and EGF-like domain- containing protein 1,disulfide bond,domain:CUB,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,
ENSG00000137078	signaling threshold regulating transmembrane adaptor 1(SIT1)	Homo sapiens				GO:0002250~adaptive immune response,GO:0007165~signal transduction,GO:0043029~T cell homeostasis,GO:0050863~regulation of T cell activation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0019900~kinase binding,GO:0042169~SH2 domain binding,						Adaptive immunity,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Signaling threshold-regulating transmembrane adapter 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Interaction with CSK,region of interest:Interaction with GRB2,region of interest:Interaction with PTPN11,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000095932	small integral membrane protein 24(SMIM24)	Homo sapiens					GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,							Coiled coil,Complete proteome,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein HSPC323,sequence conflict,signal peptide,transmembrane region,
ENSG00000265185	small nucleolar RNA, C/D box 3B-1(SNORD3B-1)	Homo sapiens								hsa03008:Ribosome biogenesis in eukaryotes,hsa03013:RNA transport,
ENSG00000128602	smoothened, frizzled class receptor(SMO)	Homo sapiens		h_shhPathway:Sonic Hedgehog (Shh) Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0001708~cell fate specification,GO:0001755~neural crest cell migration,GO:0001947~heart looping,GO:0002052~positive regulation of neuroblast proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0003140~determination of left/right asymmetry in lateral mesoderm,GO:0003323~type B pancreatic cell development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007228~positive regulation of hh target transcription factor activity,GO:0007371~ventral midline determination,GO:0007494~midgut development,GO:0009952~anterior/posterior pattern specification,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0021542~dentate gyrus development,GO:0021696~cerebellar cortex morphogenesis,GO:0021794~thalamus development,GO:0021904~dorsal/ventral neural tube patterning,GO:0021910~smoothened signaling pathway involved in ventral spinal cord patterning,GO:0021938~smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,GO:0021953~central nervous system neuron differentiation,GO:0021987~cerebral cortex development,GO:0030857~negative regulation of epithelial cell differentiation,GO:0031069~hair follicle morphogenesis,GO:0034504~protein localization to nucleus,GO:0035264~multicellular organism growth,GO:0035567~non-canonical Wnt signaling pathway,GO:0040018~positive regulation of multicellular organism growth,GO:0042307~positive regulation of protein import into nucleus,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046622~positive regulation of organ growth,GO:0048143~astrocyte activation,GO:0048741~skeletal muscle fiber development,GO:0048853~forebrain morphogenesis,GO:0048873~homeostasis of number of cells within a tissue,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050821~protein stabilization,GO:0051451~myoblast migration,GO:0051799~negative regulation of hair follicle development,GO:0060070~canonical Wnt signaling pathway,GO:0060248~detection of cell density by contact stimulus involved in contact inhibition,GO:0060413~atrial septum morphogenesis,GO:0060644~mammary gland epithelial cell differentiation,GO:0060684~epithelial-mesenchymal cell signaling,GO:0061053~somite development,GO:0061113~pancreas morphogenesis,GO:0070986~left/right axis specification,GO:0071397~cellular response to cholesterol,GO:0072001~renal system development,GO:0072285~mesenchymal to epithelial transition involved in metanephric renal vesicle formation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:2000036~regulation of stem cell population maintenance,GO:2000826~regulation of heart morphogenesis,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005929~cilium,GO:0016021~integral component of membrane,GO:0030666~endocytic vesicle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0060170~ciliary membrane,GO:0070062~extracellular exosome,GO:0072372~primary cilium,GO:0097542~ciliary tip,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005113~patched binding,GO:0005515~protein binding,GO:0008144~drug binding,GO:0017147~Wnt-protein binding,GO:0042813~Wnt-activated receptor activity,	IPR000539:Frizzled protein,IPR015526:Frizzled/secreted frizzled-related protein,IPR017981:GPCR, family 2-like,IPR020067:Frizzled domain,IPR026544:Smoothened,	hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	Basal cell carcinoma, somatic~Basal cell carcinoma, somatic,		SM00063:FRI,SM01330:SM01330,	3D-structure,Cell projection,Complete proteome,Developmental protein,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Smoothened homolog,disulfide bond,domain:FZ,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000070915	solute carrier family 12 member 3(SLC12A3)	Homo sapiens				GO:0006810~transport,GO:0006811~ion transport,GO:0006814~sodium ion transport,GO:0035725~sodium ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0015377~cation:chloride symporter activity,GO:0015378~sodium:chloride symporter activity,	IPR002948:Thiazide-sensitive Na-K-Cl co-transporter,IPR004841:Amino acid permease domain,IPR004842:Na/K/Cl co-transporter superfamily,IPR013612:Amino acid permease, N-terminal,IPR018491:K/Cl co-transporter, type 1/type 3,		263800~Gitelman syndrome,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Solute carrier family 12 member 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
ENSG00000158296	solute carrier family 13 member 3(SLC13A3)	Homo sapiens				GO:0006814~sodium ion transport,GO:0015746~citrate transport,GO:0055085~transmembrane transport,GO:0071422~succinate transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0015137~citrate transmembrane transporter activity,GO:0015141~succinate transmembrane transporter activity,GO:0015362~high-affinity sodium:dicarboxylate symporter activity,GO:0017153~sodium:dicarboxylate symporter activity,	IPR001898:Sodium/sulphate symporter,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 13 member 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,transmembrane region,
ENSG00000163053	solute carrier family 16 member 14(SLC16A14)	Homo sapiens				GO:0015718~monocarboxylic acid transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015293~symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Membrane,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Monocarboxylate transporter 14,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000125648	solute carrier family 25 member 23(SLC25A23)	Homo sapiens				GO:0002082~regulation of oxidative phosphorylation,GO:0006412~translation,GO:0006851~mitochondrial calcium ion transport,GO:0036444~calcium ion transmembrane import into mitochondrion,GO:0043457~regulation of cellular respiration,GO:0051282~regulation of sequestering of calcium ion,GO:0051503~adenine nucleotide transport,GO:0055085~transmembrane transport,GO:0071277~cellular response to calcium ion,GO:0097274~urea homeostasis,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0003735~structural constituent of ribosome,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR002048:EF-hand domain,IPR002067:Mitochondrial carrier protein,IPR011992:EF-hand-like domain,IPR018108:Mitochondrial substrate/solute carrier,IPR018247:EF-Hand 1, calcium-binding site,IPR023395:Mitochondrial carrier domain,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	calcium-binding region:1,calcium-binding region:2,chain:Calcium-binding mitochondrial carrier protein SCaMC-3,domain:EF-hand 1,domain:EF-hand 2,domain:EF-hand 3,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,splice variant,topological domain:Mitochondrial intermembrane,topological domain:Mitochondrial matrix,transmembrane region,
ENSG00000151729	solute carrier family 25 member 4(SLC25A4)	Homo sapiens		h_etcPathway:Electron Transport Reaction in Mitochondria,		GO:0000002~mitochondrial genome maintenance,GO:0006091~generation of precursor metabolites and energy,GO:0006412~translation,GO:0006810~transport,GO:0008637~apoptotic mitochondrial changes,GO:0015853~adenine transport,GO:0016032~viral process,GO:0050796~regulation of insulin secretion,GO:0055085~transmembrane transport,GO:0060546~negative regulation of necroptotic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043209~myelin sheath,	GO:0003735~structural constituent of ribosome,GO:0005215~transporter activity,GO:0005515~protein binding,GO:0015207~adenine transmembrane transporter activity,	IPR002067:Mitochondrial carrier protein,IPR002113:Adenine nucleotide translocator 1,IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,hsa05166:HTLV-I infection,	609283~Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2,615418~Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type),			Acetylation,Cardiomyopathy,Complete proteome,Direct protein sequencing,Disease mutation,Host-virus interaction,Membrane,Mitochondrion,Mitochondrion inner membrane,Progressive external ophthalmoplegia,Proteomics identification,Reference proteome,Repeat,S-nitrosylation,Transmembrane,Transmembrane helix,Transport,	binding site:Nucleotide,chain:ADP/ATP translocase 1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,sequence variant,short sequence motif:Substrate recognition,transmembrane region,
ENSG00000183780	solute carrier family 35 member F3(SLC35F3)	Homo sapiens				GO:0015888~thiamine transport,	GO:0016021~integral component of membrane,		IPR000620:Drug/metabolite transporter,IPR026505:Solute carrier family 35 member F3/F4,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 35 member F3,sequence variant,splice variant,transmembrane region,
ENSG00000144290	solute carrier family 4 member 10(SLC4A10)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006821~chloride transport,GO:0007399~nervous system development,GO:0009416~response to light stimulus,GO:0009791~post-embryonic development,GO:0015701~bicarbonate transport,GO:0021860~pyramidal neuron development,GO:0035264~multicellular organism growth,GO:0035641~locomotory exploration behavior,GO:0048854~brain morphogenesis,GO:0051453~regulation of intracellular pH,GO:0098656~anion transmembrane transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0043025~neuronal cell body,GO:0097440~apical dendrite,GO:0097441~basilar dendrite,GO:0097442~CA3 pyramidal cell dendrite,	GO:0005452~inorganic anion exchanger activity,GO:0008509~anion transmembrane transporter activity,GO:0015293~symporter activity,GO:0015301~anion:anion antiporter activity,	IPR003020:Bicarbonate transporter, eukaryotic,IPR003024:Sodium bicarbonate cotransporter,IPR011531:Bicarbonate transporter, C-terminal,IPR013769:Band 3 cytoplasmic domain,IPR016152:Phosphotransferase/anion transporter,					Alternative splicing,Antiport,Cell membrane,Complete proteome,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-driven chloride bicarbonate exchanger,modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000114923	solute carrier family 4 member 3(SLC4A3)	Homo sapiens				GO:0006810~transport,GO:0015701~bicarbonate transport,GO:0051453~regulation of intracellular pH,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005452~inorganic anion exchanger activity,GO:0015301~anion:anion antiporter activity,	IPR001717:Anion exchange protein,IPR002979:Anion exchange protein 3,IPR003020:Bicarbonate transporter, eukaryotic,IPR011531:Bicarbonate transporter, C-terminal,IPR013769:Band 3 cytoplasmic domain,IPR016152:Phosphotransferase/anion transporter,IPR018241:Anion exchange, conserved site,					Alternative splicing,Anion exchange,Antiport,Complete proteome,Ion transport,Lipoprotein,Membrane,Methylation,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Anion exchange protein 3,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,region of interest:Membrane (anion exchange),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
ENSG00000204385	solute carrier family 44 member 4(SLC44A4)	Homo sapiens				GO:0006656~phosphatidylcholine biosynthetic process,GO:0008292~acetylcholine biosynthetic process,GO:0015871~choline transport,GO:0030307~positive regulation of cell growth,GO:0055085~transmembrane transport,GO:0061526~acetylcholine secretion,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0015220~choline transmembrane transporter activity,	IPR007603:Choline transporter-like,	hsa05231:Choline metabolism in cancer,				Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Choline transporter-like protein 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,site:Breakpoint for translocation with NEU1,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000162426	solute carrier family 45 member 1(SLC45A1)	Homo sapiens				GO:0008643~carbohydrate transport,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,	GO:0015293~symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Complete proteome,Membrane,Phosphoprotein,Reference proteome,Sugar transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Proton-associated sugar transporter A,sequence conflict,transmembrane region,
ENSG00000010379	solute carrier family 6 member 13(SLC6A13)	Homo sapiens			General function prediction only,	GO:0006836~neurotransmitter transport,GO:0007268~chemical synaptic transmission,GO:0015812~gamma-aminobutyric acid transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,GO:0070062~extracellular exosome,	GO:0005328~neurotransmitter:sodium symporter activity,GO:0005332~gamma-aminobutyric acid:sodium symporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR002981:Sodium:neurotransmitter symporter, GABA, GAT-2,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Neurotransmitter transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent GABA transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000011083	solute carrier family 6 member 7(SLC6A7)	Homo sapiens			General function prediction only,	GO:0006810~transport,GO:0006836~neurotransmitter transport,GO:0015824~proline transport,GO:0035524~proline transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005298~proline:sodium symporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0015193~L-proline transmembrane transporter activity,	IPR000175:Sodium:neurotransmitter symporter,					Amino-acid transport,Complete proteome,Glycoprotein,Membrane,Neurotransmitter transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent proline transporter,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000092068	solute carrier family 7 member 8(SLC7A8)	Homo sapiens				GO:0006520~cellular amino acid metabolic process,GO:0006810~transport,GO:0006865~amino acid transport,GO:0009636~response to toxic substance,GO:0015695~organic cation transport,GO:0015804~neutral amino acid transport,GO:0015807~L-amino acid transport,GO:0050900~leukocyte migration,GO:0055065~metal ion homeostasis,GO:1901998~toxin transport,GO:1902475~L-alpha-amino acid transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015101~organic cation transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015179~L-amino acid transmembrane transporter activity,GO:0015297~antiporter activity,GO:0019534~toxin transporter activity,GO:0042605~peptide antigen binding,	IPR002293:Amino acid/polyamine transporter I,IPR004760:L-type amino acid transporter,	hsa04974:Protein digestion and absorption,		PIRSF006060:amino acid transporter,		Alternative splicing,Amino-acid transport,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Large neutral amino acids transporter small subunit 2,sequence conflict,transmembrane region,
ENSG00000101187	solute carrier organic anion transporter family member 4A1(SLCO4A1)	Homo sapiens				GO:0006811~ion transport,GO:0043252~sodium-independent organic anion transport,GO:0070327~thyroid hormone transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005215~transporter activity,GO:0015347~sodium-independent organic anion transmembrane transporter activity,GO:0015349~thyroid hormone transmembrane transporter activity,	IPR002350:Kazal domain,IPR004156:Organic anion transporter polypeptide OATP,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier organic anion transporter family member 4A1,domain:Kazal-like,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000162627	sorting nexin 7(SNX7)	Homo sapiens			Intracellular trafficking and secretion / General function prediction only,	GO:0006897~endocytosis,GO:0015031~protein transport,GO:0016050~vesicle organization,	GO:0005768~endosome,GO:0019898~extrinsic component of membrane,GO:0030659~cytoplasmic vesicle membrane,	GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,	IPR001683:Phox homologous domain,				SM00312:PX,	3D-structure,Alternative splicing,Complete proteome,Cytoplasmic vesicle,Lipid-binding,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Sorting nexin-7,domain:PX,helix,sequence conflict,sequence variant,splice variant,strand,
ENSG00000258484	sperm equatorial segment protein 1(SPESP1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007340~acrosome reaction,GO:0007342~fusion of sperm to egg plasma membrane,	GO:0001669~acrosomal vesicle,		IPR026743:Sperm equatorial segment protein 1,					Complete proteome,Cytoplasmic vesicle,Developmental protein,Direct protein sequencing,Glycoprotein,Polymorphism,Reference proteome,Signal,	chain:Sperm equatorial segment protein 1,compositionally biased region:Poly-Ala,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000160284	spermatogenesis and centriole associated 1-like(SPATC1L)	Homo sapiens					GO:0005813~centrosome,	GO:0005515~protein binding,	IPR026715:Speriolin,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein C21orf56,compositionally biased region:Poly-Leu,sequence conflict,sequence variant,
ENSG00000162032	splA/ryanodine receptor domain and SOCS box containing 3(SPSB3)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,	GO:0005515~protein binding,	IPR001496:SOCS protein, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00449:SPRY,SM00969:SM00969,	Complete proteome,Polymorphism,Proteomics identification,Receptor,Reference proteome,	chain:SPRY domain-containing SOCS box protein 3,domain:B30.2/SPRY,domain:SOCS box,sequence conflict,sequence variant,
ENSG00000188766	sprouty related EVH1 domain containing 3(SPRED3)	Homo sapiens				GO:0007275~multicellular organism development,GO:0009966~regulation of signal transduction,	GO:0016020~membrane,		IPR000697:EVH1,IPR007875:Sprouty,IPR011993:Pleckstrin homology-like domain,IPR023337:c-Kit-binding domain,				SM00461:WH1,	Alternative splicing,Complete proteome,Membrane,Methylation,Phosphoprotein,Reference proteome,	chain:Sprouty-related, EVH1 domain-containing protein 3,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:SPR,domain:WH1,
ENSG00000177570	sterile alpha motif domain containing 12(SAMD12)	Homo sapiens							IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	Complete proteome,Proteomics identification,Reference proteome,	chain:Sterile alpha motif domain-containing protein 12,domain:SAM,sequence conflict,
ENSG00000164483	sterile alpha motif domain containing 3(SAMD3)	Homo sapiens						GO:0005515~protein binding,	IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Sterile alpha motif domain-containing protein 3,domain:SAM,sequence conflict,sequence variant,splice variant,
ENSG00000197165	sulfotransferase family 1A member 2(SULT1A2)	Homo sapiens				GO:0006584~catecholamine metabolic process,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,GO:0009309~amine biosynthetic process,GO:0018958~phenol-containing compound metabolic process,GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process,GO:0051923~sulfation,	GO:0005829~cytosol,	GO:0004062~aryl sulfotransferase activity,GO:0005515~protein binding,GO:0008146~sulfotransferase activity,GO:0047894~flavonol 3-sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05204:Chemical carcinogenesis,				3D-structure,Catecholamine metabolism,Complete proteome,Cytoplasm,Lipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Steroid metabolism,Transferase,	active site:Proton acceptor,chain:Sulfotransferase 1A2,helix,modified residue,nucleotide phosphate-binding region:PAPS,sequence conflict,sequence variant,strand,turn,
ENSG00000186193	suppressor APC domain containing 2(SAPCD2)	Homo sapiens					GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,		IPR026828:Suppressor APC domain-containing protein 1/2,					Coiled coil,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Reference proteome,	chain:Protein C9orf140,compositionally biased region:Pro-rich,
ENSG00000185338	suppressor of cytokine signaling 1(SOCS1)	Homo sapiens	12.IL-6_type_cytok-signal-transduct,	h_ghPathway:Growth Hormone Signaling Pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0001932~regulation of protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0007259~JAK-STAT cascade,GO:0010534~regulation of activation of JAK2 kinase activity,GO:0016567~protein ubiquitination,GO:0019221~cytokine-mediated signaling pathway,GO:0040008~regulation of growth,GO:0042510~regulation of tyrosine phosphorylation of Stat1 protein,GO:0042512~negative regulation of tyrosine phosphorylation of Stat1 protein,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0045444~fat cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050707~regulation of cytokine secretion,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0071230~cellular response to amino acid stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0004860~protein kinase inhibitor activity,GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0019210~kinase inhibitor activity,GO:0019901~protein kinase binding,	IPR000980:SH2 domain,IPR001496:SOCS protein, C-terminal,	hsa04120:Ubiquitin mediated proteolysis,hsa04380:Osteoclast differentiation,hsa04630:Jak-STAT signaling pathway,hsa04910:Insulin signaling pathway,hsa04917:Prolactin signaling pathway,hsa04930:Type II diabetes mellitus,hsa05145:Toxoplasmosis,hsa05206:MicroRNAs in cancer,			SM00252:SH2,SM00253:SOCS,SM00969:SM00969,	Complete proteome,Cytoplasmic vesicle,Growth regulation,Nucleus,Polymorphism,Reference proteome,SH2 domain,Signal transduction inhibitor,Ubl conjugation pathway,	chain:Suppressor of cytokine signaling 1,compositionally biased region:Poly-Ser,domain:SH2,domain:SOCS box,region of interest:Extended SH2 subdomain (ESS),region of interest:Interaction with Elongin BC complex,region of interest:Kinase inhibitory region (KIR),sequence conflict,sequence variant,
ENSG00000205571	survival of motor neuron 2, centromeric(SMN2)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0006353~DNA-templated transcription, termination,GO:0006397~mRNA processing,GO:0007399~nervous system development,GO:0051170~nuclear import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0030018~Z disc,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0043005~neuron projection,GO:0043204~perikaryon,GO:0097504~Gemini of coiled bodies,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002999:Tudor domain,IPR010304:Survival motor neuron,	hsa03013:RNA transport,	253400~Spinal muscular atrophy, type III, modifier of,		SM00333:TUDOR,	3D-structure,Acetylation,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Disease mutation,mRNA processing,mRNA splicing,Neurodegeneration,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Survival motor neuron protein,compositionally biased region:Poly-Pro,domain:Tudor,helix,modified residue,region of interest:P1 (binding site for SIP1),region of interest:P2 (binding site for SM B),region of interest:Required for interaction with SYNCRIP,sequence variant,splice variant,strand,turn,
ENSG00000102362	synaptotagmin like 4(SYTL4)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0006906~vesicle fusion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0045921~positive regulation of exocytosis,GO:0046676~negative regulation of insulin secretion,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050714~positive regulation of protein secretion,GO:0071985~multivesicular body sorting pathway,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,GO:0030141~secretory granule,GO:0030658~transport vesicle membrane,GO:0070382~exocytic vesicle,GO:0098793~presynapse,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0017137~Rab GTPase binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,GO:0042043~neurexin family protein binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,IPR010911:Rab-binding domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00239:C2,	3D-structure,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Cytoplasmic vesicle,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Synaptotagmin-like protein 4,compositionally biased region:Poly-Glu,domain:C2 1,domain:C2 2,domain:RabBD,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:FYVE-type,
ENSG00000173267	synuclein gamma(SNCG)	Homo sapiens				GO:0007268~chemical synaptic transmission,GO:0008344~adult locomotory behavior,GO:0009306~protein secretion,GO:0014059~regulation of dopamine secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0050808~synapse organization,	GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0030424~axon,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001058:Synuclein,IPR002462:Gamma-synuclein,					Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Gamma-synuclein,modified residue,region of interest:4 X 11 AA tandem repeats of [EGSA]-K-T-K- [EQ]-[GQ]-V-X(4),repeat:1,repeat:2,repeat:3; approximate,repeat:4,sequence conflict,sequence variant,
ENSG00000153060	tektin 5(TEKT5)	Homo sapiens					GO:0005634~nucleus,GO:0036126~sperm flagellum,	GO:0005515~protein binding,	IPR000435:Tektin,					Cell projection,Cilium,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Tektin-5,sequence variant,
ENSG00000149256	teneurin transmembrane protein 4(TENM4)	Homo sapiens			Cell envelope biogenesis, outer membrane,	GO:0000902~cell morphogenesis,GO:0001702~gastrulation with mouth forming second,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007165~signal transduction,GO:0031641~regulation of myelination,GO:0031643~positive regulation of myelination,GO:0032289~central nervous system myelin formation,GO:0048666~neuron development,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0060038~cardiac muscle cell proliferation,GO:0060912~cardiac cell fate specification,GO:0097264~self proteolysis,GO:2000543~positive regulation of gastrulation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0043005~neuron projection,	GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR000742:Epidermal growth factor-like domain,IPR006530:YD repeat,IPR008969:Carboxypeptidase-like, regulatory domain,IPR009471:Teneurin intracellular, N-terminal,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR022385:Rhs repeat-associated core,				SM00181:EGF,	Cell membrane,Cell projection,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Teneurin-4,compositionally biased region:Poly-Pro,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:Teneurin N-terminal,glycosylation site:N-linked (GlcNAc...),repeat:NHL 1,repeat:NHL 2,repeat:NHL 3,repeat:NHL 4,repeat:NHL 5,repeat:YD 1,repeat:YD 10,repeat:YD 11,repeat:YD 12,repeat:YD 13,repeat:YD 14,repeat:YD 15,repeat:YD 16,repeat:YD 17,repeat:YD 18,repeat:YD 19,repeat:YD 2,repeat:YD 20,repeat:YD 21,repeat:YD 22,repeat:YD 23,repeat:YD 3,repeat:YD 4,repeat:YD 5,repeat:YD 6,repeat:YD 7,repeat:YD 8,repeat:YD 9,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000121101	testis expressed 14, intercellular bridge forming factor(TEX14)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007094~mitotic spindle assembly checkpoint,GO:0007140~male meiosis,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0032091~negative regulation of protein binding,GO:0032466~negative regulation of cytokinesis,GO:0043063~intercellular bridge organization,GO:0051301~cell division,GO:0051306~mitotic sister chromatid separation,	GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005623~cell,GO:0005737~cytoplasm,GO:0030496~midbody,GO:0045171~intercellular bridge,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002110:Ankyrin repeat,IPR011009:Protein kinase-like domain,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,ATP-binding,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,Kinetochore,Mitosis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	binding site:ATP,chain:Testis-expressed protein 14,domain:Protein kinase,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,
ENSG00000106537	tetraspanin 13(TSPAN13)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:1903169~regulation of calcium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005246~calcium channel regulator activity,	IPR000301:Tetraspanin,IPR018499:Tetraspanin/Peripherin,			PIRSF002419:tetraspanin,		Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Reference proteome,Transmembrane,Transmembrane helix,	chain:Tetraspanin-13,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000006555	tetratricopeptide repeat domain 22(TTC22)	Homo sapiens							IPR011990:Tetratricopeptide-like helical,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,TPR repeat,	chain:Tetratricopeptide repeat protein 22,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,sequence conflict,sequence variant,splice variant,
ENSG00000144115	threonine synthase like 2(THNSL2)	Homo sapiens			Amino acid transport and metabolism,	GO:0009071~serine family amino acid catabolic process,GO:0009088~threonine biosynthetic process,GO:0016311~dephosphorylation,GO:0046360~2-oxobutyrate biosynthetic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0004795~threonine synthase activity,GO:0005125~cytokine activity,GO:0016829~lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0070905~serine binding,	IPR001926:Tryptophan synthase beta subunit-like PLP-dependent enzymes superfamily,IPR004450:Threonine synthase-like,					Alternative splicing,Complete proteome,Cytokine,Lyase,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Secreted,	chain:Threonine synthase-like 2,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000239732	toll like receptor 9(TLR9)	Homo sapiens		h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,h_tollPathway:Toll-Like Receptor Pathway,		GO:0002224~toll-like receptor signaling pathway,GO:0002237~response to molecule of bacterial origin,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006954~inflammatory response,GO:0007252~I-kappaB phosphorylation,GO:0007409~axonogenesis,GO:0010628~positive regulation of gene expression,GO:0030277~maintenance of gastrointestinal epithelium,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032640~tumor necrosis factor production,GO:0032715~negative regulation of interleukin-6 production,GO:0032717~negative regulation of interleukin-8 production,GO:0032722~positive regulation of chemokine production,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032728~positive regulation of interferon-beta production,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032741~positive regulation of interleukin-18 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034122~negative regulation of toll-like receptor signaling pathway,GO:0034123~positive regulation of toll-like receptor signaling pathway,GO:0034162~toll-like receptor 9 signaling pathway,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0042742~defense response to bacterium,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043507~positive regulation of JUN kinase activity,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045087~innate immune response,GO:0045356~positive regulation of interferon-alpha biosynthetic process,GO:0045359~positive regulation of interferon-beta biosynthetic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0050707~regulation of cytokine secretion,GO:0050729~positive regulation of inflammatory response,GO:0050829~defense response to Gram-negative bacterium,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:1901895~negative regulation of calcium-transporting ATPase activity,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0032009~early phagosome,GO:0036020~endolysosome membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005149~interleukin-1 receptor binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0035197~siRNA binding,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR027181:Toll-like receptor 9,	hsa04620:Toll-like receptor signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05152:Tuberculosis,hsa05162:Measles,hsa05168:Herpes simplex infection,			SM00255:TIR,SM00369:LRR_TYP,	Alternative splicing,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Endosome,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Lysosome,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Toll-like receptor 9,domain:TIR,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 18,repeat:LRR 19,repeat:LRR 2,repeat:LRR 20,repeat:LRR 21,repeat:LRR 22,repeat:LRR 23,repeat:LRR 24,repeat:LRR 25,repeat:LRR 26,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000181029	trafficking protein particle complex 5(TRAPPC5)	Homo sapiens				GO:0048193~Golgi vesicle transport,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0030008~TRAPP complex,	GO:0005515~protein binding,	IPR007194:Transport protein particle (TRAPP) component,IPR016696:TRAPP I complex, subunit Trs31,IPR024096:NO signalling/Golgi transport  ligand-binding domain,			PIRSF017479:TRAPP I complex, Trs31 subunit,		Complete proteome,Endoplasmic reticulum,ER-Golgi transport,Golgi apparatus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Trafficking protein particle complex subunit 5,sequence variant,
ENSG00000196781	transducin like enhancer of split 1(TLE1)	Homo sapiens		h_wntPathway:WNT Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0009887~organ morphogenesis,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045892~negative regulation of transcription, DNA-templated,GO:1904837~beta-catenin-TCF complex assembly,GO:2000811~negative regulation of anoikis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0001106~RNA polymerase II transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,	IPR001680:WD40 repeat,IPR005617:Groucho/TLE, N-terminal Q-rich domain,IPR009146:Groucho/transducin-like enhancer,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	3D-structure,Coiled coil,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,WD repeat,Wnt signaling pathway,	chain:Transducin-like enhancer protein 1,compositionally biased region:Gln-rich,compositionally biased region:Gly/Pro-rich,compositionally biased region:Pro/Ser-rich,modified residue,mutagenesis site,region of interest:CCN domain,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,short sequence motif:Nuclear localization signal,strand,turn,
ENSG00000185332	transmembrane protein 105(TMEM105)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 105,sequence variant,transmembrane region,
ENSG00000183160	transmembrane protein 119(TMEM119)	Homo sapiens				GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0007283~spermatogenesis,GO:0030501~positive regulation of bone mineralization,GO:0031214~biomineral tissue development,GO:0033690~positive regulation of osteoblast proliferation,GO:0045669~positive regulation of osteoblast differentiation,GO:0048515~spermatid differentiation,GO:1903012~positive regulation of bone development,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,							Biomineralization,Cell membrane,Complete proteome,Cytoplasm,Differentiation,Endoplasmic reticulum,Glycoprotein,Membrane,Osteogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Spermatogenesis,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 119,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000096092	transmembrane protein 14A(TMEM14A)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR005349:Uncharacterised protein family UPF0136, Transmembrane,					3D-structure,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 14A,sequence variant,transmembrane region,
ENSG00000249992	transmembrane protein 158 (gene/pseudogene)(TMEM158)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0042277~peptide binding,						Alternative splicing,Complete proteome,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 158,compositionally biased region:Ala-rich,compositionally biased region:Poly-Ala,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,transmembrane region,
ENSG00000002933	transmembrane protein 176A(TMEM176A)	Homo sapiens				GO:2001199~negative regulation of dendritic cell differentiation,	GO:0016021~integral component of membrane,		IPR007237:CD20-like,IPR009281:LR8,					Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 176A,sequence variant,transmembrane region,
ENSG00000106565	transmembrane protein 176B(TMEM176B)	Homo sapiens				GO:0009887~organ morphogenesis,GO:0030154~cell differentiation,GO:2001199~negative regulation of dendritic cell differentiation,	GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,		IPR007237:CD20-like,IPR009281:LR8,					Alternative splicing,Complete proteome,Differentiation,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 176B,modified residue,sequence conflict,sequence variant,transmembrane region,
ENSG00000206140	transmembrane protein 191C(TMEM191C)	Homo sapiens					GO:0016021~integral component of membrane,							Coiled coil,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 191B,transmembrane region,
ENSG00000131634	transmembrane protein 204(TMEM204)	Homo sapiens				GO:0001945~lymph vessel development,GO:0030947~regulation of vascular endothelial growth factor receptor signaling pathway,GO:0051145~smooth muscle cell differentiation,	GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0016021~integral component of membrane,							Cell junction,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Stress response,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 204,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000167920	transmembrane protein 99(TMEM99)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 99,sequence variant,signal peptide,splice variant,transmembrane region,
ENSG00000105048	troponin T1, slow skeletal type(TNNT1)	Homo sapiens				GO:0003009~skeletal muscle contraction,GO:0006937~regulation of muscle contraction,GO:0014883~transition between fast and slow fiber,GO:0030049~muscle filament sliding,GO:0031444~slow-twitch skeletal muscle fiber contraction,GO:0045932~negative regulation of muscle contraction,	GO:0005829~cytosol,GO:0005861~troponin complex,	GO:0005515~protein binding,GO:0005523~tropomyosin binding,GO:0031014~troponin T binding,	IPR001978:Troponin,		605355~Nemaline myopathy 5, Amish type,			Acetylation,Alternative splicing,Coiled coil,Complete proteome,Muscle protein,Nemaline myopathy,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Troponin T, slow skeletal muscle,modified residue,sequence conflict,splice variant,
ENSG00000137941	tubulin tyrosine ligase like 7(TTLL7)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0007399~nervous system development,GO:0018095~protein polyglutamylation,GO:0030154~cell differentiation,	GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005929~cilium,GO:0030425~dendrite,GO:0043204~perikaryon,	GO:0005524~ATP binding,GO:0043014~alpha-tubulin binding,GO:0048487~beta-tubulin binding,GO:0070740~tubulin-glutamic acid ligase activity,	IPR004344:Tubulin-tyrosine ligase,					3D-structure,Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Ligase,Microtubule,Neurogenesis,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:Tubulin polyglutamylase TTLL7,domain:TTL,sequence conflict,splice variant,
ENSG00000076554	tumor protein D52(TPD52)	Homo sapiens				GO:0009653~anatomical structure morphogenesis,GO:0030183~B cell differentiation,GO:0046903~secretion,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0048471~perinuclear region of cytoplasm,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR007327:Tumour protein D52,					Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Tumor protein D52,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000198680	tumor suppressor candidate 1(TUSC1)	Homo sapiens												Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Tumor suppressor candidate gene 1 protein,compositionally biased region:Gly-rich,modified residue,sequence variant,
ENSG00000066056	tyrosine kinase with immunoglobulin like and EGF like domains 1(TIE1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001570~vasculogenesis,GO:0001701~in utero embryonic development,GO:0007165~signal transduction,GO:0007498~mesoderm development,GO:0016525~negative regulation of angiogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030336~negative regulation of cell migration,GO:0032526~response to retinoic acid,GO:0045026~plasma membrane fusion,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000742:Epidermal growth factor-like domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013032:EGF-like, conserved site,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,				SM00060:FN3,SM00181:EGF,SM00219:TyrKc,SM00409:IG,	Alternative splicing,Angiogenesis,ATP-binding,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase receptor Tie-1,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000036672	ubiquitin specific peptidase 2(USP2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0007517~muscle organ development,GO:0016579~protein deubiquitination,GO:0032922~circadian regulation of gene expression,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045475~locomotor rhythm,GO:0045931~positive regulation of mitotic cell cycle,GO:0048512~circadian behavior,GO:0048642~negative regulation of skeletal muscle tissue development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0050821~protein stabilization,	GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005938~cell cortex,GO:0048471~perinuclear region of cytoplasm,	GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0030332~cyclin binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					3D-structure,Alternative splicing,Biological rhythms,Cell cycle,Complete proteome,Cytoplasm,Hydrolase,Metal-binding,Myogenesis,Nucleus,Polymorphism,Protease,Reference proteome,Thiol protease,Ubl conjugation pathway,Zinc,	chain:Ubiquitin carboxyl-terminal hydrolase 2,helix,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000107731	unc-5 netrin receptor B(UNC5B)	Homo sapiens				GO:0001525~angiogenesis,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0033564~anterior/posterior axon guidance,GO:0043524~negative regulation of neuron apoptotic process,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,	GO:0005515~protein binding,	IPR000488:Death domain,IPR000884:Thrombospondin, type 1 repeat,IPR000906:ZU5,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR011029:Death-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa04360:Axon guidance,			SM00005:DEATH,SM00209:TSP1,SM00218:ZU5,SM00408:IGc2,SM00409:IG,	Alternative splicing,Angiogenesis,Apoptosis,Cell membrane,Complete proteome,Developmental protein,Disulfide bond,Glycoprotein,Immunoglobulin domain,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Netrin receptor UNC5B,disulfide bond,domain:Death,domain:Ig-like,domain:Ig-like C2-type,domain:TSP type-1 1,domain:TSP type-1 2,domain:ZU5,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Interaction with DCC,sequence conflict,sequence variant,signal peptide,site:Cleavage; by caspase-3,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000133958	unc-79 homolog (C. elegans)(UNC79)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0035264~multicellular organism growth,GO:0048149~behavioral response to ethanol,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR016024:Armadillo-type fold,IPR024855:UNC79,					Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein unc-79 homolog,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000177398	uromodulin like 1(UMODL1)	Homo sapiens				GO:0007338~single fertilization,GO:0010466~negative regulation of peptidase activity,GO:0010468~regulation of gene expression,GO:0042981~regulation of apoptotic process,GO:0048609~multicellular organismal reproductive process,GO:0060612~adipose tissue development,GO:0097211~cellular response to gonadotropin-releasing hormone,GO:2000354~regulation of ovarian follicle development,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,GO:0030414~peptidase inhibitor activity,	IPR000082:SEA domain,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001507:Zona pellucida domain,IPR001881:EGF-like calcium-binding,IPR003961:Fibronectin, type III,IPR008197:Whey acidic protein-type  4-disulphide core,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011489:EMI domain,IPR018097:EGF-like calcium-binding, conserved site,				SM00060:FN3,SM00179:EGF_CA,SM00217:WAP,SM00241:ZP,	Alternative splicing,Calcium,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Uromodulin-like 1,disulfide bond,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EMI,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:SEA 1,domain:SEA 2,domain:WAP,domain:ZP,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000182853	vitelline membrane outer layer 1 homolog(VMO1)	Homo sapiens					GO:0070062~extracellular exosome,		IPR005515:Vitelline membrane outer layer protein I (VOMI),					Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Polymorphism,Reference proteome,Secreted,Signal,	chain:Vitelline membrane outer layer protein 1 homolog,disulfide bond,sequence variant,signal peptide,
ENSG00000095397	whirlin(WHRN)	Homo sapiens				GO:0001895~retina homeostasis,GO:0007605~sensory perception of sound,GO:0010628~positive regulation of gene expression,GO:0021694~cerebellar Purkinje cell layer formation,GO:0045184~establishment of protein localization,GO:0050953~sensory perception of light stimulus,GO:0060122~inner ear receptor stereocilium organization,GO:1990227~paranodal junction maintenance,	GO:0001917~photoreceptor inner segment,GO:0002142~stereocilia ankle link complex,GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0030426~growth cone,GO:0032391~photoreceptor connecting cilium,GO:0032420~stereocilium,GO:0032426~stereocilium tip,GO:0036064~ciliary basal body,GO:1990075~periciliary membrane compartment,GO:1990696~USH2 complex,	GO:0005515~protein binding,	IPR001478:PDZ domain,		607084~Deafness, autosomal recessive 31,611383~Usher syndrome, type 2D,		SM00228:PDZ,	3D-structure,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Deafness,Hearing,Non-syndromic deafness,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,Signal,Usher syndrome,	chain:Whirlin,compositionally biased region:Ala/Gly/Ser-rich,compositionally biased region:Pro-rich,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000197134	zinc finger protein 257(ZNF257)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR026613:KRAB domain C2H2 zinc finger family,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 257,domain:KRAB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4; degenerate,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8; atypical,zinc finger region:C2H2-type 9,
ENSG00000124613	zinc finger protein 391(ZNF391)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 391,modified residue,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000170954	zinc finger protein 415(ZNF415)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003656:Zinc finger, BED-type predicted,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,SM00614:ZnF_BED,	Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 415,sequence variant,splice variant,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000142684	zinc finger protein 593(ZNF593)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR022755:Zinc finger, double-stranded RNA binding,				SM00451:ZnF_U1,	3D-structure,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 593,helix,sequence variant,strand,turn,zinc finger region:C2H2-type,
ENSG00000167554	zinc finger protein 610(ZNF610)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 610,domain:KRAB,sequence variant,splice variant,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000257591	zinc finger protein 625(ZNF625)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 625,sequence variant,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000182983	zinc finger protein 662(ZNF662)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 662,domain:KRAB,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
ENSG00000127903	zinc finger protein 835(ZNF835)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 835,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000152475	zinc finger protein 837(ZNF837)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 837,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
ENSG00000197385	zinc finger protein 860(ZNF860)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 860,domain:KRAB,sequence conflict,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13; degenerate,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000228623	zinc finger protein 883(ZNF883)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,
ENSG00000213988	zinc finger protein 90(ZNF90)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006412~translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005840~ribosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003735~structural constituent of ribosome,GO:0008270~zinc ion binding,	IPR000754:Ribosomal protein S9,IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR015880:Zinc finger, C2H2-like,IPR020568:Ribosomal protein S5 domain 2-type fold,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 90,domain:KRAB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; degenerate,
ENSG00000179588	zinc finger protein, FOG family member 1(ZFPM1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002295~T-helper cell lineage commitment,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003192~mitral valve formation,GO:0003195~tricuspid valve formation,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0010724~regulation of definitive erythrocyte differentiation,GO:0030218~erythrocyte differentiation,GO:0030219~megakaryocyte differentiation,GO:0030220~platelet formation,GO:0030851~granulocyte differentiation,GO:0032091~negative regulation of protein binding,GO:0032642~regulation of chemokine production,GO:0035162~embryonic hemopoiesis,GO:0035855~megakaryocyte development,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045403~negative regulation of interleukin-4 biosynthetic process,GO:0045599~negative regulation of fat cell differentiation,GO:0055008~cardiac muscle tissue morphogenesis,GO:0060318~definitive erythrocyte differentiation,GO:0060319~primitive erythrocyte differentiation,GO:0060377~negative regulation of mast cell differentiation,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0071733~transcriptional activation by promoter-enhancer looping,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein ZFPM1,modified residue,region of interest:Interaction with CTBP2,region of interest:Interaction with TACC3,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2HC-type 1,zinc finger region:C2HC-type 2,zinc finger region:C2HC-type 3,zinc finger region:C2HC-type 4,zinc finger region:C2HC-type 5,
